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CHAPTER ONE
INTRODUCTION AND LITERATURE REVIEW

Introduction
Molecular archeologists have uncovered trace evidence to suggest that
early during evolution the first form of genetic information was the self-replicating
RNA molecule (Doudna and Cech, 2002). Despite the lack of direct physical
evidence, this is not hard to believe especially given the wide variety of RNA
tertiary structures and their ability to carry out heterogeneous enzymatic
reactions. As early RNA molecules self-replicated, mutations must have been
introduced that improved the fitness of the molecules (Joyce, 2002; Doudna and
Cech, 2002).
It is estimated that the dominance of the RNA world ended almost four
billion years ago (Joyce, 2002). The exact selective pressure that favored the
evolution of the heritable genetic material from RNA to DNA is unknown. Perhaps
as the environmental milieu continued to change so too did the chemistry of
RNA until it evolved into its more stable relative, DNA. A possible mechanism of
DNA evolution may be based on an RNA template, as is the case in cilate
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genome replication. Studies on genomic replication in the cilate Oxytricha trifallax
researchers have uncovered a unique role for two forms of RNA: small RNAs
and long macronuclear RNA. Two nuclei exist that house the genomic DNA,
albeit in different forms. The mirconucleus is small in volume and envelops
germline DNA. The larger macronucleus contains fragmented genomic DNA, or
somatic DNA, in copies as high as 1000 copies per of individual gene. Genes in
the micronucleus are “scrambled” whereas DNA in the macronucleus is
organized to code for complete genes. It is postulated that small RNAs in the
micronucleus bind to short repeat sequences (or “pointers”) that aid in correctly
joining the gene fragments resulting in sense DNA. During development DNA in
the parental macronucleus is transcribed to produce long macronuclear RNAs,
which then provides the template for unscrambling the DNA strands in the
developing macronucleus (Mochizuki, 2010 and Nowacki et. al., 2008). The
process of RNA-directed reorganization of DNA also occurs in Tetrahymena
thermophila and the mitochondrian of Diplonema papillatum. Circumstantially, the
RNA-directed editing of genomic DNA may be the same mechanism of how
nucleotides evolved into the more stable DNA strand of ancestral simple
eukaryotes and, thus, multicellular organisms. Though the RNA-dominant world
has long been extinct, the importance of RNA in biological processes remains
evident (Joyce, 2002).
Today, the Central Dogma of biology states that the genetic content of
DNA is converted, or transcribed, into messenger RNA (mRNA) (Crick, 1970).
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The information contained within the mRNA is then translated into protein.

Regulation of the transcription process is essential to ensure that genes are
appropriately expressed, i.e. at the right time, in the correct location, in the
required amount, and in coordination with the proper subset of associated genes.
(Lewin, 1997; Little, 1999; Alberts, 1994)
Why study transcription? First, the inability to properly regulate
transcription often disrupts cellular homeostasis, which can lead to undesirable
events, such as disease or the loss of organismal fitness (Lewin, 1997; Alberts,
1994; Calkhoven, 1996). To understand how improper transcription impacts the
etiology of disease or the ability of cells to survive adverse environments, we
must understand how cells normally regulate transcription. Furthermore, the
exploration of transcription in both eukaryotes and bacteria has implications for
understanding evolution gene regulation (Ooi and Wood 2008; Lee et al, 2007;
Cattaneo, 2005; and Dozois, et al, 2002). The more we learn about both the
common themes and the differences of transcriptional control in both kingdoms,
the closer we come to uncovering clues about transcription in our common
ancestors.

For example, the principles that govern the initial barrier to

transcription are the same – in both kingdoms, increases or decreases of DNA
twisting are required for gene silencing or gene transcription, respectively
(Travers and Muskhelishvili, 2007). Finally, the more we learn about the rules of
gene regulation, the better we are able to design transcription-based therapies to
treat devastating diseases such as cancer, to devise strategies to defeat
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antibiotic resistant bacteria, or to construct semi-synthetic gene circuits to

perform desired functions. For example, one might modulate access to a
promoter region or use a small molecule to disrupt a critical protein-DNA
interaction (Hsu et. al., 2007; Pandolfi, 2001).

The Process of Transcription
In general, the process of transcription is the same for eukaryotes,
archaea, and bacteria. Transcription takes place in four stages. The first step
requires that RNA polymerase (RNAP) bind to promoter DNA, forming a binary
protein/DNA complex known as the closed complex (CC). Once RNAP binds to
the promoter, the DNA strands unwind (a process known as promoter melting or
isomerization). The result is known as the open complex (OC). Now,
ribonucleotides enter the RNAP, which begins to synthesize RNA using the sense
strand of DNA as the template. The result is a short RNA transcript. This protein/
DNA/RNA ternary complex is called the initiation complex (IC). Such short
transcripts often abort. If so, the initiation process re-starts. If, however,
transcription continues, the nucleoprotein complex dramatically alters its
conformation, becoming the extremely processive form known as the elongation
complex (EC). Polymerization of mRNA, or transcription, continues until
termination signals/structures are encountered (Wolfe, 2008; Higgins, 2005)
(reviewed by Rosenberg and Court, 1979).
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Transcription can be enhanced or inhibited at any of these steps, but most
often regulation occurs at one or more of the first three steps and is most often
mediated through the binding of positive or negative regulators. These regulators
can bind to sequences that overlap the promoter or bind to sequences positioned
either upstream or downstream of the promoter. As such, transcription regulation
depends on two distinct features: 1) sequences within the DNA (known as cis
elements) and 2) the proteins that bind to those sequences (known as trans
factors). Mutations that affect either cis elements or trans factors can result in
debilitating defects in eukaryotes and bacteria alike (Ooi, 2008; Kadonaga,
2004).

Transcription and Human Disease
A disruption in transcription can result in an imbalance in cellular
homeostasis, which can lead to metabolic inefficiency, arrest of cell maturation,
reduced fitness, and cell or organismal death. Many severe human diseases
result from aberrant gene expression (Pandolfi, 2001). Some of these diseases
are attributed to mutations in cis elements, while others are attributed to
mutations in trans factors. I will now describe a few examples of both.
Mutations in the gene that encodes a trans factor can disrupt the normal
function of that protein. For example, Huntington disease is a debilitating
neurodegenerative disorder that manifests itself when the normal huntingtin

6

(HTT) gene acquires mutations that magnifies its endogenous CAG repeat
(Scherzer, 2008; Cattaneo, 2005). The resulting mutant huntingtin gene (mHTT)

contains greater than 37 CAG repeats. Since CAG encodes glutamine, this
magnification results in an extended polyglutamine or polyQ tract in the mutant
protein, known as mHTT. Normal HTT functions in numerous cellular processes,
such as protein degradation and gene transcription. The extended polyQ tract of
mHTT interferes with these processes. For example, the extended polyQ tract of
mHTT disrupts its own N-terminal nuclear export sequence (NES). This
interference results in a buildup of mHTT proteins in the nucleus. The nuclear
localization of mHTT, specifically its extended polyQ domain, disrupts
transcription. This is because many transcriptional regulators contain glutaminerich domains that mediate the interaction between transcription factors and other
transcription-associated proteins. mHTT proteins disrupts these interactions,
possibly by sequestering the transcription factor (Kadonaga, 2004; Imarisio,
2008).

For example, CBP [CREB binding protein] is an important bridging

protein (co-transcriptional activator) that is proposed to link the DNA-bound
CREB transcription factor to the general transcriptional machinery. CBP activity is
required for expression of neuron survival signals through its histone
acetyltransferase function (Lu et. al., 2003). This activity decondenses the
histone/DNA complex, allowing RNAP and transcription factors to gain access to
the promoter region. The C-terminal region of CBP contains a polyQ stretch that
mediates the interaction between CBP and CREB. mHTT protein sequesters
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CBP, inhibiting DNA access and preventing transcription (Scherzer, 2008;
Cattaneo, 2005).
Mutations in the promoter sequence may also alter gene expression. The

etiology of Alzheimer’s Disease (AD) is attributed to the buildup of a spliced
version of the full-length amyloid precursor protein (APP) – the 44 amino acid
long amyloid ! (A!) variant. Many tissues express APP, with the highest
concentrations found in CNS neurons. Buildup of the A! variant form aggregates
in brain tissue, creating plaques and causing mental deterioration of the patient
(Sakanyan, 2005). Typically, the plaques are the result of increased splicing of
the full-length APP protein mediated by a mutation in the gene changing a key
amino acid from valine 717 to an isoleucine 717. Recently, however, Theuns et
al. (Theuns et al, 2006) identified a mutation in the APP promoter region of
patients exhibiting early onset stages of AD. They report that this mutation results
in increased APP gene expression, leading to increased APP protein production,
and a greater concentration of the A! variant. This mutation in the promoter
region leads to AD disease progression, mirroring that of the disease mediated
by the V717I mutation (Theuns et al, 2006; Theuns et al, 2000). Thus, this study
has identified an alternate source of AD etiology that arises from a mutation in
the app promoter region rather than from a mutation in the gene itself.

Transcription in Bacterial Pathogensis
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Likewise, bacteria regulate gene expression at the level of transcription.
This regulation occurs in response to both external and internal signals that
converge to aid in directing the transcription of genes needed to adapt to and
survive changes in the bacterium’s environment, such as the depletion of
nutrients, the presence of antibiotics, and exposure to the host immune system.
For example, the resultant alteration in gene program can result in the formation
of differentiated bacterial entities, e.g. biofilms, fruiting bodies, or spores, formed
to withstand harsh environmental conditions (Dorman and Corcoran, 2008;
Kroos, 2007).
Of particular interest is the survival of pathogenic bacteria in an animal
host. Entry into a host exposes the bacterial pathogen to nutrient-limiting
conditions, a low-pH environment, and antigen exposure to the immune system.
To survive in the host, the pathogen must express genes that encode virulence
proteins used to alter its immediate environment for survival such as
permeabilizing the membrane (membrane ruffling) or immunosuppression. Such
virulence genes must be precisely regulated to ensure proper expression. To
achieve this goal, bacteria have evolved sophisticated signaling networks and
transcriptional machinery that permits them to differentiate between their in vitro
and in vivo environments and to properly regulate the genes required for each
environment (Kroos, 2007).

9

The machinery required to process the multitude of environmental signals
and to properly transcribe a given gene often involves many signaling pathways
that pass signals to multiple transcription factors that control gene expression
from multiple promoters. Pivotal to this process is the constellation of DNA
remodeling proteins, also known as histone-like proteins or nucleoid-associated

proteins (NAPs) (Higgins, 2005; Cotter, 2000). Like eukaryotic histones, these
NAPs bind, fold, and package the DNA. As such, they participate intimately in
conformation-dependent processes including genome replication and the
regulation of transcription. Of particular interest is the small heterodimeric DNA
remodeling NAP, IHF (Integration Host Factor; ~21 KDa). IHF appears to be a
key regulator of genes located on pathogenicity islands of Enteropathogenic
Escherichia coli (EPEC) and Enterohemorrhagic Escherichia coli (EHEC), as well
as the invasion-specific genes of Shigella flexneri (Baron, 2007; Tseng et al,
2009). The ability of IHF to remodel DNA and its affects on the function of
proteins bound to the promoter region is the major focus of my dissertation.
Often, the remodeling of DNA topology by NAPs provides the appropriate
DNA conformation to allow or disallow the binding of a transcription factor to its
DNA site. Alternatively, NAPs can mediate the bringing of a transcription factor
into close proximity with RNAP to permit a required protein-protein contact
(Higgins, 2005; Ohniwa, 2006). Two well-studied transcription factors, FNR and
CRP, regulate the transcription of genes that encode proteins responsible for
survival under very specific conditions. For example, the homodimeric FNR
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(fumarate and nitrate reduction; ~30 KDa) is a homodimeric transcription factor

that responds to the environmental concentration of oxygen and, in response,
regulates genes required for cell survival under anaerobic conditions. The
functional status of FNR depends on the state of its oxygen labile [4Fe-4S]2+
cluster (Kiley and Beinert, 1998). Not only is the [4Fe-4S]2+ cluster important to
the dimerization of FNR subunits, but it also behaves as the protein’s oxygen
sensor. In the presence of oxygen (i.e., an aerobic environment), the [4Fe-4S]2+
cofactor undergoes oxidation to [2Fe-2S]2+, losing two Fe and S2- atoms, leading
to a conformational change that eliminates DNA binding to its site (Kiley and
Beinert, 1998). The reduction of FNR to its protein subunits thus results in
deregulation of all FNR-dependent genes/operons. The complete depletion of
oxygen from the environment (i.e., an anaerobic environment) restores the
[4Fe-4S]2+ cofactor and thus the ability of FNR to bind to its DNA sites in the
promoter regions of its regulon members. Expression of these genes permits the
cell to adapt to an anaerobic environment, in part, by facilitating fermentation and
anaerobic respiration (Ratledge and Dover, 2000). Additionally, FNR has been
implicated as a virulence factor. During a Neisseria meningitidis serotype B
(MenB) infection, the host immune system attempts to clear the invading
pathogen by cell-mediated and humoral-mediated immunity. Cell-mediated
clearance of a MenB infection involves phagocytosis by macrophages and the
production of small molecule antimicrobials such as nitric oxide (NO). It is under
these harsh conditions that the pathogen encounters environments with varying
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concentrations of oxygen. To withstand the armament of host weaponry, N.

meningitidis must switch from aerobic metabolism to anaerobic metabolism to
survive within the host. This transition from aerobic to anaerobic respiration is
mediated by FNR. Deleting fnr attenuates MenB virulence in mice, suggesting
that successful MenB disease progression requires FNR and thus at least some
members of its regulon (Bartolini et. al. 2006).
Like FNR, the closely related transcription factor, CRP (Cyclic AMP
Receptor Protein, also known as Catabolite Activator Protein or CAP), controls
the expression of greater than 150 genes in response to the availability of
catabolite-repressing carbon sources, e.g. glucose. In the absence of glucose,
the concentration of cyclic AMP (cAMP) rises (Lewis, M. 2005; Wolfe, 2008;
Kumari et al, 2000). This second messenger binds to the CRP dimer, altering its
conformation, and thus activating it for binding to its DNA site. Thus, the binding
of cAMP permits CRP to participate in important protein-protein interactions
(Reddy et al, 2009; Tan et al, 1991). These interactions are central to this
dissertation.

Mutations that Alter Transcription
As described previously, mutations that alter transcription may occur in
either the DNA sequence (cis elements) or the proteins that bind those
sequences (trans factors). Mutations in the promoter can specifically affect the
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binding and/or function of RNAP. Mutations in a DNA binding (DNAB) site can

specifically influence the binding or function of an associated transcription factor.
Finally, mutations can alter the overall structure of DNA and indirectly impact the
binding of both RNAP and transcription factors (Ohniwa, 2006; Higgins, 2005;
Dorman and Corcoran; 2008; El Sharoud, 2008; Hardy, 2005). Mutations in these
cis elements generally affect only the transcription of the downstream gene or
operon. For this reason, mutations in cis elements are preferable when studying
the function of a global regulator at a particular promoter, such as the focus of
this dissertation, the acs promoter.
In contrast to mutations in cis elements, mutations in trans factors may
influence the transcription of multiple genes. This is particularly true if the trans
factor functions globally. For example, mutations in RNAP that influence its ability
to properly move through the steps of transcription are expected to exert an
adverse effect on global transcription. Depending on the severity of the defect,
such a mutation could be lethal (Hermsen, 2006; Hardy, 2005). Similarly, a
mutation in a transcription factor (e.g. CRP) or a NAP (e.g. IHF) that exerts its
influence globally would be expected to cause a global defect. Because such a
mutation would be expected to impact a large number of genes directly and/or
through its ability to alter the overall structure of the nucleoid, dissection of a
given promoter is best performed with cis mutations that specifically alter the
binding of a trans factor to the promoter region itself and not by deletion of the
global trans factor itself.
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In contrast, a mutation in a transcription factor (e.g., the Lac repressor),

whose activity is limited to one or a small subset of promoters, would likely exert
a more local effect (Fried and Crothers, 1981). For example, a mutation in a local
negative regulator might be expected to result directly in constitutive expression
of its regulated gene(s). Conversely, a mutant local activator that has lost its
ability to stably bind to its DNA site within a given promoter would be expected to
result in the loss of transcription from that promoter.
Finally, mutations in a transcription factor or a NAP could affect any of the
its multiple functions, including the binding of a ligand (e.g., cAMP) or covalent
modification (e.g. phosphorylation or acetylation), oligomerization, DNA binding
or bending, and/or the interaction of the transcription factor with RNAP (MartinezAntonio, 2003). The severity of any particular mutation will depend upon the
importance of the affected gene(s).

Bacterial Transcription: the Textbook View
The typical textbook shows bacterial transcription to be rather
uncomplicated, especially in contrast to eukaryotic transcription (for example, see
Lewin, 1996). The structure of bacterial DNA is often depicted as a simple linear
“naked” structure, primarily unbound by proteins. However, this is not the
biologically relevant conformation. The binding of proteins to DNA to form
nucleoprotein complexes is essential to change the “linear” state of DNA to a
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biologically relevant conformation is required for such processes as DNA

replication, repair, recombination, and transcription (Higgins, 2005; Rice, 2008).
The topological changes of DNA can take many conformations due to the
pliability of its phosphate backbone and the base-stacking properties of its
nucleosides (Sinden, 1994; Rice, 2008). DNA can be contorted into a variety of
topologies by DNA binding (DNAB) proteins that package DNA by bending,
twisting, and spooling the overwhelmingly long genomic DNA (1 m in eukaryotes
and 1.7 mm in eubacteria) into the eukaryotic nucleus or the bacterial nucleoid.
A similar process permits the packaging of viral DNA into the space-limiting
nucleocapsid (Campos, 2009). The bending, twisting and spooling of DNA by
DNAB proteins do not just mechanically package DNA into a small space but
also protects the genome from nucleases and other destructive forces.
Additionally, these protein-induced alternative states of DNA participate in the
regulation of other DNA metabolic processes, including transcription (Lewin,
1996; Campos, 2009). Some of the proteins involved in DNA compaction and
transcription regulation in bacteria and eukaryotes are quite similar; for example,
HU of bacteria is a functional homolog of the histone H1 of eukaryotes. Most,
however, differ quite dramatically. Yet, the general themes of DNA binding and of
base pair stacking require the same four nucleotides: adenine, cytosine, guanine,
and thymine.

Adenine, Cytosine, Guanine, Thymine, and Base Pair Stacking
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All processes that involve DNA depend on its primary structure. This is
particularly true for the mechanisms that regulate transcription. The fundamental
impact on the structure and function of DNA involves the atoms that make up the
bases, the base pair interactions, and the sugar-phosphate backbone. The
structure, elasticity, polarity, and durability of DNA are due to the base pair
stacking of the adenine (A), cytosine (C), guanine (G), and thymine (T)
nucleotides in conjunction with the sugar-phosphate backbone. The overall
stability of DNA, provided by the nitrogenous bases and the sugar-phosphate
polymer, make it the ideal carrier of genetic information (Rice, 2008; Benham and
Mielke, 2005).
Sitting on the outer portion of the DNA helix is the sugar-phosphate
backbone. Due to the phosphate moiety that covalently links the 5’-OH of one
nucleotide sugar to the 3’-OH of the next nucleotide sugar (the so-called
phosphodiester bond), DNA has an overall negative charge (Sinden, 1994; Rice,
2008). The negative charge of the sugar-phosphate backbone renders it
conducive for attracting positively charged DNA binding proteins, such as
eukaryotic histones and bacterial NAPs. These proteins, when bound to DNA,
introduce the structural bends required for most DNA metabolic events (Rice,
2008; Higgins 2005). Though the phosphate moiety is a rigid tetrahedron in
nature, the binding of carbon to the oxygen atoms provides free rotation about
the phosphorous-oxygen bond. The individual nucleotide is rigid, but in a polymer
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the nucleotides have “indirect rotational flexibility” (Travers and Thompson,

2009). Therefore, the longer the DNA strand, the more overall is its flexibility. In
addition to providing the backbone for base stacking and general elasticity, the
alternating 5’ and 3’ sugar phosphate moieties give DNA directionality, or polarity
(Sinden, 1994; Travers and Thompson, 2009).
The phosphate moiety is bound to a sugar, which is then bound to a
nitrogenous base. Unlike the sugars and phosphates, the nitrogenous bases of
the nucleotides are insoluble in water. Thus, the hydrophilic sugar-phosphate
backbone of DNA is exposed to water, while the hydrophobic bases are hidden
away (Sinden, 1994). The insoluble nature, or hydrophobicity, of the nitrogenous
bases is the driving force behind the antiparallel DNA helix formation. The
Watson-Crick base pairing between A:T, T:A, G:C, and C:G bases fit into the
DNA helix much like stairs of a winding staircase. The twisting staircase structure
is the consequence of the hydrophobic bases shying away from the aqueous
environment in an effort to exclude water molecules from the DNA core (Sinden,
1994; Benham and Mielke, 2005). Since the base pairs cannot stack directly on
top of one another the bases twist slightly. The slight rotation of the DNA ladder
occurs because the length between phosphate moieties along the sugarphosphate chain is twice as long as the thickness of the bases. Though the
sugar-phosphate chain mediates the slight twist in base pair stacking, it also
limits the degree of rotation by providing a scaffold that holds the bases in place
(Sinden, 1994).
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The nucleic acid sequence of DNA plays a role in determining its overall

structure, specifically the effects of base pair stacking. Since the nitrogenous
bases attempt to minimize contact with water, they adopt the propeller twist
conformation (Rice, 2008; Sinden, 1994; Hassan and Calladine, 1996). The DNA
helix structure is determined at the atomic level by several parameters of base
stacking within them. Of these parameters, three are considered when analyzing
B form DNA, i.e. flexibility, translation, and rotation (Sinden, 1994). The flexibility
of DNA owes itself to the movement of the nucleotide bases and their stacking in
the helix. Bases encapsulated within the helix have six variables of positioning or
‘degrees of freedom’. This positioning falls under two categories: translation and
rotation. Translation is the movement of a base in any direction without rotation.
Discussion about translation movement is commonly limited to the X, Y, and Z
planes. In contrast, the rotation of a base involves twisting, rolling, and tilting
about the long and short axes of the base. To describe these movements and
their relation to a base pair step, the nitrogenous bases will be referred to as
blocks for simple illustration. Also, the sugar-phosphate backbone will not be
considered, but serves as the framework for positioning the bases (Hassan and
Calladine, 1996) (see Figure 1).
Translation positioning is the movement of a block in an X, Y, and Z threedimensional grid. The block may move vertically along the Y-axis. The base may
move into and out of the 2-D plane along the Z-axis. And finally it may move
laterally along the X-axis. The movement along the X-axis is described as the
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sliding (slide = S) of one or both blocks in relation to one another. Since block
movement in both the Y and Z directions is impeded through their covalent
attachment to the sugar-phosphate backbone, the current discussion will involve
only sliding (Rice, 2008; Bloomfield, 2000).

The three parameters of rotation used to describe the relative positions of
bases are twist, roll, and tilt. Blocks may twist about their short axis – the axis
running from top to bottom when the block is viewed from the broad side facing
into the hydrophobic core of the helix. The effect of rolling describes the position
of the side edge of the base, again when viewed on the broad side, in relation to
the horizontal axis. When the broadside of the base moves above or below, there
is either a positive or negative change in the angle relative to the horizontal
plane. Tilting is an angular change of a base relative to the vertical plane. Though
these parameters are real considerations when studying the position of base
steps relative to one another, the real world situation introduces constraints to
tilting. Therefore, further discussions of base pair step rotation will only be done
so using twist (T) and roll (R) (Sinden, 1994; Hassan and Calladine, 1996;
Bloomfield, 2000).

Base Pair Steps
So far, the translation and rotation parameters for block orientation have
been described for a single base. However, in the DNA helix, the bases are
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ordered one after another. Therefore, the change in position of one base affects

the neighboring bases. To better understand these relationships, we will consider
two base pairs (four bases in all or two pairs of complementary bases) aligned
one above the other, or a base pair step. The sugar-phosphate backbone will not
be considered in this discussion, but the parameters are applied to the confines
of the double helix. In addition to the backbone limiting base movement, the effort
to exclude water between bases or avoid the creation of a vacuum also restricts
movement and degree of this motion. The movement of the base pair step only
encompasses three of the six
parameters mentioned above:
the rotations roll (R) and twist
(T), and the translation slide
(S). When the R, S, and T
values are zero (i.e., when
there are no changes in the
position of either base), then
the bases overlap perfectly in
the dinucleotide step as
depicted in Figure 1A. Any

Figure 1. Dinucleotide Slide and Twist. (A) Depicts the
dinucleotide Slide movement in the direction of the long axis of
each base relative to its immediate base neighbor. (B) The
Propeller-Twist conformation of dinucleotide base pairs, placing
one base out of plane relative to its base partner. (Modified
from Hassan and Calladine, 1996).

permutations in the R, S, or T
parameters, thus, affect the position of the neighboring base (Postow, 2005;
Patel et al, 1983; Delmonte, 2003; Sponer et al, 1997).
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The twist parameter is properly defined as the rotation of a base about the
local twist axis running vertically through two nearby bases. Base twisting
provides the helical ladder of DNA, contributing an estimated 34.3° per base for
10.5 bases, or one turn of B form DNA. Since B form DNA is not the only
structure present within a cell, the number of bases per turn of DNA is considered
to be 11±1 bases. However, with no changes in the R or S values, each base is
estimated to “twist” by 36° (i.e., as you move one base at a time up the DNA
helix, the consecutive bases will be off-angle by 36°) (Sinden, 1994, Bloomfield,
2000). The value of the twist parameter is not uniform for the entire molecule. For
example, the T value for folded DNA will differ from circular DNA. The twist angle
is sensitive to base stacking and other helical forces (Bauer, 1993; Bauer, 1995).

Importantly for this dissertation, protein binding to DNA also affects the twisting of
DNA in order to accommodate the protein/DNA interaction.
The second rotation important for base motion with the DNA helix is the
roll parameter. Rolling results in the movement of a base that changes the
position of the broad side of the base in relation to the horizontal plane, or long
axis. The roll angles may vary from +20° to -10° in the B form DNA helix. Any
rotation upward towards the minor groove is considered positive, as depicted in
the right block of Figure 1B, and a rotation downward towards the major groove
is negative (Sinden, 1994; Rice, 2008).
The single translation parameter discussed here is base slide. This is the
lateral motion of a base along the X-axis relative to a neighboring base. If the
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upper pair of bases in a dinucleotide step moves further to the left of the vertical
axis than does the lower base pair, then this movement is considered positive.
Base pair movement towards the right of the vertical axis is given a negative

value. The values for these types of base shifts may range from +3 Angstrom to
-2 Angstrom. The sugar-phosphate chains limit the slide for a base pair in a
dinucleotide step (Sinden, 1994; Rice, 2008).

The Propeller Twist
DNA base pairs rarely occupy the same plane. Therefore, the roll angles
of the aromatic rings of the base pairs are slightly different. This gives them a
conformation similar to an airplane’s propeller-twist (Sinden, 1994; Hassan and
Calladine, 1996). This propeller-twist base conformation is the most common
base position in a DNA helix. The propeller-twist maximizes base stacking
interactions with the neighboring base, but lengthens the DNA strand and
weakens Watson-Crick hydrogen bonds. Because base stacking tends to
assume the propeller-twist conformation, it has been suggested that the
sturdiness of the DNA duplex can be attributed more to the stabilization energy
provided by base stacking than by the energy provided by Watson-Crick
hydrogen bonds (Hassan and Calladine, 1996; Mohan, 1992). Importantly for this
dissertation, the propeller-twist base pair conformation plays a key role in protein/
DNA interactions because it best accommodates the changes in base pair
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stacking and the torsional strain introduced by DNA binding proteins without
completely disrupting the helix.

The DNA molecule must be flexible and elastic enough to withstand these
changes without unraveling (Sinden, 1994; Calladine, 2004). Take for instance
the binding of the minor groove binding protein IHF. This NAP protrudes a proline
into the DNA, thus disrupting the local base pair stacking. If the bases were
unable to alter their stacking positions and depended solely on Watson-Crick
hydrogen bonds, then this proline-mediated disruption would most likely induce
strand separation, leading to inefficient protein-DNA interactions, and limiting the
effects of IHF binding. Fortunately, base pair stacking is the major stabilizing
force and the bases are able to twist, roll, and slide to adjust (Sinden, 1994;
Ramakrishnan, 1993).

Finally, it should be noted that translation and rotation

values differ in regions with different sequences. For example, a region of DNA
containing a stretch of A’s will have a sequence-induced bend, whereas a unique
sequence containing a mixture of all four bases will not (Patel, 1993; Haran,
2009).

Genome Compaction
The ability of DNA molecules to absorb topological changes are credited
to the sugar-phosphate backbone and base stacking. Though the shape of DNA
is easier to appreciate as a 2-D diagram or a linear ball and stick model, its true

23

nature within the cell is a folded, more compact, supercoiled structure that

contains many regions of looped domains (secondary structure). The folding and
unfolding of DNA in both bacteria and eukaryotes determines whether the
transcriptional machinery gains access to a promoter region. Promoter access is
governed not only by the topology of naked DNA, but also by the proteins that
bind to DNA and alter its configuration (Higgins, 2004; Akyol, 2009). In
eukaryotes, proteins called histones fold the genome, compacting it into a form
that can fit within the nucleus. To achieve compaction, these large protein
complexes spool DNA around themselves and interact with each other. By
condensing DNA, histones physically hinder the ability of RNAP to bind to the
promoter and transcription factors to bind to their respective DNA sites. By
controlling the degree of compaction, therefore, histones function as gatekeepers
that determine access to the promoter.
Bacteria also must package their genome into a limited space. To achieve
this, they use NAPs, which possess many of the same properties of histones and
function in a similar, but not identical, manner (Higgins, 2004; Sherrat, 2003).
Below, I will describe the process by which histones and NAPs compact their
respective genomes.

Compaction of the Eukaryotic Genome
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The eukaryotic genome undergoes many different levels of compaction.
The most basic level of compaction consists of the natural structural folds
constituted by intrinsic base pair interactions, forming the B-DNA double helix,
and by the intracellular density (also called molecular crowding – a physiological
phenomenon important for all cellular processes). Base pair stacking, as a result
of hydrophobic interactions between the nucleic acid bases, along with the
phosphate backbone interaction with environmental water molecules, give rise to
the B-DNA structure. Human DNA measures over 2 meter in length when all 46
chromosomes are stretched out from end to end. But the maximum cell size
measures 100 !m, with the nucleus measuring 10 !m. To compact the 2 meter
DNA into the cell nucleus, the genome undergoes a 10,000-fold reduction
(20,000 fold is the most) in volume.
The eukaryotic cell overcomes the size and volume barrier to package an
enormous amount of DNA into the confined space of a cell by first wrapping the
thin strands of negatively charged DNA around basic proteins (Campos, 2009).
These conserved basic DNAB proteins (histones) package the DNA into a tight
structure described as “beads on a string”. This term describes the wrapping of
the DNA strand around the histone octamers – a structure unique to eukaryotes –
at 150 bp intervals. The histone proteins associate with DNA in a sequenceindependent manner to form a nucleosome core particle (Fig. 2). Each octamer
core, composed of histones H2A, H2B, H3 and H4, is tethered by 50 bp of
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“linker” DNA, hence the “beads-on-a-string” description. This DNA structure is
then further compacted by creating loops of the protein-DNA beads.

The continuous spooling of DNA around core histones decreases the total
length by 7-fold, while increasing the diameter by 5-fold (the diameter of linear
naked DNA is 2 nm, while the diameter of the ‘beads-on-a-string’ structure is 10
nm) (Figure 2) (Lodish, 2003). This primary nucleosome-DNA structure is further
compacted through the interaction between the histone-associated protein H1
and the DNA strand that exits the H2A+H2B complex, creating a 30 nm hollowedsolenoid structure (Fig 2). Together, the 7-fold DNA compaction of the primary
nucleosome-DNA structure and the 6-fold solenoid compaction compacts naked
DNA by about 40-fold.
The final nucleoid structure places the 30 nm DNA-histone solenoid onto a
chromosome scaffold consisting of protein lamins and topoisomerases. Lamins
function as the structural foundation onto which the solenoid DNA lays. In
contrast, toposiomerases associated with the chromatin relieve any supercoiling
tension introduced by packaging and keeps the DNA solenoid intact during
mitosis (Lodish, 2003). Thus, ultimately, the eukaryotic DNA undergoes a
reduction in size of approximately 10,000-fold. This extreme packaging is
necessary to fit into the double membrane nucleus, a structure that also limits
protein/transcription factor access to the nucleoid.

Compaction of the Bacterial Nucleoid

26

Early TEM studies made clear the evident discrepancies between
eukaryotes and bacteria (e.g. the size differential and the presence of a double
membrane enclosure for the eukaryote’s genome and lack thereof for that of the
bacterium) (Higgins, 2004). However, these studies also made clear the curious
fact that the bacterial genome displayed some degree of order despite the
absence of a dedicated organelle to enforce organization. Current images
rebuffed earlier expectations of a widely dispersed bacterial genome with no
sense of morphology (Eltsov and Zuber, 2006).
The bacterial genome (or nucleoid) is localized in a structurally undefined
region within the cell. It is not
encapsulated within a
membrane, a defining hallmark
of eukaryotic cells. The length
of the bacterial genome
measures about 1.7 mm, while
the length of a typical bacterial
Figure 2. Histone-Mediated DNA Compaction. Histone
octameric core spools DNA, creating a nucleosome, ultimately
compacting genomic DNA into a 30 nm solenoid structure.
(Adapted from Molecular Cell Biology, 1999).

cell, e.g. E. coli, is 3 !m long.
This is a size discrepancy of
approximately 1000-fold,

which is similar to that of eukaryotes. As with compaction of the eukaryote
genome, macromolecular crowding contributes to the maintenance of bacterial
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genome compaction (Higgins, 2004; Azam, 1999). Gentle lysis of E. coli cells

releases the nucleoid, revealing strands of DNA 10 times the length of its
intracellular size (Kavenoff and Bowen, 1976). More recent studies have shown
that nucleoid-associated proteins (NAPs) mediate much of the rest of the
compaction (Higgins, 2004; Swinger and Rice, 2007).
It is now clear that the bacterial genome is organized much like the
eukaryotic genome and that it undergoes morphological changes similar to that
of the eukaryote genome (Thanbichler et. al., 2005). Just as the density of the
eukaryotic genome changes as its proceeds through the cell cycle (G1, S, G2,
and M), the density of the bacterial genome correlates with the different phases
of bacterial growth. For example, the bacterial nucleoid of actively growing and
dividing cells (e.g. those in the exponential phase of growth) looks like a
collection of loose 30 nm fibers, not unlike the 30 nm DNA-histone solenoid of
the typical eukaryote. As cells slow their rates of growth and division (i.e., during
the transition to stationary phase), the nucleoid begins to condense, forming a
structure that resembles coral. In contrast, the nucleoid of relatively inert cells
(e.g., those in late stationary phase) is an extremely compact electron dense
structure that in many ways resembles the condensed mitotic chromosome (Kim
et al., 2004; Travers and Muskehelishvili, 2005). Like the eukaryotic genome, the
bacterial nucleoid forms these increasingly compact structures by the formation
of topologically isolated DNA loops. These loops are negatively supercoiled, a
fact of vital importance for DNA metabolic events, e.g. transcription. Contained
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within these loops is stored free energy introduced by the torsional tension that

results from supercoiling. Relaxation of this tension, by single-strand nicking or
double-strand breaks, renders the nucleoid unable to perform its metabolic
processes and as such becomes functionally inert. There are an estimated 500
supercoiled domains per chromosome, reducing the radius of gyration – defined
as the root mean square distance of the supercoiled domains to the center of the
chromosome. Obviously, the formation of these supercoiled loops also
contributes to compaction of the nucleoid. Thus, looping not only maintains free
energy but also facilitates the repair process by localizing nicked strands to one
region (Postow et al., 2004) (Travers and Muskhelishvili, 2007) (Dorman, 1991)
(Azam et. al., 1999) (Azam et. al., 1999) (Azam et al., 2000) (Takeyasu et. al.,
2004).
Compaction of bacterial nucleoid is mediated by NAPs, small basic
proteins analogous to eukaryotic histone proteins. Unlike histones, the
concentrations of NAPs change according to the phase of growth. During
exponential phase, for example, FIS is the predominant NAP, while Dps is
numerically dominant during stationary phase. The physical and chemical
properties of FIS homodimer tends to facilitate the decondensation characteristic
of the exponential phase nucleoid, while the properties of the Dps dodecamer
facilitate compaction of the stationary phase nucleoid (Nystrom, 2004; Ohniwa,
2006; Roy, 2008; Jeong, 2008).
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Like eukaryotic histones, NAPs do more than compact the genome. They
also provide protection from nucleases and regulate DNA metabolism, including

transcription. However, due to the limitation of bacterial cell volume, the genomic
content must be limited to those genes that are required for survival. Reserving
genomic space to accommodate the genes that encode the histone octamers,
while also carrying genes that encode transcription factors for gene expression,
would severely decrease metabolic efficiency. Therefore, the constitutive
interaction between DNA structural proteins (like histones) and DNA is not seen
in bacteria for two reasons: 1) these proteins play multiple roles in the life of the
cell and 2) the dynamic interplay between DNA and NAPs provides the cell with
the ability to adjust more rapidly to the ever-changing extracellular milieu. Though
the use of DNA binding proteins is absolutely required for the compaction of
DNA into the very limited intracellular space, maintaining compaction is a difficult
task since the protein-DNA interaction is very dynamic.
Today, as technology provides us with the resolution necessary to clearly
see within the tiny bacterial cell, the long-held belief that the bacterium is a
simple organism without sophisticated spatial and temporal organization has
begun to rapidly change. The bacterial genome clearly undergoes organized
morphological changes similar to that of the eukaryote genome (Thanbichler et.
al., 2005). From the decondensed DNA fibers of exponential phase to the
electron dense nucleoid of late stationary phase, these changes are mediated by
NAPs.

Bacterial Nucleoid Associated Proteins
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Escherichia coli cells possess twelve nucleoid proteins. Five of these
NAPs are thought to be the major protein components of the bacterial nucleoid:
factor for inversion stimulation (Fis), histone-like nucleoid structuring protein
(HNS), heat-stable nucleoid protein (HU), integration host factor (IHF), and
stationary phase-expressed DNA binding protein from starved cells (Dps) (Azam
and Ishihama, 1999; Ishihama, 1999).
These NAPs have structural similarities to some eukaryotic histones and/
or transcription factors. For example, they possess DNA binding domains
structurally similar to those found in histone proteins. Note, though, that they
possess little or no sequence similarity. Unlike histones, some bacterial NAPs
actively participate in multiple functions within the cell. For example, Fis and IHF
both package the genome and function as pleiotropic regulators that bind specific
DNA sequences. As such, they play specific roles in the regulation of DNA
replication and segregation, recombinatorial events, and transcription. In
contrast, the sequence-independent DNA binding protein, Dps, appears to
function, like histones, strictly as a packaging protein (Nystrom, 2004; Ohniwa,
2006; Roy, 2008; Jeong, 2008; Higgins, 2004). Because NAPs perform such
central and diverse roles, deletion of the gene that encodes a particular NAP
almost certainly will have pleiotropic effects and the study of a physiological
behavior in a cell that lacks a given NAP will be riddled with secondary effects.
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Thus, to study the role of a NAP (e.g. IHF), it is preferable to simply disrupt
binding to a specific DNA site.
Though the characteristic motions of the bases contribute flexibility and
adaptability to the change in the overall structure of the DNA, short regions of

DNA are actually intrinsically stiff. NAPs can be utilized to overcome this rigidity,
permitting genome manipulation and transcription regulation. For example, the
binding of DNA by NAPs introduces the bends needed to promote the binding of
transcription factors and other proteins required for the regulation of transcription.
Below, I will describe the major NAP most central to this dissertation, IHF.

IHF
Integration Host Factor (IHF) initially was identified as an E. coli protein
required for ! phage site-specific recombination. Since its discovery, we now
better understand the functional significance and importance of IHF to the life
cycle of E. coli. The requirement of IHF for cell survival and normal biological
processes is not limited to E. coli, as its homologues, identified in many other
proteobacterial species such as Salmonella typhimurium, Shigella flexinerii,
Sinorhizobium meliloti, and Neisseria gonorrhoeae, function in the same capacity
(Hill et. al., 2002; Higgins, 2005). Universal identification of IHF, and its
homologues, underscores the importance of protein mediated manipulation of
DNA topology during the life cycle of the bacterium. As is the case with E. coli,
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the concentration of IHF varies with the stage of cell development. In exponential
phase the estimated concentration of IHF is 6,000 dimers per cell whereas
approximately 27,000 dimers are present within stationary-phase cells (roughly
five times the number of IHF dimers measured by Ditto et. al., 1994). Not
surprisingly the concentration of IHF dimers correlate with the status of DNA
shape: loose, beads on a string during growth phase and tightly compacted
under non-growth, nutrient limiting conditions. (Azam, 1999; Talukder, 1999).

IHF, a member of the DNA binding II (DNAB II) family of DNA binding
proteins, is a heterodimeric protein that binds the minor groove of DNA (Fig. 3).
Unlike the structurally similar homologous protein, HU, IHF binds DNA in a sitespecific manner, although the 30-35 bp consensus sequence is degenerate
(WATCARXXXXTTR where W = A or T; X = A, T, C OR G; R = A OR G). In
addition to the 13 bp core sequence, IHF sites also contain an AT-rich region
(depicted as WWWWWW) located 8 bases 5’ of the core 13 bases. However,
sequence specific binding, or direct recognition, is not the only factor that
contributes to IHF binding. Indirect recognition based on DNA structure (i.e. DNA
bend) also provides a signal for IHF affinity (Bonnefoy and Rouviere-Yaniv, 1991;
Thompson and Landy, 1988; Teter et. al., 2000). Direct and indirect DNA
recognition are inherent features of IHF and its natural interaction with DNA. This
built-in versatility allows IHF to actively participate in transcription at specific
promoters when cells are grown in nutrient-rich media while non-specifically
binding DNA, and thus compacting it, when those nutrients are used up.
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Furthermore, it has been postulated that high affinity sites, such as yjbE ORF

and BIME gyrB sites, are nearly completely saturated with IHF dimers in
exponential phase but the percentage of saturation changes to somewhere
between 50 to 70% in stationary phase. The low-affinity IS1 site displayed near
70% saturation in stationary phase, while displaying only 25 to 30% saturation in
exponential phase, emphasizing that cell cycle phase and the proteins
associated with cellular adjustment to the nutrient status affect the function and
binding affinity of IHF (Murtin e. al., 1998).
Two genes encode the IHF heterodimer: himA, the alpha subunit (Mr
11350) and himD, the beta (Mr 10650) subunit. The alpha and beta subunits are
similar in sequence (25% homology), as well as structure. IHF possesses two
distinct conformational features: 1) the alpha helical body and 2) two beta sheet
arms, one from each subunit. The alpha helical domain mediates IHF
dimerization, while the flexible beta sheet arms are responsible for DNA binding.
IHF-DNA interaction results in DNA bend angles of up to 180º. The folding of
DNA is induced through the intercalation of proline tips (Proalpha65 and Probeta64)
located in the beta sheet arms between AT-bases of the minor groove of DNA.
The disruption of the base pair stacking upon proline insertion introduces an 80º
bend at each site. The DNA bend angle is further exacerbated through
electrostatic interactions between the mostly positive charged body of IHF with
the negative phosphate DNA backbone. For example, the residues Arg60 and
Arg63 of the alpha subunit and Arg46 of the beta subunit make direct contact with
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specific bases whereas the Ser47 residue of the alpha subunit binds the dA/dT

tract. Due to the variation of genomic IHF sequences, the DNA bend angles
differ. However, the closer a site is to consensus the more severe the contortion.
This severe conformational change increases the accessibility of the bound DNA
to enzymes, such as recombinases and endonucleases (Higgins, 2004;
Mengeritsky, 1993).
The major topological changes in DNA induced by IHF, and other DNA
binding proteins, are required for all DNA metabolic events and are universal
themes across all bacteria, archaea, and eukaryota. Specific to this dissertation
is the mechanism of IHF-mediated negative regulation of transcription. For
example, promoters sytR, galR, and Pu are all dependent on IHF binding to fold
DNA for either activation, by bringing distant activators into close proximity with
the RNAP holoenzyme, or repression, by folding the promoter DNA into a
complex that traps RNAP and/or transcription factors. The protein content bound
to a given promoter region often dictates how IHF will affect transcription.

NAPs and Transcription: Location, Location, Location
Direct sequence recognition by proteins is an effective way to precisely
direct specific protein binding and thus to regulate DNA processes. DNA binding
sequences are found at origins of replication, DNA recombination sites, and
promoters. The precise alignment of protein binding sites in relation to the origin
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of replication or transcription start site determines the functional behavior of the
protein within a given DNA region. However, the structural features of DNA also
contribute to protein recognition.
The interactions between DNA and NAPs are subcategorized into two

groups: indirect and direct. Some NAPs (e.g. HU) bind DNA nonspecifically. They
do not recognize a specific sequence, but rather structural features of DNA such
as the major or minor grooves, DNA backbone, hydration shell, flexibility, and
intrinsic curvature. The inherent bend is mostly found to be A:T-rich DNA regions.
This recognition of and binding to DNA based on its bent structure is termed
indirect. Other NAPs (e.g. Fis and IHF) bind DNA specifically. They recognize
and bind to stretches of DNA that contain their consensus sequence. Such NAPs
are called direct binders (Higgins, 2004; Rice, 1997). However, the mechanisms
of DNA binding by direct or indirect recognition are not mutually exclusive. For
example, despite the identification of an IHF sequence motif, IHF also binds
DNA non-specifically throughout the genome, an important function for DNA
compaction. The presence of an A:T-rich region, perhaps inherently curved, 5’ of
the consensus site, may provide the initial recognition signal for IHF binding. As
demonstrated by Hales et al. (1994), mutations introduced into the A:T-rich
region of DNA increases the efficiency of IHF binding (Hales, 1994).
The direct binding NAP IHF can either enhance or inhibit transcription,
depending upon the location of its binding site. Like many DNA binding proteins,
IHF can compete directly with RNAP for promoter access and thus repress
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transcription. This repression occurs if an IHF site is positioned such that it
overlaps the promoter sequences that recruit RNAP. IHF also can activate

transcription. Unlike many transcription factors, activation by IHF is not attributed
to direct protein-protein interactions. Instead, IHF’s importance in activation
appears to stem from its ability to deform DNA (Rice, 1997; de Lorenzo, 1991).
For example, the severe bend mediated by IHF binding can bring two proteins
bound to distant sites into close proximity. Such a scenario occurs at the Pu
promoter of Pseudomonas putida, which transcribes genes that control the
degradation of xylene and toluene. Activation of this promoter requires a
transcription factor that binds an upstream activating sequence (UAS). It also
requires that IHF bind a DNA site positioned between the UAS and the promoter.
The binding of IHF performs two functions: it recruits RNAP to the promoter and it
induces a sharp turn in the DNA. This severe bend brings the UAS and its
associated activator into close proximity to the bound RNAP, thereby activating
transcription. Eliminating IHF binding to the Pu promoter abrogates transcription
at this promoter (Perez-Martin and de Lorenzo, 1997). Further evidence that IHF
functions primarily to deform DNA comes from experiments in which an IHF site
has been replaced by an HU site. At certain IHF-dependent promoters,
researchers introduced base pair mutations within the IHF consensus site. These
mutations ablated transcription. Promoter activity, however, was restored when
those researchers substituted the IHF site with an A:T-rich sequence that
conferred a bent structure to the DNA and thereby promoted the indirect binding
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of HU (Swinger and Rice, 2003; Swinger and Rice, 2004; Swinger and Rice,

2007). The ability to induce dramatic changes in DNA conformation makes IHF a
versatile protein that can be used in a variety of scenarios. In the specific case of
transcription, as described above, the placement of the IHF binding site within a
promoter region can dictate how IHF regulates transcription from that promoter.
However, the binding of other proteins (e.g. CRP) in the vicinity of the promoter
can modulate the function of IHF.
Interestingly, there are many examples of promoter DNA that contain Atract (or T-tracts) sequences and, therefore, curved DNA regions. Curved DNA is
most commonly found at two locations in core promoter regions: 1) immediately
upstream of the -35 hexamer and 2) further upstream beyond the -35, such as
-120 of the ilvIH operon. These regions of curvature have been shown to
enhance RNAP binding to promoter DNA as well as recruit transcription factor
binding. The presence of curved DNA on its own affects transcription activation,
both positively and negatively, based solely on its structure. Likewise,
transcription factors, such as IHF, remodel promoter DNA to regulate
transcription. However, the effects of curved DNA and transcription factor binding
are not mutually exclusive. The ilvPG2 promoter, which drives the expression of
the ilvGMEDA operon, contains both intrinsically bent DNA at -50 and an IHF
binding site at -90, both of which activate transcription (Pagel et. al., 1992).

CRP-Dependent Activation
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Most mechanistic studies of bacterial transcription activation have focused
on simple situations in which a single transcription factor can activate a given
p r o m o t e r. M o s t o f t h e s e
activators bind upstream of the
transcription start site, make
direct contacts with RNAP, and
recruit it to the target promoter.
These activators partition into
two classes based on the
location of their binding sites.
Figure 3. Crystallographic Model of IHF Bound to the !H"
Site. The "-subunit (cyan) and $-subunit (blue) of the IHF
heterodimer make direct contact with DNA The proline finger
located in the beta-ribbon arm of each subunit intercalates into
ApA steps (orange) of the minor groove. The bent
conformation is stabilized by hydrogen bonds with the A-tract
(magenta). Other parts of heterodimer bind to the remaining
bases of the WATCAANNNNTTR sequence (red and green)
(Aeling et al, 2007).

Class I activators bind to
upstream locations near
position !61, !71, !81 or !91
relative to the transcription start
site. They activate transcription

by making direct contacts with the carboxy-terminal domain of the " subunit ("CTD) of RNAP, stabilizing the initial steps in the pathway of open complex
formation. In contrast, Class II activators bind sites that overlap the !35 hexamer
of the target promoter and, typically, activate transcription by contacting domain
4.2 of the #70 subunit of RNAP and the "-NTD, the amino-terminal domain of ".
In some cases, Class II activators also make productive contacts with the "-CTD,
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which often binds upstream of the bound activator. Arguably, the best-studied
simple transcription factor is CRP (cAMP receptor protein, also known as CAP).
Over 200 genes are regulated
by CRP. This transcription
factor becomes activated to
bind DNA only when bound by
cAMP. The active cAMP–CRP
complex (hereafter referred to
as CRP) can function either as
a Class I activator that
contacts the !-CTD via a wellcharacterized surface
determinant called activation
region 1 (AR1) (Fig. 4A), or as

Figure 4. CRP-Dependent Activation. (A) Activation by CRP
can occur by a Class I mechanism, in which CRP binds to an
upstream site centered near positions –61, -71, -81, -91 and
interacts through Activation Region 1 (AR1, 1) with an !-CTD.
(B) Activation by CRP also can occur via a Class II mechanism, in
which the activator binds a site near the –35 hexamer and
interacts with RNAP via two surfaces (AR1) and Activation
Region 2 (AR2, 2). With some proteins (e.g. FNR), a third surface
called Activation Region 3 (AR3, 3) can interact with " region 4.2.

a Class II activator that interacts with RNAP via AR1 and AR2, which contacts
RNAP via the !-NTD (Fig. 4B). CRP also can function in tandem combinations of
both, either Class II–Class I or Class I–Class I. These more complex
arrangements are often called Class III (Busby and Ebright, 1999).
FNR is a paralog of CRP; in addition to AR1 and AR2, it possesses a third
surface (AR3), which permits it to also contact region 4.2 of "70 (Fig. 4B) In CRP,
this surface is masked; certain mutants remove the mask, exposing this nonnative surface (Busby and Ebright, 1999; Lawson et al., 2004; Rhodius, 2000).
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Acetyl-CoA Synthetase

Acetyl coenzyme A synthetase (Acs) catalyzes the conversion of acetate
to acetyl-CoA through an
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Figure 5. Acetyl-CoA Synthetase (Acs) and Transcription
of its Gene (acs). (A) Acs catalyzes the activation of acetate
to acetyl-CoA in an ATP- and HS-CoA-dependent manner.
The by-products are pyrophosphate (PPi) and adenosine
monophosphate (AMP). The resultant acetyl-CoA enters the
TCA cycle and the glyoxylate shunt (GS). (B) acs transcription
is induces as glucose (glc) levels approach depletion and
acetate (ace) concentration begins to peak. Peak
transcription occurs as cells enter stationary phase.

for cells entering a nutrient poor environment (reviewed by Wolfe, 2005).

41

Like many other genes required for the use of secondary carbon sources,

acs is subject to catabolite repression (Kumari et al., 2000): cells growing on their
preferred carbon source (e.g. glucose for E. coli) inhibit acs transcription (Kumari
et al., 2000; Oh et al., 2002; Shin et al., 1997). However, the major byproduct of
glucose metabolism is acetate, which cells excrete into their environment. Thus,
the extracellular concentration of acetate rises as the concentration of glucose
falls (Fig. 5B). Just prior to exhaustion of the glucose, cells induce acs
transcription. This event occurs during the transition from exponential growth to
stationary phase (Kumari et al., 2000; Shin et al., 1997). As the culture enters
stationary phase, transcription peaks and then decreases rapidly. A similar
expression pattern happens during growth in tryptone broth, a mixture of amino
acids. As E. coli cells exhaust L-serine, their preferred amino acid, they induce
acs transcription (Pruss et al., 1994; Kumari et al., 2000; Browning et al., 2004).
As with glucose, transcription peaks as the culture enters stationary phase
(Kumari et al., 2000), decreases rapidly, and then slowly increases - this time, in
parallel with the concentration of extracellular acetate (Wolfe, 2005).
The enzymatic process catalyzed by Acs improves fitness. When first
grown on glucose or acetate as the sole carbon source and then permitted to
starve, cells that retain Acs out-compete those that lack Acs. The implication of
these results is that starving cells rely on the ability of Acs to scavenge for scarce
acetate in the environment (Wolfe, unpublished data). However, if left
unregulated, Acs can be dangerous. Overexpression of Acs is lethal (Kumari et
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al., 2000). This is likely due to its use of CoA as a substrate. The unregulated

activity of Acs would deplete the cell’s store of CoA, which is maintained in
limiting quantities. Thus, cells regulate the activity of Acs (via N-lysine
acetylation) and the transcription of acs, the gene that encodes it (reviewed by
Wolfe, 2005).
Regulation of acs transcription occurs primarily at the level of initiation
(Kumari et al., 2000). As befits a critical survival gene, this regulation is quite
complex. What follows is a description of the machinery that controls the initiation
of acs transcription.
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Figure 6. The acs Operon and the nrf-acs Intergenic Region. (A) acs is the first gene in a
three gene operon. Its transcription is controlled by 3 promoters, which transcribe divergently
from the nrf promoter, which drives transcription of the nrf operon. (B) The region 5’ of acs
includes three promoters, two DNA sites for the transcription factor CRP and three sites each for
the nucleoid proteins FIS and IHF. The numbers are in reference to the +1 of acsP2. (C) The
repressed state of acsP1 results from the action of two nucleoid proteins (FIS and IHF) and
several transcription factors (FNR, NsrR, NarP, and NarL). X-10, the extended –10 of the nrf
promoter; -10, the –10 hexamer of acsP1. The numbers are in reference to the +1 of acsP1.

acs Operon and Promoter Architecture
acs is the first gene in an operon that includes yjcH, a hypothetical gene,
and actP (formerly known as yjcG), which encodes an acetate permease (Fig.
6A) (Gimenenz et al., 2003) whose physiological purpose remains unknown. No
evidence exists for internal promoters; thus, transcription of the acs operon
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apparently initiates only from the regulatory region of acs, located upstream (5')
of the acs open reading frame.
The regulatory region of acs includes three !70-dependent promoters: the
proximal major promoter acsP2; a minor promoter called acsP2A located 18-bp
upstream of acsP2, and the distal minor promoter acsP1 located some 200-bp

upstream of acsP2 and acsP2A (Fig.6B) (Beatty et al., 2003; Browning et al.,
2002; Kumari et al., 2000a, Kumari et al., 2000b).

Activation of acsP2
In vitro, RNAP alone does not efficiently transcribe the proximal acsP2. It
does, however, bind and melt an extensive region of DNA that includes both
acsP2 and acsP2A (Beatty et al., 2003). For efficient transcription, it requires
CRP. Because acs transcription depends on CRP, it is subject to catabolite
repression (Beatty et al., 2003; Kumari et al., 2000). This well-studied regulatory
mechanism results from the normal action of the phosphoenolpyruvate (PEP)dependent sugar phosphotransferase system (PTS). Using PEP as the
phosphoryl donor, the PTS simultaneously phosphorylates certain sugars (for
example, glucose) and transports them across the cytoplasmic membrane into
the cytosol, where the phosphorylated sugars enter glycolysis. As the sugars
become scarce, the PTS instead activates adenylate cyclase, which synthesizes
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cAMP. The cAMP can then bind the CRP homodimer, altering its conformation so
that it can bind to its DNA sites (reviewed by Deutscher et al., 2006).
CRP can activate the major promoter acsP2 using a variant of the Class III
mechanism (Fig. 7C). At this
promoter, two CRP homodimers
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dimer bind the proximal CRP I. To achieve maximal transcription, however, a
second dimer also must bind to the distal CRP II (Beatty et al., 2003).

46

Most often CRP functions from Class I sites by stabilizing the closed

complex (CC). Using the surface determinant AR1, the CRP dimer contacts the
287 surface determinant of the !-CTD (Fig. 4A). This interaction stabilizes the
CC, permitting the subsequent formation of a open complex (OC), the next
intermediate in the transcription initiation pathway (Browning and Busby, 2004;
Busby and Ebright, 1999). At acsP2, the mechanism is a bit more complex.
Although CRP I, AR1 and determinant 287 help to stabilize the TCC, their
contribution cannot be limited to this role: RNAP alone can bind both acsP2A and
acsP2 and form TOCs, albeit in inactive forms (Fig. 7A, B) (Beatty et al., 2003).

Modulation of CRP-Dependent Activation by Nucleoid Proteins
Of the twelve nucleoid proteins of E. coli, both FIS and IHF can inhibit
transcription of acs. Within the acs promoter region, FIS and IHF can each bind
to three sites (Fig. 6B). Furthermore, all six sites can be occupied simultaneously.
Finally, both nucleoid proteins function independently to antagonize CRPdependent activation of acsP2 (Browning et al., 2004).

Negative Regulation by FIS
FIS can inhibit CRP-dependent acsP2 transcription directly by a
mechanism called anti-activation. This mechanism relies on the ability of FIS to
bind to two higher affinity sites: FIS II and FIS III (Fig. 8). FIS II (centered at -98)
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lies between CRP II (-122.5) and CRP I (-69.5), while FIS III (-59) overlaps CRP

I. Competitive DNase I footprint and electrophoretic mobility shift analyses, and in
vitro transcription assays indicate that FIS can displace CRP from both its sites.
In vivo, a mutation in FIS II that diminishes its affinity for FIS by more than tenfold increases acs transcription two- to three-fold during growth in tryptone broth.
A similar increase results from a mutation that favors the binding of CRP over
that of FIS to their overlapping sites (CRP I and FIS III). Thus, the competition
between FIS and CRP for binding to their overlapping and tandem sites helps to
keep acsP2 transcription low (Browning et al., 2004). Because FIS levels rise
dramatically during outgrowth in rich medium from stationary phase and then
progressively diminish throughout exponential growth (Azam et al., 1999; Ball et
al., 1992). FIS appears to be responsible for maintaining acs transcription at
basal levels during rapid growth conditions when the activity of acs is
unnecessary.

Negative Regulation by IHF
The concentration of IHF in cells harvested from early exponential growth
has been estimated at about 0.7 nM (Murtin et al., 1998). This concentration
increases progressively throughout growth until, during stationary phase, it
becomes the second most abundant nucleoid protein (Azam et al., 1999;
Ishihama, 1999). The binding of IHF to its specific sites causes the DNA to bend
up to 180 degrees and to wrap around the protein (Lynch et al., 2003; Rice et al.,
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1996; Travers, 1997). IHF affects acs transcription by binding to three high affinity
sites (IHF I - III) located between positions -140 and -240 relative to the +1 of
acsP2 (Fig. 6B) (Browning et al., 2004). Of particular importance to this
dissertation is the observation that the 31-bp sequence IHF III causes a severe
inhibition of CRP-dependent activation.
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DNA sites. BecauseAnti-Activation
CRP cannot bind, transcription
does not occur.

Figure 8.
Transcription. FIS out-competes CRP binding to their overlapping DNA
sites. Because CRP cannot bind, transcription does not occur.

Concluding Remarks
The acs promoter exemplifies the complexity of bacterial promoters. At
first glance, transcription from the acs promoter appears to be simple enough:
acsP2 is a weak CRP-dependent promoter activated by the tandem Class I
variant of the Class III mechanism. Deeper study, however, shows that this
promoter is subject to considerably more sophisticated regulatory mechanisms
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that involve intricate competition between multiple transcription factors and
multiple NAPs.

It was the goal of my dissertation to understand how IHF III inhibits CRPdependent acs transcription. The initial studies performed in collaboration with
Bianca Sclavi led to the recognition that occupancy of IHF III causes the
formation of a stalled nucleoprotein complex comprised of RNAP, two CRP
homodimers, and IHF. Further investigation led to the discovery that IHF III is a
composite sequence comprised of two overlapping DNA sites for IHF. One,
orientated towards the promoter, sits on one face of the DNA helix orient. The
other, orientated away from the promoter, sits on the other. Together, they control
CRP-dependent acs transcription.

CHAPTER TWO
MATERIALS AND METHODS

Chemicals and Biological Reagents
Chemical reagents were purchased from Fisher Scientific (Pittsburgh, PA)
and Sigma Chemical Company (St. Louis, MO). !-galactosidase assay reagents
were purchased from Pierce Biochemicals (Rockford, IL). Restriction
endonucleases and modifying enzymes were purchased from Promega Corp.
(Madison, WI), New England Biolabs (Beverly, MA) or Gibco BRL (Gaithersburg,
MD). Primers were purchased from Integrated DNA technologies (Iowa). Media
components were obtained from Difco.

Bacterial strains, plasmids, bacteriophage, and promoter fragments
All bacterial strains, plasmids, bacteriophage, and promoter fragments
used in this study are listed in Tables 1-4. Derivatives of the E. coli K-12 strain,
AJW678, were used for all experiments.
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By convention, all locations within the nrfA - acs intergenic region (Fig. 9A)
are numbered relative to the transcription start site of acsP2 (+1) with upstream
and downstream locations prefixed ‘-‘ and ‘+’, respectively.
The constructions of the promoter fragments FL, 1xIHF, and 0xIHF
(pacs444, pacs236, and pacs205 respectively) were described previously (Beatty
et al., 2003; Browning et al., 2004). Promoter fragment 1xCRP (pacs155) was
constructed by digestion of pCB63 (Browning et al., 2004), followed by re-ligation
to form a promoter fragment that lacked sequences upstream of CRP II. This
construct was digested with EcoRI and BamHI, subcloned into the lacZ fusion
vector pRS415 to generate pCB91, and recombined with the lacZ fusion vector
!RS88, using the method of Simons et al. (Simons et al., 1987). The
constructions of the mutations G74C and G126C, which disrupt the binding of
CRP to CRP I and CRP II, respectively, have been described previously (Beatty
et al., 2003). The double mutation C150G/C153G, which disrupts binding of IHF
to IHF III, was generated using the Gene Editor site-directed mutagenesis kit
(Promega, Madison WI). The primer IHFIII (CTGCATGTTCGTGAAAG) was used
to mutagenize the template pCB26 (Beatty et al., 2003), generating pCB92.
Successive promoter fragments were generated using either pCB26 (the fulllength promoter cloned into pGEMT) as a template or existing promoter
mutations cloned into pGEMT (e.g. pCB26-F2m; Fis II mutation). For example,
pCB92 was used as the template to generate 1xIHF-I3m using this plasmid as a
template the primer pairs P2 (GAATTCCATAACTGCATGTTC) and 2926. After
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amplification, all promoter fragments were cloned in to TOPO2.1 vector
(Invitrogen) and sequenced to identify any present mutations. All verified
promoters were digested with EcoRI and BamHI and cloned into pRS415.
Following this cloning step, all promoters were sequenced once more and then
recombined with !RS88. A similar strategy was used to construct 2xIHF-I3m
variants carrying the G74C and G126C mutations. Single lysogens of strain
AJW678 ("lac) were constructed and verified, as described previously (Simons
et al., 1987). Primers specific for the ! attachment sites were used to determine
whether the resultant lysogens were in single or multiple copies (as described by
Sowell et al, 1994):
!attB (GAGGTACCAGCGCGGTTTGATC)
!attP (TTTAATATATTGATATTTATATCATTTTACGTTTCTCGTTC)
!int (ACTCGTCGCGAACCGCTTC)

The "crp::Km allele was transferred from strain CB369 by generalized
transduction with P1kc (Silhavy et al., 1984).
For in vitro studies, we used the plasmids pSRacsFL and pSR1xIHF. The
construction of pSRacsFL was described previously (Beatty et al., 2003).
pSR1xIHF was constructed similarly. pSR1xIHF was PCR amplified using the
p r i m e r p a i r P 2 (GA ATTC C ATA A C TGC - ATGTTC ) a n d 2 9 2 6H i n d I I I
(AAGCTTGTTGGGTCTGCG-ATGTTG). This facilitated subcloning of the
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fragment with an upstream EcoRI linker and a downstream HindIII linker into the
in vitro transcription vector pSR (Kolb et al., 1995).
All PCR amplifications were performed in a 50 µl reaction volume. The
reactions contained 1X PCR buffer (Promega), 3 mM MgCl2, 20 nM each primer,
0.2 mM dNTPs and 1 U Taq polymerase. Reactions were subjected to 1 cycle of
95oC for 5 minutes, then 30 cycles 95oC for denaturing, 68oC for annealing, and
72oC for extension. Site-directed mutations were generated using the Gene
Editor site-directed mutagenesis kit (Promega), following the protocol provided.
The resultant PCR products were subcloned into pGEM-t and the successful
incorporation of mutations was verified by sequencing.
For cloning and transformations, plasmids were prepared using the
Wizard miniprep kit (Promega), following the protocol provided. All restriction
digestions and ligations were performed according to standard methods, as
described (Sambrook et al., 1989).

Media and growth conditions
For strain construction procedures, cells were grown in Luria Broth (LB;
1% (wt/vol) tryptone, 0.5% (wt/vol) yeast extract and 0.5% (wt/vol) sodium
chloride). For !-galactosidase assays, cells were grown at 37oC in tryptone broth
(TB; 1% (wt/vol) tryptone and 0.5% (wt/vol) sodium chloride). Media were
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supplemented with antibiotics or 5-bromo-D-chloro-galactopyranoside (X-gal), as
needed.

Promoter activity assays
!-galactosidase activity was determined quantitatively using the Y-PER !galactosidase assay kit (Pierce Biochemical). Cells were harvested at
approximately one-hour intervals over a growth curve. The activities were plotted
against optical density to standardize for subtle differences in growth rates. From
these plots, the peak activity was identified and standardized to that of the AR2
mutant for each promoter construct tested. The values expressed are the mean
and the standard error of the mean of three independent measurements. Each
experiment was performed in triplicate and assayed three to five times to
determine the reproducibility of the data. Some reporter truncations were reconstructed to ensure reproducibility from beginning to end.

Protein preparation
Purified RNA polymerase was purchased from Epicentre Technologies.
Purified WT CRP was a kind gift from Annie Kolb (Institute Pasteur, Paris,
France). The plasmids that encode the mutant proteins (CRP KE101 and CRP
HL159) and the crp mutant cells were a kind gift of Nigel Savery (University of
Bristol, UK). The mutant CRP proteins (CRP KE101 and CRP HL159) were
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prepared, as described previously (Ghosaini et al., 1988). Purified IHF protein
was prepared by the method of Nash et al. (Nash et al., 1987).

DNase I footprint analysis
Footprint analysis was a modification of the protocol described by Gralla
(Gralla, 1985). 0.1 nM supercoiled plasmid DNA was incubated with varying
concentrations of IHF, CRP, and/or RNAP in 10 µl total volume at 37oC in
footprinting buffer (20mM Hepes pH 8, 5 mM MgCl2, 50 mM potassium
glutamate, 1 mM DTT, 500 µg/ml deacetylated BSA). After 20 minutes, 1 µl of 5
µg/ml DNase I (Worthington) was added. After 20 seconds, the reaction was
stopped by adding 10 µl of stop solution (2X Taq Platinum buffer (Invitrogen), 2.5
nM labeled oligonucleotide, 2 µg/ml ctDNA, 240 µM dNTPs). One unit of
Platinum Taq DNA polymerase (Invitrogen) was added. Primer extension was
carried out in a Robocycler PCR machine (Stratagene) for 30 cycles.

Line

graphs of band intensities were obtained using ImageQuant Software (Molecular
Dynamics) and standardized by the band at -35, and, when possible, bands
upstream and downstream of the footprint.

Potassium permanganate footprint analysis
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1 nM supercoiled plasmid DNA was incubated with varying concentrations
of IHF, CRP, and/or RNA polymerase in 10 µl total volume at 37oC in footprinting
buffer (20mM Hepes pH 8, 5 mM MgCl2, 50 mM potassium glutamate, 1 mM
DTT, 500 µg/ml deacetylated BSA). After 20 minutes, 1 µl of a frozen aliquot of
200 mM potassium permanganate was added. After 20 seconds, the reaction
was stopped by the addition of 50 µl of stop solution (4% !-mercaptoethanol, 1.6
M sodium acetate, 4 µg/ml ctDNA). The samples were then cleaned by a phenol/
chloroform extraction followed by ethanol precipitation. They were then
resuspended in 10 µl of water to which 10 µl of primer extension solution was
added (2X Taq Platinum buffer (Invitrogen), 2.5 nM labeled oligonucleotide, 5 mM
MgCl2, 240 µM dNTPs, 1 unit of Platinum Taq (Invitrogen)). Primer extension was
carried out in a Robocycler PCR machine (Stratagene) for 20 cycles. Bar graphs
were obtained using ImageQuant software to quantify the band intensities, Excel
(Microsoft) to calculate the ratio of P2A, P2UP, or P2DOWN relative to total
intensity, and Origin (Originlab) to produce the plots.

Table 1. Strains, plasmids and phage not listed in Tables 2-4.
Strain, plasmid, phage

Relevant characteristics

Source or reference

Strains
AJW678

thi-1 thr-1(Am) leuB6 metF159(Am) rpsL136 !lacX74

(Kumari et al., 2000a)

CB369

MG1655 !crp::Km

C. Bausch

P90C

ara !(pro-lac) thi

(Simons et al., 1987)

pRS415

bla+ lacZ+, transcriptional (operon) fusion vector

(Simons et al., 1987)

pCB26

pGEM-t carrying -411 acs through the acs ORF,
template for site-directed mutants

(Beatty et al., 2003)

pDCRP

pBR322 derivative carrying wild-type crp gene (1+2+3o)

(Rhodius et al., 1997)

pDCRP/H159L

pDCRP derivative carrying crpH159L allele (1-2+3o)

(Rhodius et al., 1997)

pDCRP/K101E

pDCRP derivative carrying crpK101E allele (1+2-3o)

(Rhodius et al., 1997)

pDCRP/K52N

pDCRP derivative carrying crpK52N allele (1+2+3+)

(Rhodius et al., 1997)

pDCRP/H159L/K101E

pDCRP derivative carrying crpH159L K101E allele
(1-2-3o)

(Rhodius et al., 1997)

Plasmids
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pDCRP/H159L/K101E/
K52N

pDCRP derivative carrying crpH159L K101E K52N
allele (1-2-3+)

(Rhodius and Busby, 2000)

pDCRP/H159L/K52N

pDCRP derivative carrying crpH159L K52N allele
(1-2+3+)

S. J. W. Busby

pDCRP/K101E/K52N

pDCRP derivative carrying crpK101E K52N allele
(1+2-3+)

S. J. W. Busby

pGEM-t

pUC19-derived TA cloning vector

Promega

pSR

in vitro transcription vector used for all in vitro work

(Kolb et al., 1995)

pRW50

promoterless lacZYA

(Lodge et al., 1992)

bla=lacZ imm434 ind, transcriptional (operon) fusion
vector

(Simons et al., 1987)

Bacteriophages
!RS88
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Table 2. Promoter fragments used in Chapter 3, with corresponding plasmid, phage, and strains.
Promoter

Description

Plasmid

Phage

WT
strain

delta crp
strain

Reference

pacs444

AatII-HindIII fragment
carrying acs sequences from
position -379 to +65

pCB33

!CB12

AJW1941 AJW2183

(Beatty et al.,
2003)

pacs236

PCR product carrying acs
pCB60
sequences from position -171
to +65

!CB22

AJW2026 AJW2086

(Browning et
al., 2004)

pacs205

PCR product carrying acs
pCB61
sequences from position -140
to +65

!CB42

AJW2179 AJW2198

(Browning et
al., 2004)

pacs155

PCR product carrying acs
sequences from position -90
to +65

pCB91

!CB39

AJW2203 AJW2199

This study

pacs236
G74C

CRP I mutant of pacs236

pCB71

!CB29

AJW2080 AJW2192

This study

pacs236
G126C

CRP II mutant of pacs236

pCB96

!CB45

AJW2202 AJW2812

This study

pacs236
C150G/
C152G

IHF III mutant of pacs236

pCB96

!CB44

AJW2813 AJW2814

This study
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Table 3. Promoter fragments not listed in Tables 1 or 2, used in Chapter 4.
Promoter

Description

Reference

pacs1xIHF A164T

predicted to affect both IHF IIIa and
IIIb

This study

pacs1xIHF T158G

predicted to affect IHF IIIb

This study

pacs1xIHF A157G

predicted to affect IHF IIIb

This study

pacs1XIHF A156G

predicted to affect IHF IIIb

This study

pacs1xIHF C150A

predicted to affect IHF IIIa

This study

pacs1xIHF A149C

predicted to affect IHF IIIa

This study

pacs1xIHF A148C

predicted to affect IHF IIIa

This study

pacs1xIHF T142A

predicted to affect both IHF IIIa and
IIIb

This study

pacs1xIHF A148C

predicted to affect IHF IIIa

This study

pacs1xIHF-VF

swaps IHF IIIa with IHF IIIb

This study
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Table 4. Promoter fragments not listed in Tables 1-3, used in Chapter 5.
Promoter

Relevant characteristics

Source or
reference

pacs1xIHF+5

complete palindrome sequence This study

pacs1xIHF+5S

upstream 5 bases (palindrome
half-site) scrambled

This study

pacs1xIHF C152G C150G

IHF III weakened

This study

pacs1xIHF C152A C153A

IHF III strengthened

This study

pacs2xIHF

contains IHF II and IHF III

This study

pacs2xIHF-A170C T169C

contains IHF II and IHF III; IHF
II weakened

This study

pacs2xIHF-A170T

contains IHF II and IHF III; IHF
II strengthened

This study

pacs2xIHF-G134C

contains IHF II and IHF III;
CRP II mutated

This study

pacs2xIHF-C177T

contains IHF II and IHF III; IHF
II mutated

This study

pacs2xIHF C152G C150G

contains IHF II and IHF III; IHF
III mutated

This study
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CHAPTER THREE

THE MULTIPLE ROLES OF CRP AT THE COMPLEX ACS
PROMOTER DEPEND ON ACTIVATION REGION 2 AND IHF

Introduction
Previously, the Wolfe lab reported that E. coli cells control Acs activity
primarily at the level of transcription initiation (Kumari et al., 2000a). The
regulatory region of acs includes three !70-dependent promoters: the proximal
major promoter acsP2; a minor promoter called acsP2A located 18-bp upstream
of acsP2, and the distal minor promoter acsP1 (Figs.6 and 9A) (Beatty et al.,
2003; Browning et al., 2002; Kumari et al., 2000a; Kumari et al., 2000b).
Transcription is induced during mid-exponential phase and peaks as cells enter
stationary phase, whereupon it diminishes (Kumari et al., 2000a) (Fig. 5B). While
multiple factors influence transcription (Browning et al., 2002; Kumari et al.,
2000a), CRP appears to function directly as the most critical transcription factor
(Beatty et al., 2003; Kumari et al., 2000a).
CRP activates the major promoter acsP2 using a variant of the Class III
mechanism. Two CRP homodimers bind in tandem at DNA sites centered at the
62
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Class I positions -69.5 and -122.5 (Figs.7C and 9A). Using the surface
determinant AR1, each dimer contacts the !-CTD, recruiting RNAP to acsP2
and, thus, facilitating activation of acs transcription. Activation absolutely requires
that one dimer binds CRP I, the proximal, higher affinity site. To achieve maximal
transcription, however, a second dimer also must bind to CRP II, the distal, lower
affinity site (Beatty et al., 2003).
Similar to transcription regulation in eukaryotes, bacteria transcription is
also modulated by histone-like proteins that fold the genome into the highly
compacted, highly organized nucleoid (Kim et al., 2004). In both kingdoms,
changing the DNA architecture provides a structural barrier that limits the access
of transcription factors and RNAP. However, unlike eukaryotes, the interaction
between DNA and bacterial histone-like proteins is dynamic – the same nucleoid
protein may not remain stationary to the same DNA region (The Bacterial
Chromosome, Higgins, 2005). E. coli possesses twelve nucleoid proteins whose
functions are as diverse as their structures (Azam et al., 1999; Ishihama, 1999).
Of these twelve proteins, Fis and IHF inhibit transcription of acs (Browning et al.,
2004).
Within the acs promoter region, Fis and IHF each bind to three sites (Fig.
6B). Furthermore, each nucleoid protein independently antagonizes CRPdependent activation of acsP2. The mechanism of this antagonism is largely
unknown save for the direct competition between Fis and CRP at their
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Figure 9. The organization of the acs promoter. (A) This schematic shows the acs promoter
region from positions -379 to +65 relative to the acsP2 transcription start site (+1). It shows the
locations of each promoter, each CRP and IHF binding site and the extent of the promoter
fragments. The bent arrows indicate the approximate location of each promoter and its direction of
transcription. Inverted arrows indicate the locations of CRP I and CRP II, as determined by similarity
to consensus. Hatched boxes designate the locations of IHF I-III, also determined by similarity to
consensus. (B) Binding site mutations used in this study. The core consensus sequence for each
binding is underlined and the substituted nucleotide(s) positioned above the mutated one. (C) !galactosidase activity from promoter fragments pacs444 (FL), pacs236 (1xIHF), pacs205 (0xIHF),
pacs155 (1xCRP), or pacs236 (1xIHF) variants defective for CRP I, IHF III, or CRP II fused to
lacZYA. The wild type strain AJW678 was lysogenized with the hybrid phages "CB12, "CB22,
"CB42, "CB39, "CB29, "CB44, or "CB45, respectively (Table 2). The resultant strains were grown
in TB, samples harvested at one-hour intervals, the !-galactosidase activity determined, and the
peak activity expressed as a percentage of wild-type. Each value represents the mean + SEM of at
least three independent measurements. The percentage activities in relation to pacs444 (FL) are
noted within each histogram.
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overlapping sites, Fis III and CRP I (Fig. 8) (Browning et al., 2004). Because its
levels peak dramatically during outgrowth from stationary phase and then
progressively diminish throughout exponential growth (Azam et al., 1999; Ball et
al., 1992), Fis likely maintains acs transcription at basal levels under rapid growth
conditions. The role of IHF has remained less clear: in vitro it is known to bind
simultaneously with CRP and to cause inhibition of acsP2 transcription; in vivo,
however, the upstream sequence, which contains the two distal IHF sites, the
minor promoter acsP1, and the divergent promoter Pnrf, has a positive effect on
transcription (Browning et al., 2004).
In this chapter, I will describe genetic and biochemical experiments
designed to answer the following question: How does IHF inhibit transcription?
We anticipated that the underlying mechanism would be novel because, unlike
Fis, IHF does not compete directly with CRP for binding. To answer this question,
we set out to: 1) test whether the 31-bp sequence that includes IHF III was
responsible for the lowered transcriptional profile exhibited by the acsP2
promoter; 2) identify the factors involved in this IHF–mediated inhibition of acsP2
transcription; 3) determine how these factors work together to inhibit acs
transcription; and 4) determine whether Fis plays a role in this inhibitory
mechanism. This study demonstrates that interactions between wellcharacterized regulators can, within the context of complex promoters, result in
novel mechanisms of gene regulation that remain to be explored.

Inhibition of CRP-dependent transcription by IHF III depends on CRP II
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Previous results suggested the existence of multiple IHF-mediated
nucleoprotein complexes that exert differential effects upon acs transcription
(Browning et al. 2004; Browning et al 2002). To simplify the testing of this
hypothesis, we first sought to define the minimal system required for IHFdependent inhibition. We began with 1xIHF (also known as pacs236), an
acs::lacZYA promoter fusion that includes the inhibitory 31-bp sequence
(Browning et al., 2004). Since the 31-bp sequence includes IHF III (Fig. 9A), we
determined whether it participates in the inhibition of acs transcription by
introducing a double base pair replacement mutation (Fig. 9B) predicted to
diminish affinity for IHF (Browning et al., 2002; Lee et al., 1991). The mutant
promoter fusion, 1xIHF-I3m, and all others used in this study, was recombined
into a hybrid ! bacteriophage and introduced as a monolysogen into AJW678, a
"lac strain that is wild-type (WT) for both acetate metabolism and crp (Table 1).
We grew the resulting monolysogen in tryptone broth (TB) at 37oC, harvested
cells at approximately one hour intervals, and compared its !-galactosidase
activity to that of monolysogens that carried 1) its parent 1xIHF, 2) the smaller
promoter fragment, 0xIHF (also known as pacs205), that includes acsP2, CRP I,
and CRP II, but lacks IHF III (Table 2, Fig. 9A), or 3) the full-length acs::lacZYA
fusion (FL) from which 1xIHF and 0xIHF were derived (Table 2, Fig. 9A). The
mutant 1xIHF-I3m exhibited about two-fold more activity than its parent 1xIHF,
but only about a third as much as FL and only about half as much as 0xIHF (Fig.
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9C). These results support the supposition that IHF III contributes to inhibition of
acs transcription and that sequences upstream of IHF III contribute to full
activation.
To determine whether inhibition by IHF also requires the integrity of the
DNA sites for CRP, we introduced mutations (Fig. 9B) previously shown to reduce
affinity for CRP (Ebright et al., 1984). We incorporated these mutations into
1xIHF and monitored the activity of the resultant constructs (Fig. 9C). 1xIHF-C1m
displayed about half the activity of its parent 1xIHF, approximately equivalent to
basal levels (data not shown). In contrast, 1xIHF-C2m exhibited as much activity
as 0xIHF, which lacks IHF III altogether. These results verify that activation of
acsP2 transcription requires CRP I (Beatty et al., 2003) and shows that IHFdependent inhibition requires CRP II.
This latter result came as a surprise, because Beatty and co-workers had
previously reported that disruption of the CRP II site in the full-length promoter
fragment (FL-C2m) exhibited two-fold less promoter activity than did its fulllength, WT FL parent (Fig 9C) (Beatty et al., 2003). To test our previous
observation, we constructed a promoter fusion that includes CRP I but lacks
CRP II (1xCRP; pacs155) (Fig. 9A), and monitored the activity of the resultant
construct (Fig. 9C). As predicted if CRP II enhanced transcription, 1xCRP
exhibited about one-half the activity displayed by 0xIHF, which includes both
CRP I and CRP II. In the context of 1xIHF, therefore, CRP II has the opposite
effect, acting negatively instead of positively.
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Inhibition of transcription
involves K101 of CRP
Previously, the Wolfe lab had
shown that CRP-dependent
activation of acs transcription from
FL promoter depends on AR1 but
not on AR2 (Beatty et al., 2003). To
explore the mechanism of inhibition
observed for 1xIHF, we performed
similar studies on the smaller
promoter constructs (Fig. 9A; Table
2). By generalized transduction, we
introduced a crp deletion allele into
monolysogens of 0xIHF and 1xIHF.
Figure 10. IHF III-dependent inhibition involves AR2 and AR3 of CRP. !galactosidase activity from promoter fragments 1xIHF, 0xIHF, and 1xIHF-C2m
fused to lacZYA. The wild type strain AJW678 was lysogenized with the hybrid
phage !CB22, "CB42, and "CB45, respectively. Each lysogen was deleted for
crp and transformed with plasmids expressing wild-type CRP or mutant
variants. Wild-type CRP possesses AR1 and AR2, but not AR3 and is
designated as 1+2+3o. The mutants either lack AR1 (1-) or AR2 (2-) or possess
the non-native AR3 (3+) or combinations of each. The resultant transformants
were grown in TB, samples harvested are regular intervals, and the peak !galactosidase activity determined and expressed relative to the mutant that
lacks AR2 1+2-3o. Each value represents the mean ± SEM of at least three
independent measurements. For each promoter construct, all values were
standardized to that obtained in the crp mutant transformed with the plasmid
expressing the mutant CRP KE101.

We

then

transformed the
resulting strains
with a set of
plasmids, each of
which expresses a
CRP variant (Table
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1). Each variant possesses one of the eight possible combinations of WT or
mutant versions of three surfaces known to be involved in transcription activation.
HL159 is defective for the AR1 surface that contacts the !-CTD of RNAP, KE101
is defective for the AR2 surface that interacts with the !-NTD, and the KE52
mutation exposes a non-native AR3 surface that contacts region 4.2 of "70.
Activation of Class I promoters, such as acsP2, absolutely requires AR1 (Fig.
4A). In contrast, activation of Class II promoters requires AR2 and either AR1 or
AR3 (Fig. 4B) (reviewed by (Busby and Ebright, 1999)).
For both 0xIHF and 1xIHF and for all other promoter constructs tested in
this study, activation required AR1. Without it, as we previously observed with the
FL promoter construct (Beatty et al., 2003), promoter activity was reduced to
basal levels, regardless of the status of the other two surfaces (Fig. 10 and data
not shown). When AR1 was left intact, activity from 1xIHF increased in the
absence of AR2. This effect was reversed by the presence of AR3, while the
effect of having both the AR2 and AR3 surfaces was additive (Fig. 10). In
contrast, activity from 0xIHF was generally unaffected by either the status of AR2
or the addition of the AR3 surface to the AR2-less mutant. However, the
presence of both AR2 and AR3 inhibited transcription. We conclude that AR2
contributes to IHF-dependent inhibition and propose that the additional presence
of AR3 (when both AR1 and AR2 are intact) over-stabilizes RNAP on the DNA.
Since inhibition depends upon both CRP bound at CRP II and an intact
AR2, we predicted that AR2 would have no effect in the absence of CRP II. To
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test this prediction, we introduced the crp deletion allele into a monolysogen that
carries 1xIHF-C2m, and transformed the resulting strain with plasmids that
express wild-type CRP or mutants defective for AR1, AR2, and/or AR3. As a
control, we did likewise with a monolysogen that carried 1xCRP, the promoter
construct that includes only the promoter proximal CRP I. The major difference
between the 1xCRP and 1xIHF-C2m was the presence of IHF III. As observed
with all acs promoter fragments, both these promoter constructions required AR1
for activation. With 1xCRP, like with 0xIHF, neither the lack of AR2 nor the
addition of AR3 to the AR2 mutant exerted a significant effect. In combination,
however, these surfaces inhibited transcription (data not shown). Surprisingly, the
loss of AR2 decreased transcription from 1xIHF-C2m, while the presence of AR3
suppressed this defect. As observed with 1xIHF, the combination of AR2 and
AR3 quite severely inhibited transcription, resulting in levels comparable to that
of mutants that lack AR1 (Fig. 10). Thus, on 1xIHF-C2m, the presence of IHF
makes AR2 a positive component of CRP-dependent activation above that
provided by AR1.

Characterization of protein binding
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To understand the unexpected behaviour caused by disruption of AR2
and/or the presence of IHF III, we characterized the binding of each protein to the
acs promoter region in vitro. Our collaborator, Dr. Bianca Sclavi, performed
DNase I footprint analyses of both 1xIHF (Fig. 11) and FL (Figure 12) to
determine whether the presence of IHF bound at IHF III and CRP bound to CRP
II can affect the binding of RNAP and the structure of the open complex. To best
mimic in vivo conditions, I constructed supercoiled DNA templates.

CRP
As observed previously with the linearized FL template (Beatty et al.,
2003; Browning et al., 2004), WT CRP elicited patterns of protection and
hypersensitive (HS) sites characteristic of binding to both CRP I and CRP II (Fig.
11A, lane 6; Fig. 11B; Fig. 12, lane 8). Surprisingly, CRP also elicited a pattern of
protection and HS sites upstream of CRP II. This pattern appears consistent with
the existence of a third, previously unidentified CRP binding site (CRP III).
Because this “site” bears only a vague resemblance (CTGCA n6 TCAAA) to the
consensus sequence (TGTGA n6 TCACA, (Ebright et al., 1989; Gaston et al.,
1989)) and because we did not observe this site when using the linearized FL
template (Beatty et al., 2003; Browning et al., 2004), we suspect that supercoiling
might increase the affinity of the template for CRP at this site.
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Figure 11. Simultaneous binding of IHF, CRP, and RNAP results in protection between the
tandem CRP sites. (A) 0.1 nM pSRacs236 (carrying the 1xIHFacs promoter sequences from positions
-171 to +65) was incubated with purified IHF (20 nM), either wild-type CRP or the AR2 mutant KE101
(100 nM), and/or increasing concentrations of RNAP, subjected to DNase I footprinting. The
concentrations of RNAP in each reaction was as follows: lanes 1-2, 6, 13-15, 19 (0 nM); lanes 3, 7, 10,
16, 20, 23 (10 nM); lanes 4, 8, 11, 17, 21, 24 (20 nM); lanes 5, 9, 12, 18 (50 nM). The stars and
diamonds denote RNAP- and CRP-associated HS sites, respectively. C, no proteins; U, uncut DNA.
(B) Line graph representing the data from lanes 12 (RNAP only, dotted line) and 9 (RNAP plus CRP,
solid line). The stars and diamonds denote RNAP- and CRP-associated HS sites, respectively. The
binding sites for CRP and RNAP are underlined. (C) Line graph representing the data from lanes 2
(IHF and WT CRP, solid line) and 5 (IHF, WT CRP and RNAP, dotted line). The stars denote RNAPassociated HS sites. The grey bar denotes the intersite region.

IHF
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On the linearized (Browning et al., 2004) or on the supercoiled FL
template, IHF protected an extensive stretch that corresponds to IHF I, IHF II and

Figure 12. Simultaneous binding of IHF, CRP, and RNAP results in protection between the tandem
CRP sites. (A) 0.1 nM pSRacs444 (carrying the FL acs promoter sequences from positions -379 to +65)
was incubated with purified IHF (20 nM), either wild-type CRP or the AR2 mutant KE101 (100 nM), and/or
increasing concentrations of RNAP, subjected to DNase I footprinting. The concentrations of RNAP in each
reaction was as follows: lanes 1-4, 8, 15-17, 21 (0 nM); lanes 5, 9, 12, 18, 22, 25 (10 nM); lanes 6, 10, 13,
19, 23, 26 (20 nM); lanes 7, 11, 14, 20, 24 (50 nM). The stars and diamonds denote RNAP- and CRPassociated HS sites, respectively. C, no proteins; U, uncut DNA.

IHF III (Fig. 12, lanes 3,16). In contrast, because 1xIHF does not include the
sequences for the two upstream sites, IHF protected only sequences that
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correspond to IHF III (Fig. 11A, lanes 1, 14). With both templates, the binding of
IHF was characterized initially by saturation of its specific binding site(s) followed,
at higher concentrations (>20 nM), by propagation of the footprint to adjacent
regions of the DNA (data not shown), a behaviour indicative of binding to lower
affinity sites. This was followed (>100 nM) by the appearance of hypersensitive
sites (data not shown), indicative of a reorganization of the DNA, possibly due to
the formation of a regular, compact structure.

CRP and IHF
The presence of 20 nM IHF (Fig. 11A, lanes 2, 15; Fig. 11C; Fig. 12, lanes
4, 17) caused the loss of the CRP III-associated HS sites. In contrast, IHF
exerted no substantial effect on the affinity of CRP to either CRP I or CRP II (data
not shown).

RNAP and CRP
The binding of RNAP alone provided weak protection from about -30 to
about -18 and induced a quadruplet of HS sites at -9 to -6 (Fig. 11A, lanes 10-12;
Fig. 11B; Fig. 12, lanes 12-14). Since RNAP alone can bind either to acsP2A or
to acsP2 (Beatty et al., 2003), we interpret this pattern as the average of the
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protection produced by the RNAP bound to acsP2 with that produced by the
RNAP bound at acsP2A.
The presence of CRP altered the pattern of protection and HS elicited by
RNAP at multiple locations (Fig. 11A, compare lanes 7-9 to lanes 10-12; Fig.
11B; Fig. 12, compare lanes 9-11 to lanes 12-14). For example, the quadruplet of
HS sites disappeared. Instead, a doublet of HS sites appeared (at positions -24
and -26) in the 17-bp spacer region between the -10 and -35 hexamers,
indicative of a distortion of the double helix. Just downstream of the CRP I site,
an additional protection was observed, possibly due to binding of the !-CTD as a
result of its interaction with AR1. The reverse also was true; the presence of
RNAP influenced the binding of WT CRP, substantially increasing the HS
associated with all three CRP binding sites and with the HS sites between CRP I
and CRP II (Fig. 3A, lanes 7-9; Fig. 12, lanes 9-11). Taken together, these results
are consistent with the formation of a cooperative interaction between CRP and
RNAP resulting in a structural rearrangement of the open complex.

RNAP, CRP and IHF
The combination of RNAP, IHF, and CRP (Fig. 11A, lanes 3-5; Fig. 11C;
Fig. 12, lanes 5-7) increased protection throughout the region downstream of
CRP II to about -40, especially between CRP II and CRP I. This inter-site
protection required IHF: in its absence, RNAP (Fig. 11A, lanes 7-9; Fig. 12, lanes
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Figure 13. IHF and CRP influence open complex
formation. (A) Potassium permanganate footprint
analysis of complexes formed at the acs promoter
region. The figure shows the modifications produced
when pSRacs236 (1xIHF) was incubated with purified
RNA polymerase in the absence or presence of IHF
and either WT CRP or the AR2 mutant KE101 and
subjected to potassium permanganate footprint
analysis. The concentrations of proteins were as
follows: RNAP (50 nM; lanes 2-9), IHF (20 nM; lanes
3-9), WT CRP (6 nM, lane 4; 12 nM, lane 5; 50 nM,
lane 6; 200 nM, lane 7) and CRP KE101 (12 nM, lane
8; 200 nM, lane m9). (B) Line graph of the data shown
in the gel.

9-11) exerted considerably less
influence. The replacement of WT CRP with the KE101 mutant in the presence of
IHF resulted in a significant decrease in the protection between CRP I and CRP II
(Fig. 11A, compare lanes 16-18 to lanes 3-5; Fig. 12, compare lanes 18-20 to
lanes 5-7). Similar results were observed with the FL template (data not shown).
Taken together, these data show that RNAP, CRP, and IHF can bind
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simultaneously at saturating concentrations to their respective specific binding
sites. Furthermore, they show that RNAP, IHF, and the AR2 surface of CRP are
required for the protection observed between the two CRP binding sites. This
inter-site protection may be interpreted as resulting from the formation of a more
compact higher order nucleo-protein complex.

Characterization of open complex formation
Since disruption of the lower affinity CRP binding site, CRP II, increased in
vivo promoter activity from 1xIHF, we predicted that within this context low
concentrations of CRP would favor transcription, while high concentrations would
inhibit it. To test this prediction, our collaborator, Bianca Sclavi, used potassium
permanganate, which modifies thymine residues found within single-stranded
DNA, to probe the supercoiled 1xIHF template for strand separation by RNAP, a
step in the process of transcription initiation called transcription open complex
(OC) formation (Record et al., 1996). Potassium permanganate modifies singlestranded DNA that results either from OC formation or from severe bends or
kinks in the DNA (Sasse-Dwight and Gralla, 1989).
In the presence of RNAP alone (Fig. 13, lane 2), modification of the 1xIHF
template occurred over an extensive region, as observed previously with a
linearized template of FL (Beatty et al., 2003). These modifications can be sorted
into two groups: P2A (-30/-29/-28, -22/-19) and P2, which can be further
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subdivided into P2UP (-13/-12, -10/-9, -7/-6) and P2DOWN (-1/+3). In the
presence of both RNAP and 20 nM IHF (Fig. 13, lane 3), a decrease in the
amount of modifications at P2A occurred. Since the frequency of modification at
P2UP did not change, we conclude that occupancy of IHF III by IHF does not
affect the ability of RNAP to form an OC at acsP2. In contrast, the titration of WT
CRP (Fig. 13, lanes 4-7) distinctively influenced each grouping. Increasing CRP
concentration progressively decreased modification at P2A, while generally
increasing modification at P2UP, as we observed previously (Beatty et al., 2003),

Figure 14. CRP influences the structure of the open complex independently of IHF.
Bar graphs representing the intensity of the bands at P2DOWN compared to the intensity
of the band at -10. The hatched bars represent the pacs236 (1xIHF) data shown in Fig.
13, lanes 2-9; the other bars represent data from a similar analysis (performed and
analysed simultaneously) of pSRacs444 (FL) performed in the absence of IHF (black) or
in the presence of IHF (grey). The numbers on the x-axis denote the concentration in nM
of either WT CRP or the mutant CRP KE101. Two pairs of reactions with no CRP are
represented: the first was performed in the absence of IHF and the second was
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especially at -6 and -7 (Fig. 13B). Strikingly, the effect at P2DOWN was nonlinear (Fig. 13B and 14): modifications increased up to 12 nM CRP, above which
they decreased. Since low CRP concentrations favoured occupancy of CRP I,
while high concentration favoured binding of both CRP sites (Beatty et al., 2003);
data not shown), bubble extension to P2DOWN thus inversely correlates with
occupancy of CRP II. Strikingly, the OC formed in the presence of the KE101
mutation was more open at its downstream end independently of the CRP
concentration. Under these conditions, we could observe an increase in the
intensity of the bands at -1 and +3 and a decrease of the intensity of the bands at
-9, -7 and -6 (Fig 13B and 14). This observation supports the hypothesis that the
AR2 surface is involved in an interaction between RNAP and CRP bound at
CRP I and that the binding of WT CRP to CRP II can stabilize this interaction and
affect the structure of the resulting OC. Since we observed similar behaviour with
FL in either the absence or presence of IHF (Fig. 14), this effect of CRP at the
acs promoter appears to be general.

CRP stabilizes the OC in the presence of binding to lower affinity sites by
IHF
Since 20 nM IHF did not exert a large effect on the RNAP footprint, we
speculated that the negative effect of IHF observed previously on FL in vitro
(Browning et al., 2004) might be due to its binding to lower affinity sites.
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Therefore, we followed the formation of the OC at increasing RNAP
concentrations at a moderately higher concentration of IHF (30 nM). At this

Figure 15. Binding of IHF to low affinity sites inhibits RNAP binding in the absence of CRP. Open
complex formation on P2/P2A by permanganate assay on pacs236 (1xIHF) DNA. (A). RNAP titrations
in the presence of WT CRP at 12 nM (thin bars) or 200 nM (thick bars). RNAP (10, 20, 30, 50, 75 nM)
binds to both the P2 and P2A promoter in the absence of other proteins. In the presence of CRP,
RNAP binds with similar affinity to P2 and no longer forms an open complex at P2A. (B) 30 nM IHF
inhibits formation of open complex at both P2A and P2. The presence of either WT CRP or KE101
allows RNAP to form an open complex. In the presence of the KE101 mutant or at low CRP
concentrations (12 nM) the band at -1 of P2 increases in intensity. This concentration of CRP suffices
to stabilize the open complex in the presence of IHF.

concentration, IHF inhibited OC formation at both acsP2A and acsP2, even at the
highest RNAP concentration tested. However, the addition of either WT CRP
(Fig. 15A) or KE101 (Fig. 15B) following the addition of IHF permitted RNAP to
form a OC at acsP2, but not at acsP2A. This was true even at the lower
concentration of WT CRP (12 nM). Thus, the CRP-RNAP complex can
successfully compete with this concentration of IHF for access to the acsP2
promoter, while RNAP alone cannot.

Discussion
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The multiple roles of CRP during activation of acs transcription
Previously, we reported that in vitro RNAP alone could form an open
complex (OC) at both acsP2A and acsP2. These OCs, however, were poorly
productive, as determined by in vitro transcription assays. In contrast, the
presence of CRP favoured OC formation at acsP2 and inhibited OC formation at
acsP2A and, as a result, activated transcription in vitro. Similarly, activation of
transcription in vivo required CRP, its AR1 surface, and an intact CRP I. On the
basis of these observations, we proposed that CRP “focused” RNAP to acsP2
(Beatty et al., 2003). In the current study, we show that the binding of CRP does
not substantially increase the extent of OC formation by RNAP on the acsP2
promoter. Instead, it causes a rearrangement of the interactions that RNAP
makes with that promoter and thus stabilizes a different form of the OC (see
below). The increased stability of this ternary CRP-RNAP-acsP2 complex
activates transcription at multiple levels. First, it inhibits the formation of nascent
binary RNAP-acsP2A complexes, but cannot successfully compete with preexisting ones (data not shown). Second, it results in a conformation of the open
complex that permits RNAP to initiate transcription and to overcome barriers to
elongation. Third, it stabilizes the OC in the presence of non-specific IHF binding.
This third effect might be important in vivo when IHF accumulates, which occurs
during entry into stationary phase (see below).
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The following evidence supports this model. (1) On naked DNA, in the
absence of CRP, the majority of OC are formed at acsP2A (Figs. 13, 14 and 15).
(2) The presence of even small amounts of CRP dramatically diminished OC
formation at acsP2A, without significantly altering the amount of OC formation at
acsP2, although it did affect its structure (Figs. 13, 14 and 15). (3) The presence
of small amounts of RNAP influenced the pattern of CRP-dependent DNase I
protection and HS and vice versa (Figs. 11 and 12), consistent with a cooperative
interaction between RNAP and CRP. (4) Disruption of AR1 reduced the CRPdependent inhibition of RNAP-acsP2A complex formation (data not shown), most
probably by decreasing the cooperativity of the CRP-RNAP interaction. This
reduced cooperativity would diminish the stability of the ternary CRP-RNAPacsP2 complex and, thus, provide an opportunity for unbound RNAP to bind to
free acsP2A. (5) In vivo activation of acs transcription depends upon both AR1
(Beatty et al., 2003) (Fig. 10) and determinant 287 (Beatty et al., 2003), a surface
patch of the !-CTD known to interact with AR1 (Busby and Ebright, 1999).
Most often the role of CRP at a Class I promoter (e.g. lac) is to stabilize
interactions of RNAP with the promoter. Stabilization of the closed complex
permits the subsequent formation of a OC (Busby and Ebright, 1999). At the
acsP2 promoter, this is still true (Fig. 16A) and is important for the CRP-RNAP
complex to compete with IHF and possibly other nucleoid proteins (see below).
However, RNAP alone can bind the acsP2 promoter, albeit in an inactive open
conformation (Beatty et al., 2003). This inactivity might result from improper
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Figure 16. Model of the complexes formed at the acsP2 promoter. RNAP alone can form an open
complex at the acsP2 promoter. This complex, however, is inactive (Beatty et al., 2003). The occupation of
CRP I by a CRP dimer mediates a change in the structure of the open complex by making contact between
its AR1 surface and that of the !-CTD of RNAP. This results in a deformation of the spacer, stabilization of
the P2 TOC at the expense of the P2A TOC, and transcription from the former. Depending upon the
concentration of CRP, this interaction can lead to two distinct open complexes: TOCA (top) and TOCI
(bottom). These two complexes differ in the extent of opening at the downstream end of the bubble and in
the level of transcription in vivo. Concentrations of CRP that lead to the occupation of CRP I alone favor the
formation of the forward-leaning TOCA, in which the DNA is open to the -1 to +3 positions (A).
Concentrations that favor the occupation of both CRP sites favor the formation of the backward-leaning
TOCI (B). TOCI is stabilized by an interaction with the AR2 region of CRP. The increased number of
interactions formed in this complex, compared to those formed in TOCA, increases the stability of RNAP on
the promoter, which results in increased transcription. The additional occupation of IHF III either increases
or decreases transcription, depending upon the status of CRP II. When CRP II is not occupied, the binding
of IHF enhances transcription, perhaps by increasing the stability of the open complex (C). When both CRP
sites are occupied, the binding of IHF to IHF III results in significantly reduced transcription, possibly
because compaction of the upstream elements overstabilizes the complex. The binding of IHF also causes
increased protection between the two CRP sites, possibly through a rearrangement of the interaction of the
!-CTDs with the upstream elements (D and F). This protection depends upon the presence of AR2, and
thus can only occur in the TOCI conformation. Occupation of the upstream IHF sites alleviates much of the
IHF III-dependent compaction (F). The thickness of the arrows indicates the relative transcription from each
complex. Note that although RNAP possesses only two !-CTDs, in some cases three or more !-CTDs are
shown in order to represent a number of possible contacts.

positioning of the !-CTD as observed at the malT promoter, whose binding site
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for !-CTD (i.e. UP element) and single binding site for CRP resemble CRP I of
acsP2 and the DNA sequence located immediately downstream (Tagami and
Aiba, 1999). To activate acsP2 transcription (in the absence of IHF), CRP
performs two roles. The first role is to inhibit the binding of RNAP to the
overlapping promoter, acsP2A. The second is to restructure the OC. By analogy
to the malT promoter, occupancy of CRP I by CRP might reposition the !-CTD to
a more favourable position through an interaction with its AR1 surface (Tagami
and Aiba, 1999), resulting in distortion within the spacer and stabilization of a OC
open at its downstream end. The end result would be a complex that is more
efficient in promoter escape.

The role of AR2
AR2, a well-characterized surface patch of CRP, has been shown to
activate transcription of Class II promoters by interacting with the !-NTD of
RNAP (Busby and Ebright, 1999; Lawson et al., 2004). To the best of our
knowledge, AR2 has never been reported to play a role in the regulation of a
Class I promoter or of a Class III promoter comprised of tandem Class I sites,
such as acsP2. Yet here, we determined that in vivo AR2 could influence AR1dependent activation of this Class III promoter, acting to either inhibit or activate
transcription depending upon context. Furthermore, we showed in vitro that
disruption of the AR2 surface results in a different structure of the OC, similar to
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the one observed at low WT CRP concentrations, when CRP II is less likely to be
occupied.
We propose that the presence of CRP bound at CRP II contributes to the
recruitment of the RNAP to the promoter through an AR1-!-CTD interaction (see
below), causing enhanced transcription as expected for a Class III promoter
comprised of tandem Class I sites (Fig. 16, compare panels A and B). This longrange interaction results in a bend in the upstream DNA that permits an
additional stabilizing contact via the AR2 surface between RNAP and CRP bound
to CRP I. We further propose that two distinct versions of the OC can form at
acsP2 in the presence of CRP (Fig. 16). The first version, termed OCA, is
expanded at its downstream end (to include positions -1 and +3). It is associated
with the occupancy of CRP I and/or the absence of the AR2 surface. The second
version, termed OCI, is more open at its upstream end (at positions -6 and -7). It
is associated with the occupancy of both CRP sites by WT CRP and, because of
the presence of additional upstream elements (e.g. CRP bound CRP II), with a
more stable RNAP-DNA interaction.
In the context of the 1xIHF promoter construct, where the binding of IHF to
IHF III accentuates the bending of upstream DNA, these additional upstream
stabilizing interactions can result in a decrease in the amount of transcription
(Fig. 16D). This model is supported by the following observations. First, the
reduced transcriptional activity exhibited by 1xIHF required IHF, CRPII and an

!"#

intact AR2. Second, with IHF bound at its specific sites, additional protection was
observed between the two CRP sites, but only in the presence of the intact AR2
surface. Third, the non-native AR3 surface could replace AR2. Intriguingly,
evidence exists that AR3, a native surface of the CRP paralog FNR, inhibits
transcription from certain semi-synthetic FNR-dependent Class III promoters
(Wing et al., 1995). Remarkably, an AR2-dependent interaction also could exert a
positive role. Maximal transcription from 1xIHF-C2m (which includes CRP I and
IHF III, but not CRP II) depended upon the presence of both IHF and AR2 as well
as the inability of CRP to bind at CRP II (Fig. 16C).
The mechanism by which the AR2 and AR3 surfaces of a CRP dimer
bound at a Class I position can interact with RNAP remains unclear; however, it
seems reasonable to propose that they do so by interacting with their known
RNAP targets, i.e. the !-NTD and region 4.2 of !70, respectively. These
interactions could take place through a bend in the DNA region between the
binding sites for the two proteins (i.e. CRP I and acsP2) or, alternatively, by
displacing RNAP from the promoter to bind next to CRP.
Whether OCI and OCA correspond to RPO1 and RPO2 as defined by
Record and co-workers (Record et al., 1996) or the moribund and active
complexes described by Shimamoto and co-workers (Kubori and Shimamoto,
1996; Susa et al., 2006) remains to be determined (Hsu, 2002). In the first case,
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OCI would be a necessary intermediate in the formation of OCA. In the second
case, these complexes would be the products of a branched pathway.

The roles of IHF
IHF is an abundant nucleoid protein that contributes to the organization
and the condensation of the chromosome. Estimated to be about 0.7 nM during
early exponential growth (Murtin et al., 1998), its concentration further increases
throughout growth to become the second most abundant nucleoid protein during
stationary phase (Azam et al., 1999; Ishihama, 1999). When IHF binds to its
specific sites, it causes a large distortion of the DNA where the double helix
bends up to 180 degrees and wraps around the protein (Lynch et al., 2003; Rice
et al., 1996; Travers, 1997). On the acs promoter, IHF can affect transcription
from three high affinity sites (IHF I - III) located between –140 and –240 upstream
of the transcription start site (Browning et al., 2004).
A major goal of this investigation was to understand the mechanism by
which IHF binding could influence the activity of RNAP at this promoter. On the
basis of our results, we propose a model by which IHF uses two distinct
mechanisms to affect transcription. The first mechanism depends on the binding
of IHF to its specific sites and results in the formation of a wrapped nucleoprotein
complex that also includes both CRP and RNAP. In contrast, the second
mechanism depends on the role of IHF as a nucleoid protein that, when present
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at higher concentrations, binds to lower affinity, less specific, sites and, in the
process, inhibits open complex formation.
The first mechanism is supported by the following observations: (1) the
presence of IHF on its three specific sites in the FL construct or on the IHF III site
of the truncated 1xIHF does not inhibit the formation of an open complex in vitro
in either the presence or the absence of CRP (Figs. 13-15). However, in the
presence of both RNAP and CRP, IHF does mediate increased protection of the
region between the two CRP sites (Figs. 11 and 12). (2) IHF-dependent
transcription inhibition in vivo requires both IHF III and CRP II (Fig. 9). It also
requires that at least one CRP dimer possess an intact AR2 (Fig. 10). Thus, this
mode of IHF-dependent inhibition likely results from the formation of a multiprotein complex where a multitude of stabilizing contacts made by RNAP results
in the formation of a poised OC as described above (Fig. 16D).
That over-stabilization of the OC by IHF could contribute to negative
regulation in vivo is supported by observations made previously in the context of
the FL WT acsP2 promoter construct. In this context, specific single alanine
substitutions in the !-CTD subunit of RNAP resulted in an increase in the amount
of transcription (Beatty et al., 2003). These mutations were located at R265, a
residue that enhances interaction with DNA; L260 and L262, residues located
close to and perhaps part of determinant 261, known to interact with region 4 of
sigma; and T301 and I303, which are either part of the DNA interaction
determinant or of some previously unknown surface. Mutation of these amino
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acids could either decrease the stability of the open complex allowing for a faster
escape or result in a less tightly wrapped multi-protein structure.
A second mode of IHF-dependent repression results from binding to lower
affinity sites in the promoter region.

While the three specific sites become

protected with an affinity of about 2 nM, we can observe the appearance of
additional DNase I protection due to binding to these lower affinity sites
beginning at 30 nM (data not shown). Under these conditions, IHF inhibits OC
formation by RNAP, which can be overcome by the presence of low
concentrations of CRP (Fig. 15). With IHF bound to its lower affinity sites, RNAP
cannot form the closed complex, presumably due to the low stability of these
initial interactions. In contrast, IHF at this higher concentration does not inhibit
the binding of RNAP in the presence of CRP, even when the transcription factor
is present at the lower concentration (12 nM) tested (Fig. 15). It appears that
CRP can stabilize the closed complex enough to compete successfully with IHF
and, thus, form an OC. This mechanism might be essential for transcription to
proceed in the face of the increased amounts of IHF as the cells enter stationary
phase (Azam et al., 1999).
Intriguingly, IHF also enhanced CRP-dependent activation in both the
1xIHF and FL constructs (Fig. 16C). In the 1xIHF construct, this was observed in
vivo only when CRP II remained unoccupied, exemplified by the mutant 1xIHFC2m construct (Fig. 10). In vitro results suggest that it could also occur on the
WT promoter whenever CRP concentrations are low and, hence, CRP II remains
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unoccupied. Since the CRP-RNAP complex cannot compete with preformed OC
at acsP2A, the presence of 12 nM CRP only partially inhibited OC formation at
acsP2A. In contrast, the combined presence of IHF and 12 nM CRP resulted in
the formation of virtually no open complex at acsP2A (Fig. 15). Thus, the
occupation of IHF III both increases the probability that an OC will form at acsP2
and, as described above, the probability that the OC eventually will become
poised, i.e. when the CRP concentration rises to levels that favour binding at
CRP II.
In vivo, the upstream sequence that includes IHF I and IHF II exerts an
overall positive effect on transcription ((Browning et al., 2004) and Fig. 9). It still
cannot be excluded that this positive effect could result from the binding to this
region of some as yet unidentified transcription factor; however, we currently
favour the possibility that it results from the ability of the multi-protein complex to
stabilize a DNA geometry that favours transcription initiation. The high affinity of
IHF for these sites (about 2 nM, data not shown) suggests that they might be
partially occupied most of the time in vivo and, thus, might play a role in the local
organization of the nucleoid (Murtin et al., 1998), especially under growth
conditions that favour strong activation of the acs promoter. It is anticipated that
large differences in the local structure of the DNA and its degree of supercoiling
would occur when IHF binds to all three sites (Fig. 16F) relative to when it binds
only IHF III (Fig. 16D). These differences could directly affect the efficiency of
transcription initiation (Travers, 2007).
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While we did not observe a substantial difference in the overall affinity of
RNAP for acsP2, or of CRP for its sites, we cannot exclude the possibility that the
presence of IHF exclusively at IHF III and the resulting changes in DNA structure
might affect the on and off rates of binding. An increased stability of the complex
would result in a slower koff. When combined with a decrease in kon, possibly
caused by reduced accessibility to the promoter, this would result in an
unchanged affinity constant. We are currently investigating this possibility.
While investigation of the 1xIHF promoter construct permitted identification
of AR2 as a potential mediator of stabilizing interactions with upstream elements,
it should not be ignored that the CRP II-, IHFIII- AR2-dependent inhibition
observed with this truncated promoter construct could occur within the context of
the FL WT promoter. The two upstream IHF sites co-localize with binding sites for
other transcription factors (NarL/P and FNR) and with at least one promoter,
acsP1. Competition has been reported between IHF bound at IHF I and both
RNAP and FNR for their overlapping sites and between IHF bound at IHF II and
NarL/P for their overlapping sites (Browning et al., 2002; Browning et al., 2005).
One could easily imagine that competition between IHF and these other proteins
might result in incomplete saturation of the two upstream IHF sites, especially
when faster growth rates keep the IHF pool small enough to only half-saturate its
highest affinity sites (Murtin et al., 1998). If the degree of wrapping of the nucleoprotein complex depends inversely on the number of IHF sites that become filled,
then at low IHF concentrations, a tightly wrapped complex would result in over-
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stabilization, poising the RNAP on the promoter (Fig. 16D). As growth slows and
more IHF sites become filled, the structure would become “loosened”, allowing
for more efficient escape of the poised RNAP (Fig. 16F). Because the RNAP
would already be present at acsP2 in the poised OC, it could respond rapidly to
the need to utilize acetate as a carbon source, a requirement that occurs as cells
approach stationary phase and the IHF pool approaches its maximum.
The global regulator CRP, like the nucleoid protein IHF, has many low
affinity sites on the chromosome (Grainger et al., 2005). CRP III may be one of
them. However, it is contained completely within a high affinity IHF site (IHF III)
that is likely to be filled as the cells reach stationary phase. Since this low affinity
CRP site also appears to be dependent on the supercoiling of the DNA and the
negative supercoiling of the DNA decreases as the cells reach stationary phase
(Travers and Muskhelishvili, 2005), the affinity of CRP III would be expected to be
at its lowest when IHF approaches its highest concentration. Thus, the question
remains whether this low affinity CRP site functions in vivo and, if so, whether
that function is positive or negative. In either case, the presence of low affinity
sites for both IHF and CRP raises a much larger issue. Although the primary role
of nucleoid proteins is to fold and organize the chromosome and the primary role
of global regulators is to modulate transcription, their roles often overlap. The
exact role in both cellular processes will depend upon the interplay between high
and low affinity sites of any given protein and the competition for overlapping
sites.
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Concluding thoughts

It is typically thought that the regulation of transcription depends on the
ability of one or a small set of transcription factors to recruit RNAP to the
promoter and to form a complex active for transcription. These interactions must
stabilize the active
complex on the
promoter long enough
to allow for RNAP to
begin transcription.
The regulation of
the acsP2 promoter
depends on a delicate
balance of proteinDNA
Figure 17. IHF-mediated inhibition requires Fis II. (A) This schematic shows
the 1xIHF promoter fragment with its promoters (P2 and P2A, bent arrows) and its
CRP, FIS and IHF binding sites. Inverted arrows indicate the locations of CRP I
and CRP II, as determined by similarity to consensus. Open rectangles designate
the locations of FIS II and FIS III and the hatched box designates the location of
IHF III, also determined by similarity to consensus. The FIS III sequence is shown
below and the substituted nucleotide is positioned below the mutated one. (B) !galactosidase activity from promoter fragments FL, 1xIHF, 0xIHF, or 1xIHF-F2m
variant fused to lacZYA. The resultant strains were grown in TB, samples
harvested at one-hour intervals, the !-galactosidase activity determined, and the
peak activity expressed as a percentage of wild-type. Each value represents the
mean + SEM of at least three independent measurements. The percentage
activities in relation to FL are noted within each histogram.

and

protein-protein
interactions that
p e r m i t s
integration of
several different
signals, each of

which reflects different aspects of the metabolic state of the cell. For acsP2, the
most important signals appear to be those represented by the concentrations of
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CRP, IHF and FIS. The specific pattern of acs transcription results from the
requirement for a combination of specific amounts of these three global
regulators. Activation occurs through rearrangements of the OC in addition to
stabilization against binding to lower affinity sites by IHF and other nucleoid
proteins. In contrast, inhibition can occur by over-stabilization of the OC by CRP
as in the context of 1xIHF. The resulting complex (comprised of IHF bound at
IHF III, CRP dimers bound at CRP II and CRP I, and RNAP bound at acsP2)
could fold into a wrapped conformation that inhibits escape due to numerous
interactions between RNAP and several upstream elements (Fig. 16D). Inhibition
of transcription at such a late stage in the process of forming a transcriptionally
active complex could facilitate a rapid response upon a change in nutritional
status.
In summary, during the early stages of exponential phase, FIS inhibits acs
transcription by steric hindrance of CRP binding (Browning et al., 2004). AcetylCoA synthetase is a high affinity enzyme that permits the scavenging for and
metabolism of small amounts of acetate previously excreted into the medium;
thus as the primary carbon source becomes depleted, the activation of the acs
promoter by small amounts of CRP-cAMP would delay entrance into stationary
phase. Thus, the proposed mechanism would link activation of acs transcription
to this transitional period. Furthermore, once the primary and secondary carbon
sources become depleted, the further increase in cAMP concentration would
result in formation of the inhibitory complex, reflecting the reduced metabolic
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rate. Finally, condensation of the nucleosome in stationary phase by IHF and
other nucleoid proteins would result in inhibition of open complex formation at
acsP2.
This study was published as:
Sclavi, B., Beatty, C. M., Thach, D. S., Fredericks, C. E., Buckle, M., and
Wolfe, A. J. 2007. The multiple role of CRP at the complex acs promoter depend
on activation region 2 and IHF. Molecular Microbiology 65:425-440.
What follows are experiments related to but not included in Sclavi et al.
These experiments specifically explore the role of the NAP Fis and of FIS II, its
DNA site that sits between but does not overlap the two CRP sites.

Fis-Dependent Inhibition of Transcription
Previously, we reported that the nucleoid protein, Fis, binds three sites
within the acs promoter region (FIS I, FIS II, and FIS III) (Fig. 6B). We also
reported that Fis inhibits acs transcription (Browning et al 2004). Part of this
inhibition can be attributed to anti-activation, i.e. the ability of Fis to out-compete
CRP for binding at their overlapping sites (Fis III and CRP I) (Fig. 8). In contrast,
the contribution of FIS II to inhibition is unclear. That FIS II contributes to
inhibition, however, is supported by the observation that its disruption in the WT
FL promoter construct permits elevated acs transcription that approximately
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equals that attained by disruption of FIS III (Browning et al 2004). Since FIS II
does not overlap either CRP I or CRP II, we sought a mechanism distinct from
the anti-activation mechanism associated with FIS III. To seek its role, we
disrupted FIS II in the context of the 1xIHF promoter fragment (1xIHF-F2m; Table
2).
The 1xIHF-F2m promoter was compared to 1) its WT parent 1xIHF, 2) FL,
and 3) 0xIHF (Fig. 17). As we
r e p o r t e d p r e v i o u s l y, 0 x I H F
displayed high promoter activity,
while 1xIHF exhibited extremely
low activity (Browning et al.,
2004; Sclavi et al., 2007).
S u r p r i s i n g l y, 1 x I H F - F 2 m
displayed activity similar to that of
0xIHF or approximately six-fold
more activity than its WT parent
(1xIHF). Whereas the activities of
the other promoter fragments

Figure 18. Both Fis and IHF reorganize RNAP binding
from P2a to the productive P2U promoter. Potassium
permanganate footprint analysis was utilized to determine
the location of open complex formation in the presence of
constant concentrations of RNAP, CRP, and IHF.
Increasing concentrations of Fis protein were titrated into
the mix. P2D, P2 downstream; P2U, P2 upstream.

peaked near the transition from
exponential phase into stationary phase then steadily decreased in stationary
phase, the 1xIHF-F2m promoter activity remained high despite entry into
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stationary phase (data not shown). I conclude that FIS II contributes to IHFmediated inhibition of acs transcription.
To explore the role of Fis, my collaborator (Dr. Bianca Sclavi) performed a
potassium permanganate analysis on supercoiled 1xIHF promoter fragment (Fig.
18). As observed previously (Fig. 13A), modification of the 1xIHF template
occurred at both P2A and P2 (Fig. 18, lane 1), while the addition of a high
concentration of CRP (200 nM) decreased modification at P2A, while increasing
modification at P2UP (indicative of the unproductive transcription complex) and
P2DOWN (indicative of the productive complex) (Fig. 18, lane 2). Increasing
concentrations of Fis (up to 60 nM) correlated with increased modification at
P2UP (Fig. 18, lanes 3-6). The presence of IHF inhibited this effect and further
reduced the modification at P2A (Fig. 18, lanes 7-10).
We conclude that Fis does not inhibit the binding of RNAP. Furthermore,
because Fis does not shift the modification back to P2A, it likely does not inhibit
the binding of CRP. These results contrast with those obtained in the absence of
RNAP, a condition under which Fis outcompetes CRP regardless of the order of
addition. Yet, in vitro, Fis inhibits CRP-dependent acs transcription (Browning et
al., 2004). Thus, we propose that Fis-mediated inhibition does not rely
exclusively on the competition between the overlapping Fis III and CRP I sites
and raises the possibility that FIS II is indeed involved (Fig. 8).
The genetic evidence (Fig. 17) clearly implicates FIS II in IHF-mediated
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inhibition. However, the potassium permanganate footprint analysis of the 1xIHF
template does not help to explain how. Intriguingly, the genetic evidence
conflicts with the previously reported conclusion - formed on the basis of DNase I
footprint and in vitro transcription analyses - that Fis and IHF function
independently to inhibit acs transcription (Browning et al., 2004). Efforts to
identify the role of FIS II in IHF-mediated inhibition are clearly warranted.

CHAPTER FOUR
EVIDENCE THAT IHF III IS A COMPOSITE SITE

Introduction
In the previous chapter, I presented evidence that IHF-mediated inhibition
relies upon (1) the ability of IHF to bind IHF III, (2) the occupation of tandem
CRP sites (CRP I and CRP II) by CRP, and (3) the surface determinant AR2 of
CRP. On the basis of my genetic evidence and the biochemical evidence of my
collaborator, I proposed that interactions between these three proteins and
RNAP resulted in the formation of a stalled open complex (Fig. 16) (Sclavi et al.,
2007). In brief, our model predicts that IHF-induced DNA bending causes the
tandem CRP dimers to trap RNAP at the promoter in an unproductive, open
complex.
In this chapter, I will provide evidence that IHF III is actually a complex
sequence that consists of two overlapping sites for IHF (denoted IHF IIIa and
IHF IIIb) offset by 2 bp, oriented in opposite directions, and positioned on
opposing faces of the DNA helix.
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Shared Protein Binding Sites in the acs-nrf Intergenic Region
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The approximately 300-bp nrf-acs intergenic region includes the
divergently transcribed nrf and acs promoters (Fig. 6). This region also appears
to include all of the necessary regulatory elements for both promoters (Wolfe,
2009). As both promoters share many of these regulatory elements, this presents
a logistical problem. The solution to this problem, however, may be simple. By
evolutionary design or by a fortuitous coincidence, cells express the acs and nrf
operons under vastly different, extreme conditions: acs is required for survival
under carbon starvation (Wolfe, 2009), while nrf is required under anaerobicnitrogen limitation (Browning et al., 2004). Yet, transcription from the acs
promoter does not seem to influence expression from the nrf promoter and vice
versa. It is proposed that this lack of competition between promoters in such
close proximity results from the infrequent firing of both promoters (Browning et
al. 2002). Thus, it is possible to understand the regulatory control of one
promoter in relative isolation from the other promoter. However, because many of
the regulatory elements are the same, lessons learned from the study of one
promoter can be productively used to understand the other.

An Argument that IHF III is a Composite Site
The central location of the three DNA sites for IHF lends support for the
hypothesis that they play critical roles in regulating the transcription from both the
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nrf and acs promoters. This hypothesis is further supported by the fact that they
are highly conserved across all sequenced E. coli genomes (Browning et al.,
2006). The experimental data make a compelling case for IHF I: by steric
hindrance, it represses transcription from both nrf and the minor promoter acsP1
(Browning et al., 2002; Wolfe, 2009). The experimental data also provide
evidence that IHF III plays a pivotal role. The binding of IHF to this site helps
promote transcription from Pnrf by a presently uncharacterized mechanism
(Browning et al., 2006). Meanwhile, it also mediates the formation of an
unproductive stalled open complex at the acs promoter through a mechanism
that also requires tandem CRP dimers and RNAP (Fig. 16) (Sclavi et al., 2007).
The role of IHF II remains unclear (see Chapter 5).
Intriguingly, the mutations used to demonstrate the involvement of IHF III
in the regulation of Pnrf and acsP2 implicate two different DNA sites for IHF
(Browning et al., 2006; Sclavi et al., 2007). That these two sites might exist came
from the observation that mutations introduced into the central motif of IHF III did
not fully relieve IHF-mediated inhibition of acsP2 transcription (Fig. 9) (Sclavi et
al., 2007). At first, I thought that incomplete relief of inhibition might result from
incomplete loss of IHF binding. However, this conclusion seemed unlikely, as
mutations of this kind in the central motif had been shown to cause severe
defects in binding (Lee et al., 1991; Hales et al, 1994; Yang and Nash, 1995; and
Aeling et al, 2006). A clue to this somewhat surprising result came from my
realization that IHF III might actually be a composite site. The IHF III site reported
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by our long time collaborators, the Busby lab, activated nrf transcription

(Browning et al., 2006); however, it was not the same IHF III site that we had

Figure 19. The putative IHF IIIa and IHF IIIb sites. IHF IIIa is on top reading from left to right with the
consensus sequence below. IHF IIIb is on the bottom reading from right to left with the consensus
sequence above. W, A or T; R, A or G; n, any nucleotide. The 5!-W6, central WATCAA, and 3!-TTR motifs
are denoted by a light blue, yellow, and green rectangles, respectively.

reported (Sclavi et al., 2007). The two sites overlapped, sat on opposite faces of
the DNA helix and were offset by 2 bp (Fig. 19). Could both sites exist?
Preliminary Evidence Supporting the Composite Site Hypothesis
To answer this question, I first tested the alternative hypothesis: that IHF III
is a single site consisting of only IHF IIIa. If this hypothesis is correct, then
mutations that alter this site should affect 1xIHF promoter activity in a predictable
fashion. For example, introduction of the double mutation C150G C152G into the
central motif of the putative IHF IIIa (CCTCAA to CGTGAA) reduces the site’s
similarity to consensus (WATCAA). As described above, this mutation resulted in
moderately enhanced transcription from the acsP2 promoter (Sclavi et al., 2007),
as would be predicted if the binding of IHF to IHF III were an inhibitory event. If
so, I reasoned that mutations that brought the central motif of IHF III closer to
consensus would decrease transcription from acsP2. Therefore, I constructed the
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C152A C153A double mutant, which converts the native central motif from
CCTCAA to AATCAA, which is identical to central motif of the phage IHF site H’,
considered by many to be the ideal IHF sequence (Lee et al., 1991).
Both mutations were introduced into the 1xIHF promoter fragment (Table
3). The mutant promoter fusions were then recombined into a hybrid
bacteriophage and introduced as a monolysogen into AJW678, a lac strain that is
WT for both acetate metabolism and crp (Table 1). The resulting monolysogens
were grown in TB at 37oC, cells were harvested at approximately one hour
intervals, and their !-galactosidase activity compared to that of monolysogens
that carried the parent promoter fragment 1xIHF. As a control, I also tested the
0xIHF promoter fragment, which does not carry IHF III (Table 3).
As observed previously (Fig. 9) (Sclavi et al., 2007), the C150G C152G
mutant (also known as 1xIHF-I3m) yielded activity intermediate to the WT 1xIHF
and 0xIHF promoter fragments (Fig. 20). Contrary to our prediction, the C152A
C153A mutant alleviated inhibition. Thus, I concluded that the alternative
hypothesis was probably incorrect.
Coincidentally, the C153A mutation in the IHF IIIa site is predicted to
strengthen the central motif (from GAACAT to TAACAT) of the putative IHF IIIb
site reported by Browning et al. (2006). This led us to propose and then test the
hypothesis that both sites existed and that they both influence acsP2
transcription.

Systematic Mutation of IHF IIIa and IHF IIIb Sites
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Since the discovery
of IHF, extensive work has
been done to understand
the mechanism by which it
recognizes and binds to
DNA. Like its homologue,
HU, IHF has the propensity
to bind to bent DNA
structures. However, IHF
does so in a sequence
specific manner. There are
two distinct DNA regions in

Figure 20. Initial mutagensis of IHF III. !-galactosidase activity
from promoter fragments 0xIHF, 1xIHF, and the 1xIHF variants
C152G C150G and C153A C152A fused to lacZYA. The wild type
strain AJW678 was lysogenized with the hybrid phages. The
resultant strains were grown in TB, samples harvested at onehour intervals, the !-galactosidase activity determined, and the
peak activity expressed as a percentage of wild-type. Each value
represents the mean + SEM of at least three independent
measurements. Promoter activity is relative to that of the 0xIHF
construct.

an IHF site. The first being the core sequence WATCAA-n4-TTR (W = T or A; R =
A or G; n = any base). These core bases are sufficient for IHF binding; however,
binding is further enhanced when a dA-dT rich region is present 5’ to the core
sequence. Because the bases of the dA-dT rich region vary, it is simply depicted
as: 5’-W6-n8 (Hales et al, 1996; Goodrich et al, 1990).
To identify bases of the core sequence and dA-dT rich region important for
IHF binding, Lee et al. (1991) generated single base pair mutations in three
phage IHF sites - H’, H1 and H2 – and tested IHF affinity using a challenge
phage assay. The resultant mutations were sequenced and categorized as weak,
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moderate, or strong mutants (Fig. 21). Briefly, these studies revealed that single
base pair mutations in the C of the central WATCAA motif and in the middle T of
the TTR severely reduced IHF binding. Based on this study, I introduced a series
of single base pair replacement mutations into the putative IHF IIIa site or the

Figure 21. Mutations reported to cause defects in IHF binding. The 5!-W6, central
WATCAA, and 3!-TTR motifs of the consensus and H! sites are upper case, bold and blue. The
non-consensus nucleotides are lower case and black. Substitution mutations reported to cause
binding defects are shown below. The length of the arrow denotes the strength of the defect.
(adapted from Lee et al. 1991)

putative IHF IIIb site or both to favor IHF binding to one site or the other. The goal
was to: 1) determine if IHF III is a dual overlapping IHF site; 2) assuming that
both sites do exist, then determine if either or both sites affect acs transcription;
and 3) finally determine the effect (either positive or negative) on acsP2
transcription of IHF when bound to either IHF IIIa or IHF IIIb.
Each mutation was introduced into the 1xIHF promoter fragment. The
mutant promoter fusions were then recombined into the hybrid bacteriophage
and introduced as a monolysogen into AJW678 (Table 1). Each resulting
monolysogen was aerated in TB at 37oC, cells were harvested at approximately
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one hour intervals, and their !-galactosidase activity compared to that of
monolysogens that carried the parent 1xIHF, 0xIHF, and the FL promoter
fragments (Table 3). Figure 22 summarizes the results of these studies.

Mutations in the 3’-TTR motifs
A164T T142A. If both sites exist, I predicted that disrupting the second T in each
TTR, and thus disrupting the ability of IHF to bind both sites, would result in
behavior that resembles the 0xIHF promoter fragment. Thus, I substituted a T for

Figure 22. Sytematic mutagenesis of the putative composite IHF III site. The IHF IIIa and IHF IIIb sites
and matching consensus are as in Figure 19. The relative promoter activities of the 1xIF and 0xIHF promoter
fragments are shown above as dashed lines. Nucleotide substitutions are located above the sequences.
Nomenclature is according to the top strand (IHF IIIa). Blue, red, and purple mutations are predicted to
disrupt IHF IIIa only, IHF IIIb only, or both IHF IIIa and IHF IIIb, respectively. The length of the arrow denotes
the mutant promoter strength relative to that of the 1xIHF and 0xIHF constructs.

the native A at bp 164 and an A for the native T at bp 142. Each of these
mutations targets the middle T of the respective TTR, which is a mutation shown
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to severely reduce IHF binding to lambda phage H’ (Fig. 21) (Lee et al., 1991).
Note that the each mutation also alters the opposing site’s dA-dT rich region in a
manner that severely diminished IHF binding (Lee et al., 1991). Thus, both
A164T and T142A are predicted to reduce the consensus of both their respective
3’-TTR motif and the opposing site’s 5’- W6 motif. The result should be a severe
reduction in the ability of IHF to bind either site. Indeed, the double mutant
A164T T142A performed well, resulting in activity that sometimes resembled that
of the 0xIHF promoter fragment (Fig. 22) and sometimes that of the FL promoter
(data not shown).

A164T. Since the A164T mutation reduces the consensus of the 3’-TTR motif of
IHF IIIb and the 5’-W6 motif of IHF IIIa (Fig. 22), I chose to test this single mutant.
As predicted, this mutation in the context of the 1xIHF promoter fragment
increased promoter activity to a level that resembled that of the 0XIHF promoter
fragment.

T142A. In contrast, the T142A mutation reduces the consensus of the 3’-TTR
motif of IHF IIIa and the 5’-W6 motif of IHF IIIb (Fig. 22) and, as such, is also
predicted to reduce IHF binding to both IHF III sites. Unlike A164T, the T142A
mutant promoter fragment exhibited activity intermediate to the 1xIHF and 0xIHF
promoter fragments.
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A141T. To be thorough, I also mutated the R of the IHF IIIa TTR motif,
substituting a T for the native A, reducing consensus and thus likely binding
affinity. According to Lee (Fig. 21), this mutation also should slightly increase
consensus of the IHF IIIb 5’-W6 motif, by substituting the more consensus A for
the native T on the complementary strand. The result of this mutation was
promoter activity at or above that observed with the 0xIHF construct (Fig. 22).
Together, these results confirm the key role that IHF III plays in the inhibition
of CRP-dependent acsP2 transcription. However, since these mutations are
predicted to disrupt binding of IHF to both sites (Lee et al., 1991), I could not
distinguish the influence of each individual site. To do that, I had to introduce
mutations predicted to exert a major effect on only one site. For IHF IIIb, I
introduced G156T, the mutation reported by Browning and co-workers (Browning
et al., 2006) and T155G; for IHF IIIa, I introduced C150A and A149C.

Mutations that disrupt one site or the other but not both
G156T and T155G. The substitution of either a T for the native G at bp 156 or G
for the native T at bp 155 reduces the consensus of the central WATCAA motif of
IHF IIIb (located on the complementary strand) from GAACAT to GAAAAT or
GACCAT, respectively. They both are predicted to disrupt binding of IHF to IHF
IIIb (Lee et al., 1991). Because they alter the n8 between the 5’-W8 and the
central motif, however, these substitutions should exert little or no effect upon the
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binding of IHF to IHF IIIa. The G156T mutation severely diminished Pnrf activity,
leading to the hypothesis that IHF III played a role in nrf transcription (Browning
et al., 2006). Both mutations resulted in acsP2 transcription intermediate to that
of the 1xIHF and 0xIHF promoter fragments (Fig. 22). On the basis of these
observations, it appears that IHF IIIb exists, that it plays a positive role for Pnrf
activity, and that it plays some inhibitory role at acsP2.

C150A and A149C. In contrast, replacement of either an A for the native C at bp
150 or C for the native A at bp 149 reduces the consensus of the central
WATCAA motif of IHF IIIa from CCTCAA to CCTAAA and CCTCCA, respectively.
Both substitutions are predicted to disrupt binding to IHF IIIa (Lee et al., 1991).
However, both mutations should be without substantial, if any, affect on the
binding of IHF to IHF IIIb because both substitutions alter the n8 located between
the central and 5’ motifs. Both mutations exerted strong effects on acsP2
transcription, resulting in activity that matched or exceeded that of 0xIHF (Fig.
22). On the basis of these results, it appears that IHF IIIa exists and that it plays
a major inhibitory role at acsP2.

Replacement of IHF IIIa with IHF IIIb and Vice Versa
The experiments described above are consistent with the hypothesis that
IHF III is a composite site composed of two overlapping sites that are oriented in

o p p o s i t e

!!"

directions and that
sit on opposing
faces of the DNA.
M u t a t i o n s
predicted to
severely reduce
the affinity of both
IHF IIIa and IHF
IIIb (A164T or
T142A or both)
resulted

in

e l e v a t e d
transcription from
the

1xIHF

p r o m o t e r
f r a g m e n t .
M u t a t i o n s
predicted to

Figure 23. Swapping IHF IIIa and IHF IIIb. (A) The native IHF III sequence with
the conserved motifs shown in red. (B) The VF sequence, in which IHF IIIb is
positioned in the native IHF IIIa location and vice versa. (C) !-galactosidase activity
from promoter fragments FL, 1xIHF, 0xIHF, 1xIHF-VF fused to lacZYA. The wild
type strain AJW678 was lysogenized with the hybrid phages and the resultant
strains were grown in TB, samples harvested at one-hour intervals, the !galactosidase activity determined, and the peak activity expressed as a percentage
of wild-type. Each value represents the mean + SEM of at least three independent
measurements. Promoter activity relative to that of the FL construct.

severely reduce the affinity of either IHF IIIa (C150A or A149C) or IHF IIIb
(T155G or G156T) provided evidence that both sites exist. However, the data are
not definitive. To perform a more rigorous test of the composite site hypothesis, I
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constructed a promoter fusion (1xIHF-VF; Table 3) in which the IHF IIIa and IHF

IIIb sites are swapped. If IHF III is a composite site and if both sites contribute to
regulation of acsP2 transcription, then I reasoned that the activity of the mutant
promoter 1xIHF-VF would exhibit behavior that is similar, if not identical, to the
WT 1xIHF promoter.
I constructed the 1xIHF-VF promoter (see Figure 23B) using a 45 bp primer
encoding the 5’ – IHF IIIb – 3’ aligning it on the same DNA strand as the tandem
CRP sites (CRP I and CRP II) and the RNAP binding site. Thus, in 1xIHF-VF,
IHF IIIb is positioned in the exact original location of IHF IIIa. Simultaneously,
IHF IIIa is placed onto the opposite DNA strand in the original location of IHF IIIb.
I recombined the mutant promoter fusion, 1xIHF-VF into the hybrid
bacteriophage and introduced it as a monolysogen into AJW678 (Table 1). I grew
the resulting monolysogen in TB at 37oC, harvested cells at approximately one
hour intervals, and compared its !-galactosidase activity to that of monolysogens
that carried the 1xIHF, 0xIHF, or FL promoter constructs (Fig. 23C).
As shown previously (Fig. 9C), the FL promoter fragment exhibited the most
activity, while the 0xIHF promoter fragment displayed somewhat less activity. In
contrast, the 1xIHF promoter fragment exhibited even less. Strikingly, the 1xIHFVF promoter fragment displayed activity that most closely resembles the weak
activity of the 1xIHF promoter. Although this result is consistent with the
hypothesis that IHF III is a composite site, alternative explanations could be
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envisioned. It is unlikely, however, that other mechanisms would require all of the

Figure 24. 1xIHF and 1xIHF-VF activities involve AR2 and AR3 of CRP. !-galactosidase activity from
promoter fragments 1xIHF and 1xIHF-VF fused to lacZYA. Each lysogen was deleted for crp and
transformed with plasmids expressing wild-type CRP or mutant variants. Wild-type CRP possesses AR1
and AR2, but not AR3 and is designated as 1+2+3o. The mutants either lack AR1 (1-) or AR2 (2-) or possess
the non-native AR3 (3+) or combinations of each. The resultant transformants were grown in TB, samples
harvested are regular intervals, and the peak !-galactosidase activity determined and expressed relative to
the mutant that lacks AR2 1+2-3o. Each value represents the mean ± SEM of at least three independent
measurements.

elements shown to be required for IHF-mediated inhibition of transcription from
the 1xIHF promoter fragment. I reasoned that the more properties that 1xIHF-VF
shares with 1xIHF, the more likely that the same mechanism regulates their
transcription. Thus, I tested whether the poor activity elicited by 1xIHF-VF
required the same surfaces of CRP that influence the activity exhibited by 1xIHF.
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Activity from the 1xIHF-VF and 1xIHF Promoters Involves the Same
Activation Regions
As described previously, CRP possesses three surfaces that interact with
RNAP: AR1, AR2, and AR3 mediate protein-protein interactions with the -CTD,
the -NTD, and region 4.2 of the sigma subunit, respectively (Fig. 4). Transcription
activation from the 1xIHF promoter fragment requires AR1; without it, activation
does not take place, regardless of the status of AR2 and AR3. In contrast, AR2 is
a key component of IHF-mediated inhibition; eliminating AR2 relieves inhibition.
In the absence of AR2, the presence of AR3 can compensate while the presence
of both AR2 and AR3 causes an even more severe inhibition of transcription
(Sclavi et al., 2007).
Monolysogens of either the parental 1xIHF or the mutant 1xIHF-VF
promoter fusion, defective for endogenous CRP (crp::kan), were transformed with
plasmids carrying either WT CRP, the AR2 mutant, the AR2/AR3 mutant, the AR3
mutant, or the AR1 mutant (Table 1). The resultant transformants were aerated in
TB at 37oC, the cells were harvested at approximately one hour intervals, and
their !-galactosidase activity measured.
The behavior of the 1xIHF-VF promoter fragment (Fig. 24B) completely
resembled that of its 1xIHF parent (Fig. 24A). Transformants of either promoter
fragment that expressed WT CRP (AR1+ AR2+ AR3o) exhibited poor
transcriptional activity, while those that expressed the AR2 mutant (AR1+ AR2AR3o) displayed substantially more activity and those that expressed the AR2/
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AR3 double mutant (AR1+ AR2- AR3+) exhibited activity similar to that of WT. In
contrast, transformants of either promoter fragment that expressed the AR3
mutant (AR1+ AR2+ AR3+) exhibited activity about as low as that displayed by the
AR1 mutant (AR1- AR2+ AR3o).

Thus, for both promoters, disruption of AR2

caused relief of inhibition in the context of both promoter fragments, the
unmasking of AR3 on a CRP protein that retains AR1 compensated for the
disruption of AR2, the presence of all three surfaces caused extremely low
transcription that resembled that of the AR1 mutant.
Thus, the requirements for IHF-mediated inhibition are the same for 1xIHF
and 1xIHF-VF. The simplest explanation is that IHF III is indeed a composite
binding site consisting of two overlapping IHF sites.

Discussion
IHF III is a composite site
The data obtained from the systematic mutational analysis is consistent with
the hypothesis that transcription depends on more than one IHF III site. For
example, A149C disrupts the central IHF binding motif of IHF IIIa. This mutation,
predicted to reduce or eliminate IHF binding to IHF IIIa, resulted in activity that
was higher than that of the 0xIHF promoter fragment. This behavior might be
explained in terms of enhanced binding of IHF to the opposing site IHF IIIb,
which would function in a positive manner. This scenario is unlikely, however,
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because disruption of the central motif of IHF IIIb also resulted in enhanced
promoter activity. Furthermore, these central motif mutations resulted in activity
similar to that obtained when both sites were disrupted. I therefore proposed that
both sites exist and that they both contribute to IHF-mediated inhibition of acs
transcription. My proposal was validated by the behavior of the 1xIHF-VF
promoter construct that, in all tested characteristics, mirrored that of the parental
1xIHF promoter fragment.
The degree to which each mutation altered inhibition varied from mutation
to mutation. A simple explanation for the different degrees of promoter activities
may be attributed to the relative importance of certain bases in protein-DNA
interactions between IHF and the two IHF III binding sites. Mutations in single
IHF sites show profound differences in protein binding and thus activity (Lee et
al., 1991). This is not to suggest that this is true for all IHF sites. It is entirely
possible that mutations made in overlapping IHF sites may be masked by the
presence of an additional site. IHF binding to the weakened IHF III sequence
may be compensated by the second IHF site or by preserving the general DNA
secondary structure or through sequence recognition. Additionally, the
requirement for specific bases may vary from binding site to binding site and is
probably dictated, to some degree, by upstream and downstream sequences as
well as the proteins present at any given time. Taken together, however, the
results presented in this chapter support our hypothesis that both IHF IIIa and
IHF IIIb exist.

Both IHF IIIa and IHF IIIb Contribute to Inhibition
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On the basis of these results, I also propose that both sites contribute to
IHF-mediated inhibition. In support of this hypothesis, Dr. Cathy Lawson (Rutgers
University) used in silico molecular modeling to determine the overall structure of
an IHF/IHF IIIa- or IHF/IHF IIIb-mediated complex in the context of CRP dimers
bound to the downstream CRP II and CRP I and the -CTD bound to the region
just adjacent to CRP I (Fig. 25). The modeled output for both complexes shows
almost identical DNA bends when IHF is placed on either IHF IIIa or IHF IIIb.
Thus, when the downstream sites are occupied, IHF is predicted to bend the
DNA in the same manner regardless of the IHF III site that it binds. Though the
modeling program generated structures that are consistent with available
crystallography data, these predictions were performed out of the context of the
upstream sites (e.g. IHF II) and some of the downstream sequences (e.g. the -35
and -10 hexamers). Though IHF interaction with either site may result in similar
bend angles, it should be noted that the DNA structure in vivo might prove to be
very different when bound along side the proteins that bind these additional sites.
It is curious that both IHF III sites seem to mediate inhibition. Originally, we
had predicted that the opposing IHF site, IHF IIIb, would counterbalance the
negative affects of IHF IIIa in order for transcription to proceed. However,
according to my data, both sites are required for inhibition – mutating either site
resulted in promoter activity higher than that of the 1xIHF fragment and often as
high as that of the 0xIHF construct. Based on these results, I conclude that
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inhibition is not advanced by the reduction of binding affinity of either site.
Perhaps IHF oscillates between IHF IIIa and IHF IIIb, interrupting the interaction
between CRP and RNAP and thereby disrupting transcription. For transcription to
occur, it is possible that proteins bound to upstream sequences insulate the
transcription apparatus from the effects of the IHF/IHF III complex (see Chapter
Five). Further investigation is warranted to identify the exact mechanism of IHF
III-mediated inhibition by this complex site.

Figure 25. A folding model for IHF IIIa versus IHF IIIb in the context of 1xIHF. IHF (purple)
bound to either IHF IIIb or IHF IIIa, CRP (blue) bound to CRP II and CRP I, and one !-CTD
(green) bound to the region directly adjacent to CRP I. The DNA double helix is in white and
cream. Note the similarity of the bends caused by the binding of IHF to IHF IIIb and to IHF IIIa
and the lack of difference of effect on the downstream structure. Also note the lack of space
between the CRP dimers for the binding of the other !-CTD (modeling performed by C.
Lawson, Rutgers University).

CHAPTER FIVE

EVIDENCE THAT THE UPSTREAM SINGLE IHF II SITE
ANTAGONIZES IHF IIIa/b-MEDIATED INHIBITION
Introduction
In the previous chapter, I presented evidence that IHF III is a composite
site, comprised of inverted dual-overlapping sites (denoted IHF IIIa and IHF IIIb).
I proposed that when IHF binds to either IHF IIIa or IHF IIIb, it severely inhibits
CRP-dependent transcription, at least in the context of the 1xIHF promoter
fragment. This severe inhibition appears to require both sites through some
currently unknown mechanism.
However, IHF-mediated inhibition is relieved by DNA sequences located
upstream of IHF III (Browning et al., 2004; Sclavi et al., 2007). Since IHF is
always present at moderately high levels in the cell (Azam, 2004), the low level of
transcription exhibited by the 1xIHF promoter fragment is what we would expect
from the FL promoter in vivo. Instead, the FL promoter exhibits considerably
higher activity.
To explain this dichotomy, we propose that a cis element and/or a trans118
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factor must antagonize IHF-dependent inhibition - otherwise acs transcription

might never take place. Interestingly, the region encompassing both IHF III and a
short sequence immediately upstream includes two sequences that may offer an
explanation for how IHF-mediated inhibition is counteracted: a perfect palindrome
and IHF II.
In this chapter, I will provide evidence that the palindrome does not appear
to influence acs transcription. I will then present evidence that supports the
hypothesis that IHF II can antagonize the negative effects of IHF III on acsP2
transcription and that occupancy of IHF II could guide IHF binding to IHF IIIb and,
as a consequence, activate transcription from acsP2.

The Palindrome does not Modulate IHF-Mediated Inhibition
Experimental evidence verified the existence of a DNA site for IHF (IHF II)
located immediately upstream of IHF III (Browning et al., 2004; Sclavi et al.,
2007). Bioinformatic analysis also revealed the existence of a perfect palindrome
that overlaps the junction between IHF III and IHF II.
To determine if either sequence influenced acs transcription, I constructed
two promoter constructs: 1xIHF+5 and 2xIHF (Fig. 26A; Table 4). The former
adds 5 bp to the 5’ end of the 1xIHF promoter fragment; thus, reconstituting the
entire palindrome. The latter adds 25 bp; thus, reconstituting both the palindrome
and IHF II.
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Both promoter fragments were recombined into a hybrid bacteriophage
and introduced as a monolysogen into AJW678 (Table 1). The resulting
monolysogens were grown in TB at 37oC, cells were harvested at approximately
one hour intervals, and their !-galactosidase activity compared to that of
monolysogens that carried the FL, 1xIHF and 0xIHF promoter fragments.
As shown previously, the FL promoter exhibited the highest activity, the
1xIHF construct yielded the least activity, and the 0xIHF construct displayed an
intermediate activity (Fig. 26B). Interestingly, the 1xIHF+5 promoter exhibited
somewhat more activity than 1xIHF, while the 2xIHF promoter fragment yielded
activity that resembled that of 1xIHF.
On the basis of these results, I hypothesized that the palindrome was an
antagonist of IHF III-mediated inhibition. A palindromic sequence can function
either as a binding site for a homodimeric transcription factor or as a region of
DNA that can form a secondary structure, called a cruciform, that could influence
protein binding or some aspect of DNA metabolism. If the increased transcription
exhibited by 1xIHF+5 resulted from the presence of the palindrome, then
disruption of one of its half sites would be predicted to prevent protein binding or
efficient formation of cruciform DNA. Thus, we expected to observe reduced
promoter activity to levels similar to that exhibited by the 1xIHF promoter.
Because the downstream half-site overlaps IHF IIIa and IHF IIIb, I scrambled the
5 bps of the upstream half-site. Unexpectedly, this construct (1xIHF+5S; Table 4)
exhibited activity similar to that of the 1xIHF+5 promoter (data not shown).
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Based on this result, I conclude that the palindrome does not affect acs
transcription, either
as a binding site for
a

protein

homodimer or as a
site for hairpin loop
formation. I do not
understand why the
5 bp adjacent to
IHF III in the
context of the
1xIHF promoter
fragment enhances
transcription;

Figure 26. Presence of the complete palindrome sequence increases transcription from 1xIHF+5
promoter. (A) This schematic shows the acs promoter region from positions -379 to +65 relative to the acsP2
transcription start site (+1). It shows the locations of each promoter, each CRP and IHF binding site and the
extent of the promoter fragments. The bent arrows indicate the approximate location of each promoter and its
direction of transcription. Inverted arrows indicate the locations of CRP I and CRP II, as determined by
similarity to consensus. Hatched boxes designate the locations of IHF I-III, also determined by similarity to
consensus The orange rectangle indicated the approximate location of the palindrome. (B) !-galactosidase
activity from promoter fragments 0xIHF, 1xIHF, 1xIHF+5, 2xIHF, or FL fused to lacZYA. The wild type strain
AJW678 was lysogenized with the hybrid phages carrying the corresponding acs promoter fragment. The
resultant strains were grown in TB, samples harvested at one-hour intervals, the !-galactosidase activity
determined, and the peak activities compared. Each value represents the mean + SEM of at least three

however, the negative result in response to such a massive alteration in
sequence led me to end this line of investigation and instead focus on IHF II.

Evidence that IHF II is a Positive Modulator of IHF III-Mediated Inhibition
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The weak promoter activity exhibited by the 2xIHF construct (Fig. 26B) is
consistent with a model in which IHF bound at IHF II plays a minor role at best.
Indeed, a mutation in its central motif, changing the sequence from TTTCAA to
TTTGAA such that the binding of IHF to IHF II should be substantially diminished
(Table 4), resulted in activity similar to that of the 1xIHF and 2xIHF promoter
fragments (data not shown).
To determine if this weak promoter activity resulted from the same
mechanism as observed in the context of the 1xIHF promoter construct, I tested
the involvement of the activation surfaces of CRP. To do so, I used P1
transduction to introduce crp into the monolysogen that carried the 2xIHF
promoter fragment. The resultant strain was then transformed with plasmids
carrying various mutant CRP genes (Table 1). The resultant transformants were
grown in TB at 37oC, the cells were harvested at approximately one hour
intervals, and their !-galactosidase activities were compared. Like the 1xIHF
promoter fragment, promoter activity from the 2xIHF construct required AR1 and
was inhibited by AR2 and AR3 (data not shown). On the basis of these results, it
would seem that IHF II plays no significant role in acs transcription; however,
subsequent studies revealed that this conclusion was untrue.
In an effort to thoroughly examine the role of IHF II in the context of IHF IIImediated inhibition, I disrupted CRP II and IHF IIIa in the context of the 2xIHF
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construct. The resulting mutant promoter constructs (denoted 2xIHF-IHF3m and
2xIHF-C2m; Table 4) were recombined into the hybrid

bacteriophage and

introduced as monolysogens and compared to that of monolysogens that carried
the FL, 2xIHF, 1xIHF and 0xIHF promoter constructs. The controls all behaved as
expected based on the results of previous experiments. The mutant 2xIHF-C2m
exhibited activity similar to that of 0xIHF (Fig. 27), a result that also suggests that
the weak promoter activity of 2xIHF results from a mechanism similar or identical
to the one that maintains low transcription from 1xIHF. Intriguingly, however, the
activity from the 2xIHF-I3m promoter fragment was substantially higher than both
the 0xIHF and full-length promoter constructs. On the basis of this result, we
proposed that IHF II can play a positive role in the regulation of acs transcription
and that IHF IIIa might antagonize this effect.
Using EMSA and DNase I footprint analyses, Drs. Douglas Browning and
Bianca Sclavi obtained evidence that IHF binds IHF III with higher affinity than it
does IHF II (Browning, Sclavi, and Wolfe, unpublished data). Thus, it is possible
that occupation of the higher affinity IHF III might interfere with occupation of the
lower affinity IHF II. Armed with this information, I used genetics to direct IHF/
DNA interaction to either IHF II or IHF III by simply strengthening or weakening
IHF II (i.e. mutating the native sequence to bring it closer to or further from
consensus). The promoter fragments, 2xIHF-I2wk (IHF II weakened) and 2xIHFI2st (IHF II strengthened), were cloned into pRW50, a low copy plasmid that
permits more rapid analysis of promoter-lacZ fusions. Similar constructs were
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built for FL, 1xIHF and 2xIHF (Table 4). The resultant plasmids were introduced
into AJW678 by transformation, the resultant transformants were grown in TB at
37oC, cells were harvested at approximately one hour intervals, and their !galactosidase activity compared.
As expected, the FL promoter displayed high promoter activity whereas
1xIHF was low (Fig. 28C). However, 2xIHF showed an unusually high level of
transcription unlike that observed when 2xIHF was assayed as a monolysogen
(Fig. 26). Thus, despite the previously described evidence to the contrary (in the
phage system), the 1xIHF and 2xIHF promoter constructs did not behave
identically (in the plasmid system). The simplest explanation is that the presence
of IHF II can influence acs transcription, at least when the promoter is located on
a plasmid. But why does the 2xIHF promoter fragment exhibit vastly different
behaviors when carried by the two different reporter systems? The different
behavior could be attributed to the difference in copy number. The plasmid
pRW50 is present in about ~10 copies per cell (Lodge et al, 1992), whereas the
monolysogen is by definition present in single copy. Another possibility involves
differences in topology. Topological state can impact local gene expression either
promoting transcription or inhibiting it. DNA supercoiling tends to promote protein
binding and the binding of those proteins can influence transcription (Niehaus et
al, 2008). Plasmids tend to be more supercoiled than the chromosome. Because
the prophage that carries the acs::lacZ fusion integrated into the chromosome,
the fusion is expected to take on the degree of supercoiling characteristic of the

loop-domain into which it has inserted.

!"#$

To determine if the plasmid system is a valid tool for assessing the behavior
of the acs promoter, I disrupted IHF III in the context of the 1xIHF construct (Fig.
28B), introducing the C152G C150G and C153A C153A double mutations used
in Chapter 4 to assess the behavior of the 1xIHF monolysogen (Table 4). For
both mutations (here denoted I3wk and I3st), I observed the same behavior, i.e.
alleviation of inhibition (Fig. 28C). Thus, the plasmid system appears to be valid.
Next, I introduced two different mutations into the TTR motif of IHF II in the
2xIHF promoter construct (Fig. 28B). By substituting CC for the native AT, the first
mutation (I2wk) should reduce affinity. By substituting a T for the native A, the
second mutation (I2st) should increase affinity. In the context of 2xIHF,
weakening of IHF II resulted in transcription similar to that obtained with the
1xIHF promoter fragment, while strengthening of IHF II resulted in a slight
increase in promoter activity compared to that exhibited by the 2xIHF promoter.
Taken together, these data are consistent with the hypothesis that IHF II can
behave as an IHF III antagonist. Thus, we now possess genetic evidence that
each site can antagonize the other.
Because they are predicted to sit on the same face of the DNA helix, IHF II
and IHF IIIa are unlikely to be bound by IHF simultaneously. In contrast, since
IHF II and IHF IIIb are predicted to sit on opposing faces, it is possible for both of
these sites to be occupied simultaneously (Fig. 29). This led me to re-investigate

the influence of IHF IIIa and IHF IIIb on acs transcription.
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Figure 27. Mutating IHF IIIa in the context of 2xIHF alleviates inhibition. !galactosidase activity from promoter fragments 0xIHF, 1xIHF, 2xIHF, 2xIHF-C2m,
or 2xIHF-I3m fused to lacZYA. The wild type strain AJW678 was lysogenized with the
corresponding hybrid phages. The resultant strains were grown in TB, samples
harvested at one-hour intervals, the !-galactosidase activity determined, and the peak

Individual Analysis of IHF IIIa and IHF IIIb
I chose to perform this re-investigation in the plasmid context because it
seems to enhance the effect of IHF II. To reduce the complexity of the analysis, I
deleted the composite IHF III site and instead replaced it with two single IHF sites
(Fig. 30A): one construct had the DNA site for IHF in the position of IHF IIIa
(denoted 1xIHF-2R3a; Table 4) and one had the site in the position of IHF IIIb
(denoted 1xIHF-2R3b). In this manner, I could determine how the individual sites
might contribute to acs regulation. For the single site, I chose the confirmed
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Figure 28. IHF II is a positive modulator of acs transcription. (A) Alignment of the IHF consensus, IHF IIIa,
IHF IIIb, and IHF II. The consensus nucleotides are in bold blue. (B) The native arrangement of IHF II and IHF
IIIa. The consensus nucleotides are in bold blue. Mutations above the sequence improve consensus, while the
mutations below the sequence diminish consensus. (C) !-galactosidase activity from promoter fragments FL,
1xIHF, 1xIHFwk, 1xIHFst, 2xIHF, 2xIHFwk, or 2xIHFst fused to lacZYA. The fusions were carried by the low
copy reporter plasmid pRW50. The resultant constructs were transformed into the wild type strain AJW678

single site IHF II.
Intriguingly, 1xIHF-2R3a and 1xIHF-2R3b had opposite effects on their
promoter activities (Fig. 30B). 1xIHF-2R3a resulted in extremely low activity. In
contrast, 1xIHF-2R3b displayed much higher activity, even more than that
exhibited by the 0xIHF promoter. Thus, it appears that IHF bound in the IHF IIIa
position can exert a negative effect on acs transcription and that IHF bound in the
IHF IIIb position can exert a positive effect.
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Notably, when carried by the phage system, the same constructs both
displayed higher promoter activity relative to that exhibited by 1xIHF (data not
shown). Such a result might be due to a less topologically constrained DNA
template, which could partially negate the effects of IHF IIIa.

Figure 29. Proposed model of simultaneous occupation of IHF III and IHF II. (A) Diagram of
2xIHF promoter fragment. Relative positions of IHF, CRP and Fis binding half-site positions are
indicated above or below their respective sites. IHF III and IHF II are contiguous sites predicted to
access the minor groove of the top DNA strand. (B) Proposed space-filling model of the DNA bend
induced by the simultaneous occupation of IHF III and IHFII in the absence of CRP and RNAP. !
and " subunits are depicted in teal and purple, respectively. Red and yellow DNA strands represent
the coding strand for IHF III and IHF II, respectively. (Adapted from D. Browning; personal
communication)
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Discussion
A Proposed Model
We propose that the occupancy status of IHF II plays a major role in
dictating whether IHF binds to IHF IIIa or to IHF IIIb and thus whether
transcription from acsP2 becomes activated or becomes stalled by the
mechanism described in Chapter 3.
This hypothesis is supported by the following observations: (1) in the
context of the phage system, a mutation (C152G C150G, also known as I3m or
I3wk) that reduces the consensus of IHF IIIa and enhances the consensus of
IHF IIIb resulted in activity from the 2xIHF promoter construct greater than that
exhibited by the 0xIHF or FL constructs (Fig. 27); (2) also in the context of the
phage system, the 2xIHF promoter exhibited 1xIHF-like activity (Fig. 26B) that
was unaltered by a mutation that reduces IHF II consensus (data not shown); (3)
like the poor activity of 1xIHF, this poor activity of 2xIHF depends on AR2 (data
not shown) and CRP II (Fig. 27); (4) in the context of the plasmid system, 2xIHF
exhibited high activity, while 1xIHF exhibited weak activity (Fig. 28C); (5) also in
the plasmid system, the I2wk mutation, which is predicted to decrease the affinity
of IHF II for IHF, resulted in low levels of transcription resembling that of the
1xIHF construct (Fig. 28C); (6) also in the plasmid system, the placement of a
simple site into the IHF IIIa position resulted in poor promoter activity from the
1xIHF construct, while placement of that same simple site into the IHF IIIb
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position resulted in strong activity (Fig. 30B); and finally (7) IHF II and IHF IIIa are
predicted to sit on the same face of the DNA helix, while IHF II and IHF IIIb are
predicted to site on opposite faces (Fig. 29).

Figure 30. IHF bound at the IHF IIIa or IHF IIIb positions can be a negative or positive
effector, respectively. !-galactosidase activity from promoter fragments 0xIHF, 1xIHF, 1xIHFA164T/T142A, 2R3a, 2R3a-rev, or 2R3b fused to lacZYA. The fusions were carried by the low
copy reporter plasmid pRW50. The resultant constructs were transformed into the wild type strain
AJW678 The resultant strains were grown in TB, samples harvested at one-hour intervals, the !galactosidase activity determined, and the peak activities compared. Each value represents the
mean + SEM of at least three independent measurements. 2R3a, 2R3a-rev, and 2R3b are
described in the text.

IHF III Competes with IHF II
In the context of 2xIHF, the weakening of IHF IIIa coupled with the
strengthening of IHF IIIb (C152G C150G) resulted in acs transcription that was
far greater than that of the 0xIHF construct (Fig. 27). This observation suggests
that IHF II can play a positive role. It also supports the hypothesis that occupation
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of IHF IIIa can inhibit the positive function of IHF II, at least when the promoter
fusion is integrated into the chromosome.
When both IHF sites are available (as in the 2xIHF construct), perhaps
IHF prefers to bind to IHF IIIa because of a more favorable consensus site. This
preference would have to be due to specific nucleotide composition rather than
divergence from consensus, because both IHFII and IHF IIIa have the same
number of differences from consensus.
Alternatively, the preference for IHF IIIa may rely on the pre-existing DNA
structure induced by the CRP/RNAP complex (Sclavi et al., 2007). CRP binding
within a promoter region bends DNA up to 45 angles per homodimer. RNAP also
induces DNA bending when bound to DNA. Together, the total DNA bend angle
may exceed 90. Studies on the effects of DNA curvature (e.g. as AT-rich
stretches) and DNA binding proteins (specifically the nucleoid protein IHF and its
paralog HU) show that these proteins have a greater affinity for curved DNA
(Bonnefoy and Rouvière-Yaniv, 1991). Therefore, the affinity for IHF IIIa may not
be as dependent on sequence as it is on the proximity of IHF IIIa in relation to the
CRP/RNAP complex.
In either case, the weak activity of the 2xIHF promoter may be the result of
the inability of IHF to occupy both IHF II and IHF IIIa simultaneously. With a
preference for IHF IIIa, IHF would mediate inhibition of CRP-dependent
transcription. And, yet, DNase I analyses show that IHF can occupy both IHF II
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and IHF III simultaneously (Browning et al., 2004; Sclavi et al., 2007). Because
IHF should be unable to simultaneously bind IHF II and IHF IIIa, I propose that
simultaneous binding occurs at IHF II and IHF IIIb.

Why does the 2xIHF construct behave differently in the plasmid and
phage systems?
In the context of the phage reporter system, the 2xIHF promoter exhibits
about as much activity as the 1xIHF promoter (Fig. 26B). Thus, when integrated
into the chromosome, the natural IHF II site cannot overcome the inhibitory
effects of IHF IIIa. In contrast, in the context of the plasmid system, the 2xIHF
construct yielded activity that resembled that of the 0xIHF construct. As
described above, the two obvious reasons for this dichotomy is copy number and
superhelicity.
The copy number difference is about one order of magnitude. If some trans
factor that helped determine whether occupancy of IHF II was favored was
limiting, then the increase in copy number could have a significant impact on acs
transcription. The simplest possibility is IHF itself. Although IHF is synthesized in
large amounts, its DNA sites are numerous. Thus, titration could influence the
occupancy of the three binding sites in the 2xIHF construct: IHF II, IHF IIIa, and
IHF IIIb. Titration of IHF would likely favor the higher affinity IHF III site over the
lower affinity IHF II. Thus, for titration to influence acs transcription, it would have

to favor occupancy of IHF IIIb over that of IHF IIIa.
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Alternatively, the key factor might be a difference in the superhelicity of the
plasmid relative to that of the integrated phage. This is important because the
degree of superhelicity affects the binding of proteins and the binding of those
proteins can influence transcription (Niehaus et al, 2008).
In either case, the plasmid system allowed me to demonstrate that IHF II
can antagonize IHF III-mediated inhibition and might explain how (in the FL
construct) the upstream sequences counteract IHF IIIa-mediated inhibition. In this
model, the binding of a protein upstream would somehow help IHF to bind to IHF
II. As a consequence, IHF would bind to IHF IIIb instead of IHF IIIa.

Does IHF IIIb Function as a Positive Modulator of acs Transcription?
If this model is correct, then occupancy of IHF IIIb must have a positive
effect on acs transcription. In the context of the phage system, this is clearly not
true: mutations predicted to favor binding to IHF IIIb did not enhance transcription
from the 1xIHF construct. In contrast, such a mutation (C152G C150G or I3m) in
the 2xIHF construct resulted in the highest transcription observed (Fig. 27). This
led me to ask if IHF IIIb could favor acs transcription. In fact, in the plasmid
system, it did. Placement of a simple IHF site (IHF II) in the location of IHF IIIb
resulted in strong promoter activity in the 1xIHF construct (1xIHF-2R3b). In
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construct, placement of the same site in the position of IHF IIIa resulted in very
weak activity (1xIHF-2R3a) (Fig. 30).

CHAPTER SIX
!DISCUSSION
!Prior Studies
To survive a variety of environmental conditions, a bacterium must adjust
swiftly and efficiently to signals it perceives concerning its milieu (Roszak and
Colwell, 1987) (Kussell et al., 2005). To adapt to harsh conditions, bacteria up- or
downregulate genes and/or operons that are necessary for survival. Therefore for
immediate reaction some transcription factors with global activities responsible
for coordinating the response preexist in the cytoplasm eliminating some time
required for transcription factor synthesis (Zhou et al., 2008) (Kort et al., 2008)
(Kussell et al., 2005). The expression of proteins, such as acs during carbon
starvation, that respond to the specific signal/stress are upregulated to help the
bacterium adapt to the altered milieu. This network of effectors and sensors are
precisely coordinated to reduce or eliminate any inefficiency (Slauch et al., 1997)
(Khmel, I. A., 2005). Removal drastically alters the cells survivability under
normal conditions and spell disaster in challenging ones.
Due to the large variety of environmental stresses encountered by a
bacterium, many genes are needed to survive. However, the volume of the
135
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absolutely required. To conserve space, bacterial genes are often organized as
operons, with many genes or operons overlapping, while others are encoded on
opposing DNA strands.
Much like this dense organization of genes on the chromosome, promoter
elements also maximize the amount of regulatory information for precise gene
expression. Missteps in transcription can lead to cellular death during times of
carbon limitation. At the most basic promoter, DNA sequence information directs
RNAP to bind to the -35 and -10 sequences, hallmarks of any promoter. At these
“simple” promoters, the stability of RNAP binding does not require a transcription
factor to stably bind the promoter region. However, not all promoters allow for
stable RNAP binding. To more stably anchor RNAP to the DNA some promoters
have an additional cis element located just upstream of the -35 hexamer, called
an UP element. The UP element is an A-T rich sequence that is recognized and
bound by the RNAP !-CTD, thereby providing a more stable RNAP/DNA
interaction. Not only does promoter sequence provide a means for RNAP
recognition for higher affinity binding but also DNA structure. The UP element
and -10 hexamer (TATAAT) are A-T rich regions that are prone to creating
intrinsic DNA bends. This sequence-induced DNA secondary structure creates an
environment that is more conducive for DNA recognition and protein docking to
the promoter region*. However, the location of an UP element may exist 100 bp
further upstream than ones found proximal to the -35. To activate and enhance
transcription at these promoters, a transcription factor solely utilized for DNA
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remodeling is required to bring this distant UP element into close proximity to the
!-CTD. Despite the straightforward regulation of simple promoters, the protein/
DNA dynamics at the majority of bacterial promoters involve more than one
activator,! more than one inhibitor, and many relevant DNA sequences within the
same region of DNA.
The majority of bacterial promoters have many multiple relevant
sequences where cis and trans factors contribute to regulating transcription. Due
to the various DNA sequences, and the proteins that bind to them, within
complex bacterial promoters the dynamics between transcriptionally relevant
inputs complicates our understanding of the mechanisms by which transcription
occurs. This limits our ability to utilize this knowledge for applications ranging
from treating disease to enhancing biotechnology. At a complex promoter,
multiple transcription factors bind to multiple sites to either activate or inhibit
transcription. The nucleotide sequence arrangement of transcription factor and
RNAP binding sites of complex promoters have evolved to optimally position
DNA binding sites to ensure precise regulation of a given gene or operon.
Deciphering the code of gene regulation is not a straightforward process because
the positioning of DNA binding sites makes it rather complex to understand the
precise role of inhibitors, activators, RNAP, and the contribution of promoter
sequence and structure to regulation. Thus, to deconstruct the operating
mechanisms of a given promoter region, we must study the individual and group
contributions of any identified, putatively relevant sequence. My studies revolved
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around the isolation of individual nucleotide elements and then introducing point

mutations to each site within the whole to measure the transcriptional output of a
reporter construct.
The acs-nrf intergenic region, our model promoter, was an ideal choice to
study regulation of a complex promoter for many reasons. Among them are: 1)
the acs operon and its protein products are not essential under our assay
conditions and media (37°C with aeration in tryptone broth, or TB); therefore,
reduced or disabled gene expression does not interfere with promoter analysis;
2) the complexity of the promoter region is sufficiently crowded – the acs
promoter contains four RNAP binding sites, Pnrf, acsP1, acsP2A, and acsP2, two
Fis binding sites, two CRP site, three IHF sites, and a putatative ArcA site whose
function will not be discussed further. The protein binding sites identified as
acting upon acs do not include the transcription factors NarL, FNR, and NarP that
regulate transcription of the opposing, divergent nrf promoter. Interestingly, a few
of the protein binding sites shared by both regulatory regions affect transcription
of each operon, specifically those for the nucleoid protein IHF (Fig. 6) (reviewed
by Wolfe, 2005; Wolfe, 2009).
The functions of these promoters and binding sites were identified through
the use of nested 5’ truncations with the intent to identify those DNA sequences
that most affected transcription from the major acs promoter, acsP2. To ensure
that no relevant sequences were missed, Beatty and Wolfe designed a 444 bp
‘full-length’ promoter (FL, acs444) that included the entire acs-nrf intergenic
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region and its flanking sequences (from +101 bases downstream of the nrf

transcription start site (+1) to +76 bases downstream of the acsP2 +1). The merit
of this approach became apparent when 3’-truncations (lacking the 76 bases
downstream of the acsP2 +1) showed noticeably different promoter behaviors
than their more full-length variants (Thach, Beatty and Wolfe, unpublished data).
Although this phenomenon supports the hypothesis that the downstream
sequences contribute to the regulation of acs transcription, the mechanism
remains unknown and dissection of that mechanism remained outside the scope
of this dissertation. To evaluate the function(s) of specific promoters and sites,
these researchers also chose to mutate specific DNA sites rather than deleting
the gene that encodes the transcription factor or NAP predicted or known to bind
to that sequence. Beatty and Wolfe reasoned that the complete absence of a
global regulator might result in formation of a non-native nucleoid and thus
increase the probability that the resulting data would reflect a non-native
mechanism. They also reasoned that deletion of a global regulator with multiple
functions at a given promoter would reflect only one of those functions. The merit
of this approach was demonstrated by the behavior of a himA mutant, which
exhibited substantially reduced acs transcription despite the clear indication that
its gene product, IHF, functions primarily as an inhibitor (Beatty and Wolfe,
unpublished data). I chose to follow their lead, working with and constructing
additional 5’ nested truncations of the FL promoter and introducing specific and,
wherever possible, well-characterized point mutations into those truncations.
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Coupling the point mutation strategy with conventional in vitro transcription
assays, Wolfe and co-workers demonstrated that acsP2 functioned as the
primary promoter. They further showed that the ability of acsP2 to transcribe
depends on the ability of CRP to bind to a high-affinity promoter-proximal site

(CRP I) from where one of its surfaces (AR1) must make physical contact with a
surface (determinant 287) of the !-CTD of RNAP (Beatty et al., 2003). Moreover,
they showed that modulation of this CRP-dependent activation involves the
binding of multiple proteins (CRP, IHF, and Fis) to multiple binding sites located
5’ to CRP I. For example, they showed that the binding of CRP to a low-affinity
promoter-distal site (CRP II) enhanced transcription about two-fold (Beatty et al.,
2003). They also demonstrated that Fis inhibits CRP-dependent transcription in
part by binding to Fis III, which overlaps CRP I. Thus, the binding of Fis to FIS III
hinders the required binding of CRP to CRP I. Since Fis interferes with the
activator CRP and not RNAP itself, the inhibitory process is termed anti-activation
(Browning et al., 2004). In contrast, the mechanism by which the binding of Fis to
FIS II remained unclear.
Wedding the truncation strategy to in vitro transcription assays, Wolfe and
co-workers further identified a 31-bp sequence located just upstream of CRP II
that exerted a strong inhibitory effect on the CRP-dependent activation of acs
transcription. They further showed that sequences located further upstream
alleviated this inhibition. On the basis of their observation that the 31-bp
sequence bound IHF, they proposed that the inhibition resulted from the binding
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of IHF to this 31-bp sequence (Browning et al., 2004). It was the purpose of my
dissertation to test this hypothesis and to dissect the underlying mechanism.

IHF Mediates Formation of a Stalled Open Complex
First, I verified the genetic observations that led to this hypothesis. As
reported previously (Browning et al., 2004), the FL construct displayed the
highest promoter activity and the 0xIHF (acs205) promoter fragment exhibited
about two-thirds the FL activity. In contrast, the 1xIHF (acs236) promoter
fragment achieved very low activity, reaching levels less than one-fourth of 0xIHF
and one-sixth that of FL (Fig. 9C). Thus, my co-authors and I concluded that the
31-bp sequence (denoted IHF III) exerted a negative influence on acsP2
transcription.
I extended these observations by introducing individual mutations into the
CRP I, CRP II, and IHF III sites of the 1xIHF promoter fragment (Fig. 9). As
expected, introduction into CRP I of a mutation predicted to severely decrease its
affinity for CRP essentially eliminated acs transcription. In contrast, introduction
into CRP II of a similar mutation gave us a most peculiar result. This promoter,
denoted 1xIHF-C2m, exhibited promoter activity similar to that of the 0xIHF
promoter fragment. This result was consistent with an inhibitory role for CRP II, a
conclusion diametrically opposed to that obtained from the introduction of the
identical mutation into the FL promoter (Beatty et al., 2003). To verify that CRP II
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could enhance CRP I-dependent transcription, I tested the promoter fragment
1xCRP (acs155), whose transcription is controlled by the single CRP I site. As
expected if CRP II can function as a positive element, 1xCRP exhibited about
half the activity of 0xIHF, which carries both CRP sites. We concluded that CRP II
could function either as a positive or negative element and that the mechanism
underlying IHF-mediated inhibition depends on the status of CRP II (Sclavi et al.
2007).

I next tested a mutant 1xIHF promoter fragment (1xIHF-I3m) in which a G
was substituted for the native conserved C within the central WATCAA motif. This
mutant fragment exhibited activity intermediate to 1xIHF and 0xIHF, suggesting
that the 31-bp-dependent inhibition depends on IHF, as previously proposed (Fig.
9) (Browning et al., 2004; Sclavi et al., 2007). IHF is a protein demonstrated to
affect DNA structure by inducing an IHF-DNA bend angle reaching up to 180°.
Though hard biochemical evidence measuring the bend angle induced by IHF at
the acs promoter in the presence of RNAP and CRP has not been reported here,
we do provide genetic evidence to support the requirement of IHF-mediated
DNA remodeling. This was a surprising result, as disruption of CRP II, in the
context of 1xIHF, resulted in a transcription profile similar to 0xIHF. This result
suggested that CRP II was more important for inhibition than IHF III. Yet, as I
explained above, CRP II functions as a positive effector in the absence of the 31bp sequence that includes IHF III. Thus, my co-authors and I concluded that IHFmediated inhibition required the combined function of IHF III and CRP II. We
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proposed that together these two sites determine whether CRP bound to CRP I

can activate transcription by RNAP bound at the acsP2 promoter (Sclavi et al.,
2007).
To gain insight into the mechanism by which this IHF-CRP tandem inhibits
transcription, I identified the surfaces of CRP required for or involved in IHFmediated inhibition of CRP-dependent acs transcription. By deleting the crp gene
and complementing with either WT CRP or mutants of the surfaces known to
interact with RNAP, I learned that IHF-mediated inhibition requires AR2 (Fig. 10).
Interestingly, the non-native AR3 can compensate in the absence of AR2 (Sclavi
et al., 2007). Armed with the results of my genetic analyses and plasmid
constructs that I specifically constructed for in vitro analyses, my collaborator (Dr.
Bianca Sclavi) performed DNase I and potassium permanganate footprint
analyses. On the basis of her studies, we concluded that IHF mediates the
formation of a complex that also includes RNAP and both CRP homodimers. This
complex, we proposed, entraps RNAP in an unproductive open complex (Fig.
16). The specific role of AR2 remains unknown. Since this unproductive complex
includes two CRP homodimers and since each subunit of the CRP dimer
includes its own AR2 surface, there exist four distinct AR2 surfaces within the
stalled complex. To identify the required AR2 surface(s) would require the use of
oriented heterodimer analysis (Zhou et al, 1993), a genetic ‘trick’ that allows the
investigator to direct a mutant surface to a specific binding site and to orient that
surface either upstream or downstream.
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How does IHF mediate the formation of this stalled complex? I propose
that this is all made possible by the conformational and torsional strain induced
on DNA by IHF when bound to IHF III. Upon binding to DNA, IHF inserts proline
“fingers” into the minor groove of DNA. This insertion helps induce a bend but
does not change the superhelicity of the immediate DNA strands of the IHF
binding site. In contrast, DNA superhelicity is changed upstream (positive) and
downstream (negative) (Aeling et al, 2006; Swinger and Rice, 2004; Swinger et
al, 2003). The introduction of negative supercoiling in the region where CRP and
RNAP bind may cause the CRP dimers to come into close contact with each
other and RNAP. The additional protein-protein interaction then stabilizes the
complex, thwarting promoter escape. Our genetic and footprint analyses support

this conclusion, but analysis of the actual DNA structure of the inhibition complex
remained beyond the scope of this thesis.

Countering IHF-Mediated Inhibition
The conclusions drawn from the study described in Chapter 3 (Sclavi et
al., 2007) are limited to the 236-bp promoter fragment, 1xIHF. Although both
genetic and biochemical analyses also were performed on the FL promoter, the
differences in the architecture and behavior are substantial. The FL promoter
measures 444 base pairs long and includes many additional protein binding sites
that are not only relevant to acs regulation but also to the divergent promoter,
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Pnrf. Furthermore, this construct exhibits six times more promoter activity than

does 1xIHF (Fig. 9). This behavior is most interesting. Clearly, the upstream
sequences somehow counterbalance the inhibitory effect caused by the binding
of IHF to IHF III.
In Chapter 3, I proposed that the countering mechanism might revolve
around the occupancy of CRP II (Fig. 16). If IHF III remains occupied during
exponential growth, then the occupancy of CRP II becomes the critical factor.
During mid-exponential growth, when cAMP begins to accumulate, the higher
affinity CRP I can become occupied, but the lower affinity CRP II remains
unoccupied, the CRP dimer bound at CRP I would be free to activate acs
transcription by a typical Class I, AR1-dependent mechanism. As the
concentration of cAMP increases, however, CRP II can become occupied and
RNAP becomes stalled in an AR2-dependent mechanism.
Another intriguing possibility that is not mutually exclusive with the
mechanism proposed in the previous paragraph is titration. IHF is a global
regulator of many DNA-related events of which transcription is only one. Although
IHF is made in moderately large amounts during exponential growth, the pool is
limited. The chromosome possesses a large number of DNA sites for IHF.
Perhaps the combination of limited IHF molecules and excess DNA sites titrates
IHF away from IHF III, permitting some acs transcription even when both CRP
sites are filled.
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Together, these and other mechanisms could explain the expression
profile of acs. Under the conditions tested (37°C in tryptone broth with aeration),

acs transcription remains low during early exponential growth, gradually
increases during mid-exponential growth, peaks upon the transition into
stationary phase, and drops markedly as the culture progresses further into
stationary phase (Kumari et al, 2000).
Inhibition during early exponential growth. During early exponential
growth, acs transcription remains low most likely through a lack of CRPdependent activation and Fis-dependent anti-activation. As described at the end
of Chapter 3, if IHF were also bound to IHF III, the Fis-dependent anti-activation
would be even stronger.
Activation during mid-exponential growth. As the favored carbon sources
become depleted, cAMP becomes more prevalent and Fis becomes less so,
shifting the balance of acs-bound proteins from Fis to CRP. Even if IHF is bound
at IHF III, there should only be enough CRP to bind the higher affinity CRP I site
and thus transcription would ensue.
Inhibition following entry into stationary phase. As the culture enters into
stationary phase, the concentration of cAMP continues to increase and the
concentration of IHF approaches its maximum, while Fis becomes undetectable.
Under these conditions, the lower affinity CRP II site could become occupied
simultaneously with IHF III. The binding of both RNAP and CRP should induce a
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DNA bend. Since IHF targets bent DNA the secondary structure induced by the
binding of both RNAP and CRP should facilitate the binding of IHF (Swinger and
Rice, 2007; Teter et al, 2000).
If this were indeed the mechanism that underlies IHF-mediated inhibition
of CRP-dependent acs transcription, then the 1xIHF promoter would follow a
similar pattern of gene expression, albeit at a lower level due to the absence of
upstream sequences required for the maximal transcription as seen with the fulllength (FL) promoter. Because expression levels from 1xIHF reaches only

13-15% of FL during the course of an 8-10 hr experiment, we conclude that IHFmediated regulation is not solely dependent upon the number of IHF molecules
available for binding. If IHF-mediated inhibition of the 1xIHF promoter depended
on only the number of IHF molecules present, then we should observe
transcription to be higher that the reported level (13-15% of FL) when IHF levels
are relatively low during log phase. A precipitous drop in transcription should
occur when the cellular concentration of IHF reaches its peak. This led us to
ponder how the inhibitory effect of IHF at acs is regulated.

IHF III is a composite site
Mutational analysis of the 31-bp sequence that includes IHF III restored
1xIHF promoter activity to approximately 50% of that exhibited by the 0xIHF
promoter fragment. If the binding of IHF to IHF III was the underlying reason for
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the 31-bp-dependent inhibition, we expected this mutation to restore transcription

to a level similar, if not identical, to that of the 0xIHF promoter fragment (Beatty et
al, 2004). The puzzling results provided me with a new focus: if the 31-bp
sequence includes a single 27-bp IHF III site, then why does a replacement
mutation predicted to severely decrease IHF binding fail to completely restore
transcription to the level exhibited by the 0xIHF promoter fragment?
As mentioned earlier, the intergenic region between the acs and nrf
operons share protein binding sites that regulate their expression, albeit under
different physiological conditions. acs transcription occurs under aerobic
conditions as preferred carbon sources diminish. In contrast, nrf expression is
activated under anaerobic, nitrogen limiting conditions (Wolfe, 2005). However, a
key factor in transcription at both promoters is IHF III – activating transcription at
nrf and inhibiting acs expression (Browning et al, 2004; Browning et al., 2006).
Initially, it was unclear how a single IHF III site could have contradictory functions
at divergent promoters. We imagined that the function of IHF at both promoters
was dependent upon the specific conditions under which transcription takes
place from both promoters, i.e. anaerobic in the presence of RNAP and FNR at
Pnrf and aerobic in the presence of CRP with RNAP at Pacs. But how does an
IHF binding site 127 base pairs upstream of the nrf +1 activate transcription from
one strand of DNA, while functioning as an inhibitor of acs expression on the
other DNA strand?
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Theoretically, IHF III could exist as a single site and function as both an

activator of transcription and inhibitor because of its ability to cause topological
changes. IHF binding not only causes DNA bending and folding, but it also can
cause changes in DNA supercoiling both upstream and downstream of its binding
site and, as a consequence, affect gene expression at either long or short
distances from that site. For example, at the !54 Pu promoter of Pseudomonas
putida, IHF binding to an upstream region spanning -56 to -86 is crucial for
activating transcription. The folding of DNA brings an enhancer region
(surrounding position -104) into contact with the "-CTD of RNAP (Macchi et al
2003). Not surprisingly, the direction of DNA bending is crucial to activation as
insertion of an additional five bp, which places the IHF binding site on the
opposite face of the DNA helix, causes a loss of transcription.
Our collaborators at the University of Birmingham (UK) have
demonstrated that their predicted IHF III (denoted as IHF IIIb) sequence is
physiologically relevant to nrf regulation (Browning et al., 2006), while we have
published reports on the negative affects of our predicted IHF III sequence
(referred to as IHF IIIa) on acs transcription (Browning et al., 2004; Sclavi et al.,
2007). When we analyzed the sequence of both predicted sites, we concluded
that they both could be real, as they each possess strong similarities to the IHF
consensus site (WATCAANNNNTTR) with the same number of bases diverging
from consensus. Furthermore, they overlap and are offset by two bases.
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van Rijn and co-workers first reported the presence of two transcriptionally
relevant, overlapping and inverted IHF sites (1991). The early promoter (Pe) and
the repressor promoter (Pc) of bacteriophage Mu share the same intergenic
region. These convergent promoters are both activated by IHF. These dual
inverted overlapping IHF binding sites (designated ihfa and ihfb) are offset by
three bases and are the only reported activators of transcription in this intergenic
region. Thus, the mechanism of transcriptional activation appears to be solely
dependent on the conformation of DNA induced by IHF.
Like van Rijn et al., we tested the hypothesis that IHF III is a composite
site containing an IHF IIIa site relevant to acs transcription and an IHF IIIb site
that controls nrf transcription. To determine whether two overlapping IHF binding
sites existed and whether either or both sites were relevant to acs promoter
regulation, I introduced single base pair mutations into the conserved motifs in
accordance to results reported by Lee et al, (1991) and Hales et al (1994).
Coincidentally, IHF IIIa and IHF IIIb sequences are offset by two base pairs. Each
of their 3’ TTR motifs sits opposite the opposing dA-dT region. Whereas

mutations in the dA-dT have been reported to cause weak to moderate defects in
IHF binding (Lee et al, 1994; Hales et al, 1996; Fyfe and Davies, 1998),
mutations in the TTR have been shown to cause severe defects in IHF binding,
For example, the substitution of the second T with an A disrupts required
hydrogen bonding between E44, R42, and R46 of the ! subunit of IHF, resulting
in a severe decrease of IHF/DNA interaction (Granston and Nash, 1993;
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Mengeritsky et al, 1993). Using this information as my guide, I inserted mutations
into the TTR and coincidentally into the opposing dA-dT region. Because of the
overlap, these substitutions were predicted to reduce IHF binding to both sites
and, as expected, they caused moderate to severe loss of IHF-mediated

inhibition. I next inserted mutations into the central WATCAA motifs of either site.
Since these mutations were predicted to disrupt binding to one site at a time, I
used them to determine whether either or both sites existed. On this basis, I
concluded that both sites likely existed and that they both exerted an inhibitory
effect upon acs transcription.
To test this hypothesis, I swapped the two IHF III sites. I reasoned that if
two IHF III sites existed, then re-positioning IHF IIIa to the native location of IHF
IIIb on the opposite DNA strand, and vice versa, would result in promoter activity
from this mutant construct (denoted 1xIHF-VF) that was similar, if not identical, to
the wild-type 1xIHF promoter. Indeed, I observed virtually identical levels of
promoter activity from both 1xIHF and 1xIHF-VF. Their near identical promoter
activities led us to test whether the low transcription activity exhibited by 1xIHFVF required the same distinguishing features for low transcription activity as
displayed by 1xIHF. These include IHF, RNAP, both CRP dimers, and at least one
of the four AR2 surfaces (Sclavi et al., 2007). Thus, the effects of IHF-mediated
inhibition can be bypassed if: a) CRP cannot bind CRP II and/or b) the AR2
surface has been eliminated. I chose to test the involvement of the CRP
surfaces, as they provide more information than simply disrupting CRP II.
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In the context of the 1xIHF promoter fragment (Chapter 3), IHF-mediated
inhibition requires a functional AR2 surface. In its absence, the non-native AR3

surface can compensate and the presence of both AR2 and AR3 results in
extreme inhibition. Remember that all three activation surfaces (AR1, AR2, and
the mutant AR3) mediate protein-protein interaction. Importantly, they are
independent of the surface responsible for binding DNA. At Class III promoters of
the Class I-Class I kind (e.g. acsP2), it is proposed that the !-CTD, linked to the
body of RNAP by a flexible tether, contacts AR1 of both CRP dimers to activate
transcription (Busby and Ebright, 1999). In contrast, AR2 and AR3 are reported to
directly contact the body of RNAP. AR2 is reported to interact with the !-NTD
(Busby and Ebright, 1999) and AR3 is reported to make contact with Region 4 of
"70 (Rhodius et al; 2000). For AR2 or AR3 to bind to the body of RNAP, a CRP
site must be located near the RNAP binding site and yet the proximal site is
located at a distance from the promoter, centered at -69.5. Given that promoter
constructs that do not exhibit IHF-mediated inhibition (e.g. 1xIHF-C2m) are
unaffected by AR2 or AR3, we surmise that IHF alters the local DNA topology
enough to permit intimate contact between the CRP dimer bound at CRP I and
either the !-NTD (mediated by AR2) or Region 4 of "70 RNAP (mediated by
AR3). Application of a similar analysis to 1xIHF-VF yielded results that were
virtually identical to those obtained with the parental 1xIHF. Therefore, I conclude
that IHF III is a composite site and that IHF IIIa and IHF IIIb both contribute to
inhibition, at least in the 1xIHF context.
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IHF III-mediated inhibition of CRP-dependent transcription involves dual
overlapping IHF III binding sites
Previous work on acs regulation and the divergent nrf operon yielded
contradictory information concerning the function and location of the IHF III site.
According to data obtained through our studies, IHF bound to IHF III induces an
inhibition loop if tandem CRP dimers bind to CRP I and CRP II and RNAP binds
the promoter. A point mutation introduced into CRP II or the AR2 surface of CRP
relieves IHF-dependent inhibition. Conversely, Browning et al. demonstrated that
IHF occupation of IHF III helps promote transcription of the divergent promoter,
nrf. Here, IHF assists activation in the absence of inhibitors (Browning et al.,
2006). The IHF binding site relevant to acs (designated IHF IIIa) is offset by two
base pairs compared to the IHF site identified as important for nrf activation
(designated IHF IIIb). Point mutations in both predicted IHF binding sites do not
completely abolish IHF binding (Sclavi et al., 2008; Browning et al., 2006),
though this was not an unreasonable result given the IHF degenerate consensus
sequence. Mutations in IHF III, within the confines of the 1xIHF promoter,
decreased transcription as measured by expression of the reporter gene, lacZ.
Total abolition of lacZ expression, or restoration of transcription to levels at or
near that exhibited by the 0xIHF promoter, was never observed.
Further, my effort to generate proper mutations that would localize IHF
heterodimers to either IHF IIIa or IHF IIIb, or to eliminate IHF binding altogether
was met with less than definitive results. Using published work by Lee et al., I
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designed a library of 1xIHF promoters that had mutations directed to either the AT rich sequence, the central WATCAA motif, or the TTR motif. These mutations
were constructed in the effort to definitively conclude whether IHF IIIa, IHF IIIb, or
both sites exist. However, this systematic mutational analysis did not allow us to
make strong conclusions as to whether two overlapping IHF sites that are offset
by two base pairs, oriented in opposite directions, and positioned on opposing
faces are a reality and have biological significance to acs regulation. Though we
could not clearly assign function or relevance to either IHF IIIa or IHF IIIb using
mutational analysis by base pair replacement, the varied results did suggest that
IHF III was not your typical IHF binding site. Mutations in the single IHF nearconsensus sequence, H’ of ! phage, reveals specific nucleotide replacement at
important binding motifs had measurable affects on IHF binding. They observed
that specific bases strongly inhibited IHF binding, while some base pair
replacements only mildly or moderately did so. In our study of IHF III, the same
base pair replacement mutations that targeted either IHF IIIa or IHF IIIb only had
weak to moderate effects. Furthermore, double nucleotide replacement meant to
severely limit IHF binding to both predicted sites (A164T T142A; both
replacements were done in the TTR motif) ! restored promoter activity to levels
matching 0xIHF. The single mutations in the TTR of either site, specifically
T142A and A141T, displayed only an intermediate effect on promoter activity and
thus IHF binding.
However, replacing IHF IIIa with IHF IIIb, and, consequently, IHF IIIb with
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IHF IIIa, produces a promoter (designated 1xIHF-VF) whose activity strongly

resembles the 0xIHF promoter. Furthermore, the requirements for inhibition are
the same as the wild-type 1xIHF promoter, namely, AR2 of CRP and CRP bound
to CRP II. Swapping single IHF sites from one DNA strand to the complementary
strand would alter the effects of IHF binding on the downstream promoter. For
example, if IHF IIIa were the only site pertinent to both acs and nrf transcription,
then repositioning it to other DNA strand, while preserving the directionality of
binding, IHF would not cause inhibition of acs. In fact, our promoters 1xIHF-2R3a
and 1xIHF-2R3b confirm this prediction. Placement of the single IHF binding site,
IHF II, in the position of IHF IIIa inhibited acs transcription. In contrast,
replacement of IHF III with the single IHF II site did not cause inhibition.
Interestingly, the activities of these 1xIHF promoter variants behaved rather
differently when they were assayed from the low-copy plasmid pRW50 relative to
the single copy promoter fusions inserted into the chromosome using !phage. As
single fusions, 1xIHF-2R3a increased transcription beyond the activity of the
0xIHF promoter, whereas 1xIHF-2R3b displayed activity similar to that of 0xIHF.
We postulate that the difference in promoter activity from the plasmid versus the
single-copy fusion depends on the surrounding DNA and its protein-associated
contents. pRW50 is not a typical plasmid as it is larger (~17 kb) than the
everyday cloning plasmid (~3 kb) and, like all plasmid DNA, undergoes
compaction and supercoiling much like genomic DNA. However, the number of
genes on pRW50 (~6; Lodge et al., 1992) pales in comparison to the E. coli
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genome, which contains over 4300 genes, thus providing more promoter DNA for

transcription factors and RNAP to bind. Therefore, I suspect that the difference in
reporter gene expression from the pRW50 plasmid and the integrated singlecopy of the same promoter construct on the genome is due to a titration effect of
available transcription factors and RNAP. To wit, not only do proteins specific for
transcription affect gene expression but also local DNA structure, surrounding
protein content, and relative transcription activity within the surrounding region
influence transcription (Speck et al., 1999; Su’etsugu et al., 2001; Han et al.,
2009). Thus, the depth of DNA decoration on the genome may cause the single
2R3a IHF site to behave as a co-activator of transcription rather than an inhibitor.
On the other hand, repositioning a single IHF site to yield 2R3b might allow IHF
to bind with minimal consequence to acs transcription due to the direction of the
DNA bend. However, when both sites are layered, as they are within the natural
promoter, IHF may dynamically change binding positions from IHF IIIa to IHF IIIb.
Finally, the consequence of IHF binding to either site is brought forth by the
proteins that are bound downstream, and perhaps, upstream of IHF IIIa/b. It is
well documented that proteins affect DNA structure upon binding and the
aftereffect of such interactions provides the groundwork for further protein
binding (Han et al., 2009).
In future studies, we would need to address whether the dual-overlapping
IHF sites could function at other promoters similar to the acs architecture (i.e.
tandem activator sites)? How would IHF IIIa/b affect a Class II promoter or a
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complex Class II promoter? Can we find promoters in other organisms that have
opposing dual-overlapping binding sites for the same transcription factor? Are
there nucleotides outside of the consensus motifs that are critical to IHF binding
that might be mutated to more completely reduce binding to either or both sites?

This particular experiment would be useful to discern the effects of IHF choosing
to bind to either IHF IIIa or IHF IIIb through the use of oriented heterodimer
analysis. This type of analysis would provide us more control over the location of
IHF binding and better understand IHF IIIa and IHF IIIb by dictating when
occupation takes place. If we were able to isolate distinct mutations that affected
only IHF IIIa or IHF IIIb then we could use the resultant promoters to generate
IHF mutants that recognize the distinct mutants as was done by Busby and
Ebright for CRP (1994). This would allow us to introduce mutant IHF
heterodimers into single-copy phage lysogens without eliminating the native IHF
gene. We would bypass the metabolic problems seen in cells lacking this global
regulator and avoid competition for binding by the natural IHF heterodimer. Such
a study would permit us to analyze the activity of the 1xIHF promoter in a more
natural state while determining the functional properties of the individual IHF IIIa
and IHF IIIb sites. Additionally, we would like to ask: does the current location of
IHF IIIa/b in relation to the tandem CRP sites and RNAP allow it to function
optimally? Or would shifting it up- or downstream change how IHF IIIa and IHF
IIIb effect transcription? And finally, how does the swapping of IHF IIIa with IHF
IIIb affect the opposing divergent promoter, nrf? Thorough investigation of IHF
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IIIa/b is needed to understand how this unique transcription factor binding site
influences transcription and the surrounding protein binding sites at divergent
promoters, acs and nrf, under different metabolic conditions. Designing

finely

tuned future synthetic promoters may benefit from utilizing such as site for
manipulation in drug production, metabolic enhancements, etc.

Tipping the Scales of acs Promoter Regulation by IHF IIIa/b
In this thesis, I provided evidence that the upstream, contiguous IHF binding
site, IHF II, may help determine the location of IHF binding to IHF IIIa/b at a given
time. Whereas we had seen severe IHF-mediated inhibition in the context of the
1xIHF promoter, the additional presence of IHF II (in the promoter fragment
denoted 2xIHF) modestly relieved inhibition and produced gene expression
levels similar to the 1xIHF mutant constructed by Dr. Beatty (Sclavi et al., 2008).
When I extended Dr. Beatty’s mutant by adding IHF II expression levels of the
reporter gene (lacZ) soared past her mutant 1xIHF fragment and even the fulllength promoter, a construct with the highest possible expression tested to date.
We reason that the 1xIHF mutant weakens IHF binding to both IHF IIIa/b but
does not eliminate binding altogether; thus, it results in intermediate level of gene
expression. The addition of IHF II appears to have positioned an IHF heterodimer
at either IHF IIIa or IHF IIIb. Based on their locations relative to IHF II, we believe
that two IHF heterodimers would be sterically hindered at IHF II-IHF IIIa
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positions. However, it would be more feasible for two IHF proteins to bind at an

IHF II-IHF IIIb conformation. The latter scenario would not form an inhibition loop
and may position all proteins in an optimal or a better than optimal position for
transcription. Alternatively, IHF may bind to only IHF II as it would be a higher
affinity site than the mutant composite IHF III site. This scenario may actually be
more ideal because there would be one less DNA bending protein. A less
crowded acs promoter would permit CRP dimers to fully wrap promoter DNA and
extend the bend angle they impose positioning both DNA and CRP proteins in a
more optimal location relative to RNAP.
To discern between the two different scenarios, promoter fragments with
single IHF IIIa and IHF IIIb binding sites, in the context of the 2xIHF promoter,
would be tested. The single IHF site, IHF II, would be used construct the
promoters 2xIHF-2R3a and 2xIHF-2R3b to answer the questions: does IHF to
IHF II and IHF IIIa or b simultaneously? If so, what are the affects on
transcription? The proposed promoters would help determine the optimal
orientation of IHF binding to two scenarios where dual IHF sites allows two
heterodimers to bind either on the same DNA face or on opposing strands.
Additionally, the same promoter fragments could be used to determine whether
either 2xIHF-2R3a and 2xIHF-2R3b fragments have different IHF binding
affinities.

IHF II is a Positive Modulator of IHF-Mediated Inhibition

160

I next reconsidered the mechanism underlying the vast difference in the
weak activity exhibited by the 1xIHF promoter construct and that of the FL
construct. Two sequences upstream of the composite IHF IIIa/b caught my
interest: a perfect palindrome and IHF II. A construct that included the palindrome
but not IHF II (1xIHF+5) reproducibly displayed more activity than 1xIHF (Fig.
26). Since perfect palindromes are exceedingly rare, I invested a lot of effort
trying to understand this behavior. In the end, however, I had to conclude that the
palindrome did impact acs transcription – at least not under the conditions that I
tested. I therefore turned my attention to IHF II.
IHF II is contiguous with IHF III and is predicted to site on the same face of
the DNA helix as IHF IIIa. Because of their proximity, we propose that the binding
of IHF to IHF IIIa would sterically hinder the binding of IHF to IHF II and vice
versa. Under some conditions, the stronger affinity IHF IIIa would become filled at
the expense of the lower affinity IHF II. This would lead to IHF-mediated
inhibition. Under other conditions, IHF II would be occupied at the expense of
IHF IIIa. Since IHF IIIb is predicted to sit on the opposite face of the helix from
IHF II, occupancy of IHF II would permit the simultaneous occupancy of IHF IIIb.
This complex would mediate CRP-dependent activation of acs transcription. The
following observations support these proposals. (1) Using the crystallographic
data for IHF bound to H’, a model was constructed for the simultaneous binding
of two IHF heterodimers to IHF II and IHF IIIb (Fig. 29).

A similar model for
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simultaneous binding to IHF II and IHF IIIa was unsuccessful (Doug Browning,

personal communication). (2) In the phage system, the 2xIHF construct behaved
like the 1xIHF construct (Figs. 26-28). It exhibited low activity that depended on
both CRP II and AR2. In contrast, weakening IHF IIIa and strengthening IHF IIIb
relative to consensus (the I3m or C152G C150G mutation) caused a much more
dramatic increase in transcription in the context of 2xIHF than in the context of
1xIHF (Fig. 27). Thus, the balance between IHF IIIa and IHF IIIb appears to be
the fulcrum controlling transcription from the 2xIHF construct. (3) In the plasmid
system, the weakening of IHF II in the 2xIHF construct resulted in low activity
similar to that of the 1xIHF construct. In contrast, strengthening IHF II caused a
small increase in activity. (4) Also in the plasmid system, the placement of a
simple site (IHF II) into the native location of IHF IIIa resulted in poor transcription
from the 1xIHF construct, while the placement of that same simple site into the
native location of IHF IIIb resulted in strong transcription. On the basis of these
observations, we hypothesize that binding of IHF to IHF II induces the switch
from IHF IIIa to IHF IIIb and thus the transition from the stalled unproductive
complex to a transcriptionally active complex. We further propose that, at the
native acs promoter, some upstream cis element and/or trans factor helps IHF II
to dictate whether IHF will bind to IHF IIIa or IHF IIIb and thus whether acs
transcription will be inhibited or activated.
The underlying cause(s) of the difference in 2xIHF behavior when assayed
in the phage and plasmid systems remain(s) unknown. The simplest explanation
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is that the different behaviors result from some basic property of plasmids relative
to a prophage integrated into the chromosome. The two most obvious differences
are copy number and superhelicity. In the plasmid system, the copy number is

about one order of magnitude greater than in the phage system. This could result
in a titration effect that would alter the balance between the trans factors that
control acs transcription. Similarly, the superhelicity of a plasmid is likely different
than that of a phage genome that has integrated itself into the chromosome.
Such a difference in superhelicity could have definite consequences on
transcription because superhelicity influences the binding of transcription factors,
NAPs, and RNAP. By controlling copy number, one could test its role. There are
numerous ways to do this, but one of them is a temperature-sensitive expression
plasmid that permits control of its average copy number (Lin et al, 1994;
Hashimoto and Sekiguchi, 1976; Sheridan et al, 1999). We could test the role of
superhelicity in vivo by using combinations of gyrase and topoisomerase mutants
and in vitro using templates that possess different states of supercoiling. It should
be noted that the manipulation of topoismerase and gyrase activity would affect
the overall health of the cell thus making interpretation difficult.
We are left questioning whether a competition takes place between IHF
IIIa and IHF IIIb for IHF binding. Does IIIa help promote transcription whereas IIIb
exists to regulate IHF binding to IIIa? If IIIa does indeed enhance transcription,
then does this mean transcription may be unregulated in the absence of IIIb?
Does the dynamic nature of IHF III, due to the dual-overlapping sites, help
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determine when inhibition takes place in conjunction with the available
components: CRP, protein contacts via AR2, DNA bending by IHF leading the
“trapping” of RNAP at acsP2? Finally, are there fundamental differences in IHF
binding affinities between IHF II and IHF IIIa/b? Though intriguing, the answers to
these questions are beyond the scope of this dissertation.

The Dynamics of Fis- and IHF-dependent Inhibition on CRP-dependent
Activation
Previous studies have determined that the binding of CRP to CRP I and
CRP II activates transcription (REF). In contrast, two FIS binding sites, one (Fis
II) that overlaps CRP I and one (Fis III) situated between both CRP sites, inhibit
transcription by competing with the binding of the activator CRP (REF).
Interestingly, a point mutation introduced into CRP I completely disables
transcription, despite the presence of an intact CRP II. It is clear that acs
transcription depends upon CRP I and the interaction between RNAP and CRP.
Any point of regulation would begin with modulating CRP binding to CRP I, in this
case by Fis occupation of the overlapping Fis II site. Therefore, inhibition of CRPdependent activation takes place through competition when Fis occupies Fis II. In
contrast, the contribution of Fis III is currently unknown; but, based on the
influence of Fis on DNA topology (bend angles from 50 to 90°), the occupation of
both Fis I and Fis II may incur a change in promoter structure not conducive to
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CRP binding. As Fis and CRP compete for binding at their overlapping sites, the
second Fis dimer could tip the balance in favor of inhibition when active CRP

concentrations are low. This raises the question: if Fis is an effective inhibitor of
CRP-dependent transcription, why would acs regulation need IHF?
I speculate that fluctuations of intracellular concentrations of Fis and CRP,
during the course of growth and glucose depletion, will reach a point where there
are equimolar concentrations of both proteins and will result in an event where
neither protein can influence promoter activity. This would lead to RNAP binding
inducing only basal transcription. Possibly, to overcome this stalemate the
presence of IHF, specifically, when bound to IHF III, may be the key to deciding
the fate of transcription. IHF, whose concentrations are never depleted from the
cell, but increase during stationary phase, may be the protein that occupies the
acs promoter region at IHF III more often than CRP, Fis, or RNAP. When Fis
molecules outnumber active CRP dimers, IHF may remodel the promoter into a
conformation that promotes Fis-mediated inhibition - possibly when bound to IHF
IIIa - thus preventing any competition from CRP. The presence of Fis may allow
IHF to bind more stably to IHF IIIa based on the downstream distance of both Fis
sites. However, with IHF still bound, Fis molecules decrease as active CRP
dimers increase, and with the constant presence IHF, a more active competition
between Fis and CRP takes place at the overlapping Fis II/CRP I sites, perhaps
destabilizing IHF at IHF IIIa. As IHF moves back and forth from IHF IIIa and IHF
IIIb it now disfavors Fis and decreases the effect of Fis I. As the rising
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concentration of CRP outcompetes Fis, maximal transcription takes place,
perhaps with IHF now bound to IHF IIIb. However, transcription then comes to a
halt when active CRP becomes unavailable and IHF concentrations increase
thereby forming an inhibition loop preventing additional CRP dimer access and
RNAP promoter escape.

Relevance and Contribution to the Field
The morphological line that distinguishes eukaryotes from bacteria is
beginning to blur. The cellular organelles characteristic of eukaryotes might be
absent in bacteria, but much of their basic organizations are similar. For example,
it is well established that the cellular processes of eukaryotes tend to be
compartmentalized and that specialized cytoskeletal proteins provide the
scaffolds that allow these processes to take place without the cell collapsing. In
the past, compartmentalization and cytoskeletal proteins were thought to be
absent in bacteria. With the advancement of biological technology, however, the
gap between the ‘sophistication’ of eukaryotes and the ‘primitiveness’ of bacteria
has been closing rapidly. For example, early data mining of bacterial genomes
revealed no obvious homologues of eukaryotic cytoskeletal proteins. Through the
use of high resolution imaging methods and fluorescence technology, however, it
was discovered that bacteria actually do possess cytoskeletal proteins, many of
which turn out to be distantly related to eukaryotic cytoskeletal proteins.
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Furthermore, these techniques have been able to resolve subcellular structures.

Likewise, the once defining characteristics of the eukaryotic chromosome
(i.e. chromosomal multiplicity, ploidy, linearity, transcriptional silencing,
partitioning, and packaging) also have now been described for bacteria (Bendich
and Drlica, 2001). For example, it is now clear that the E. coli chromosome is a
highly compact and organized structure. Despite being compact, it is very
dynamic, undergoing massive reorganization to adjust to the environmental
conditions. Both bacterial and eukaryotic chromosomes are bound by proteins
that package these enormous structures into the relatively small confines of the
cell. However, unlike the eukaryotic chromosome, which has stationary histone
proteins to wrap and package DNA into the membrane-bound nucleus, the NAPs
associated with the bacterial chromosome do not remain stationary. Furthermore,
they perform functions above and beyond packaging. Many of these functions
are critical for survival.
Interestingly, some NAPs share sequence and/or functional homology with
eukaryotic histones. For example, HU shares amino acid homology, while H-NS
shares functional activity with histone H2B. By regulating promoter access and
DNA topology, histones and NAPs can regulate transcription (Higgins et al, 2005;
Rouviere-Yaniv et al, 1979). For example, both histones and NAPs (together with
topoisomerases) induce DNA looping. This important topological change in DNA
has consequences for genomic compaction and thus transcription regulation. In
transcription, these domains act as a barrier, confining gene expression to a
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particular gene, operon, or region. They also provide a structure more conducive
to transcription. In bacteria, these loop-domains also protect the integrity of a
functional chromosomal structure. If a nick in the DNA double strand occurs
within a negatively supercoiled loop, the rest of the chromosome is insulated

from this potentially detrimental event. In contrast, a nick in plasmid DNA relaxes
its structure, rendering it transcriptionally inactive (Postow et al, 2006).
Eukaryotic and bacterial promoters also share structural similarities, e.g.
low stability, higher curvature, and bendability (Kanhere and Bansal, 2005). The
transcriptional machinery, the RNAP holoenzyme, first must gain access to the
promoter and then bind to the appropriate sequences. Promoter activity is
dependent on cis and trans factors. The sequences of the -35 and -10 hexamers
in bacteria and the TATA and CAAT boxes in eukaryotes are identified consensus
sites for RNAP binding. The relative promoter strength correlates with the
similarity of a given promoter sequence to the consensus sequence of these
hexamers and boxes. For example, a weak promoter generally possesses poor
resemblance to consensus. At such promoters, an activator is generally needed
to stabilize the interaction of the RNAP with the promoter. In contrast, a strong
promoter generally shares much similarity with consensus. Such promoters are
often repressed by the binding of a transcription factor to a DNA site adjacent to
or overlapping the transcription initiation site (+1), the -10 hexamer or the -35
hexamer.
In addition to the basic principles of promoter recognition and binding of
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the RNAP holoenzyme, the next set of steps that lead to transcription are similar
in all organisms. For example, in all organisms, the binding of RNAP results in
closed complex formation followed by formation of an open complex around the

-10 hexamer (the TATA box in eukaryotes). The low stability of the AT-rich
sequence allows for the strand separation of the DNA duplex characteristic of
open complex formation, which permits RNAP to begin ribonucleotide
polymerization. An assessment of the region upstream of the transcription start
site reveals a propensity for DNA curvature. This curvature promotes RNAP and
transcription factor binding and thus transcription. Upon binding, RNAP, as well
as some transcription factors, wraps the DNA around itself, perhaps for a more
stable interaction. The bendability of the DNA strand also brings distant upstream
enhancer sequences with their associated proteins into close proximity to the
RNAP.
It is generally accepted that eukaryotic promoters are very complex, often
encoding many sites for the binding of a multitude of transcription and accessory
factors. In contrast, the early (and too often prevailing) view of bacterial
promoters suggested a simple mechanism of activation, where one transcription
factor (activator or inhibitor) influences RNAP function (see above). Yet, a survey
of bacterial promoters demonstrates the existence of both simple and complex
promoters. Within a complex bacterial promoter there can be many binding sites
for a variety of DNA binding proteins, as well as multiple start sites, enhancer
sequences, and regions of DNA recombination. The location of these features
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within a promoter provides the platform that determines the mechanism of
regulation.
The information gathered from the studies described in this dissertation

expands our knowledge of the complex acs promoter and bacterial gene
regulation, in general. My dissection of the complex nrf-acs intergenic region
allows us to build on the general knowledge of bacterial transcription and
contribute insight into the rules of promoter design that Nature has encoded into
DNA regulatory regions.
Not surprisingly, the multifaceted nature of NAPs is location-dependent
and is influenced by proteins bound upstream and downstream of the promoter.
For example, IHF bound to a single site located midway between an enhancer
activation sequence (UAS) 100 bp upstream and the downstream RNAP site in
the Pu promoter behaves as an activator of transcription. It does so by folding the
DNA, thereby bringing the UAS into close proximity to RNAP. Eliminating IHF
binding to this site shuts off transcription. However, replacing this IHF site with a
DNA sequence with an intrinsic bend compensates for the loss of IHF. Similarly,
IHF activates transcription at the ilv promoter, also by bending the DNA and
repositioning a UAS (Sheridan et al, 1999). Indeed, DNA remodeling by IHF is so
profound that it has the capability of inducing V(D)J recombination in !RAG Bcells.
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In contrast, IHF can also behave as an inhibitor. For example, at the ilvPG1

promoter, the IHF binding site at this promoter overlaps that of RNAP, these sites
are not located on the same face of the DNA helix. Thus, although IHF occludes
RNAP binding, it does not do so through physical occlusion. Instead, it remodels
the DNA structure, preventing RNAP from gaining access to the promoter.
In this dissertation, I provided evidence that supports the existing notion
that the location of an IHF protein binding is just as important as the affinity of
that site for IHF. What is novel is the discovery of a composite IHF site (IHF III)
comprised of two inverted and overlapping sites. This dissertation also reports
the ability of an upstream, contiguous site (IHF II) that can counteract the
inhibitory effect of IHF III, presumably by guiding IHF to bind to IHF IIIb, which
appears to function as a positive effector of acs transcription, instead of IHF IIIa,
which appears to be a negative effector. The most pressing issue is how IHF II
becomes occupied. In the context of the 2xIHF promoter construct, activation
required expression from a highly supercoiled multicopy plasmid or disruption of
IHF IIIa. The mechanism by which IHF II becomes occupied in the native acs
context requires further exploration.
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